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Introduction
Spina bifida (SB) means ‘split spine’ and is one of the most prevalent major 
birth malformations with a worldwide incidence of approximately one in 
2,000 live births [1-3]. It can result in lifelong impairment of the lower 
extremities, bowel and bladder dysfunction, sexual dysfunction and mental 
impairment. Although spina bifida is a nonlethal condition, it can be a devas-
tating disorder because of the long-term severe morbidity [4, 5]. Spina bifida 
is one of the most common birth defects involving the central nervous sys-
tem. In addition to spina bifida; anencephaly, encephalocele, and, although 
rare, craniorachischisis and iniencephaly are within the clinical spectrum of 
neural tube defects (fig. 1).
Neural tube defects (NTDs) result from abnormal development of the brain 
or spine. In spina bifida aperta; spinal cord, nerves and meninges protrude 
through a defect of the vertebral arch, muscle and skin, most commonly in 
the lumbar and sacral regions of the spine (fig. 2). Such in contrast with spina 
bifida occulta in which only a defect of one vertebral body is present, covered 
by skin, and generally without functional anomalies. A myelomeningocele 
(MMC) is the most frequent form of spina bifida, characterized by the extru-
sion of the spinal cord and/or nerves through a bony defect of the spine into 
a sac filled with cerebrospinal fluid (CSF).
Based on a prevalence of 10 per 10, 000 births, each year more than 4, 500 
pregnancies in the European Union are affected by NTDs (anencephaly, 
spina bifida or encephalocele) [6]. Worldwide, each year approximately 
300,000 newborns are born with a NTD [7]. In The Netherlands, the preva-
lence of isolated spina bifida was 4.1 per 10, 000 births in the period 2000-
2009 (Eurocat Update: Actual numbers congenital anomalies in Northern 
Netherlands 1981-2009). Spina bifida accounted for 57% of all NTDs fol-
lowed by anencephaly (33%) and encephalocele (10%). In 45% of the cases 
with spina bifida registered within the Dutch registration of Eurocat, parents 
decided to terminate pregnancy after prenatal diagnosis. This is consistent 
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with numbers from the USA however, in some areas of the Netherlands, 
this figure is considerably higher [8]. Since the introduction of the routine 
20-weeks ultrasonographic screening in The Netherlands, the number of pre-
natally detected spina bifida before 24 weeks’ gestation increased and conse-
quently also did the number of elective terminations of pregnancy because of 
spina bifida before 24 weeks’ gestation. Still, 61% of all newborns with a spina 
bifida were life born in the period 1999-2008 (Eurocat Update: Actual num-
bers congenital anomalies in Northern Netherlands 2010). Twelve percent 
ends in miscarriage or stillbirth.
Etiology
NTDs are complex multifactorial defects. Interaction with external agents, 
like environmental factors, may trigger or suppress a genetic predisposition 
[9]. Geography, race and ethnicity, nutrition, medication, maternal illness, 
socioeconomic status, family history and previous affected pregnancy are 
important epidemiologic determinants of NTDs [7, 10]. Together with long-
term trends over time, they suggest the importance of environmental and 
genetic contributions. However, the cause is not known in most cases [11]. 
North China shows a high prevalence of NTDs and within the USA a higher 
prevalence in Hispanic/non-Hispanic whites is found comparing to African-
American and Asian women [7, 12]. Prevalence is also higher with lower soci-
oeconomic status [7]. Important established risk factors with an increased 
relative risk (RR) for spina bifida includes: history of previous affected preg-
nancy with same partner (RR 30), valproic acid and carbamazepine use (RR 
10-20), pregestational maternal diabetes (RR 2-10) and inadequate maternal 
intake of folic acid (RR 2-8) [12]. Also, the risk of having a child with spina bif-
ida is increased in obese women (RR 1.5-3.5), probably attributable to hyper-
insulinaemia [12]. In the literature, girls tend to be more affected than boys 
however, this could not be confirmed in the Dutch Eurocat registration [1, 12].
 
Both multiple congenital anomalies and genetic syndromes, especially tri-
somy 13 (Patau syndrome) and 18 (Edwards syndrome) are associated with 
spina bifida. However, syndromal NTDs represent only a minor part of all 
NTD cases. In 71% of all cases no other syndromes or anomalies are found 
(Eurocat Update: Actual numbers congenital anomalies in Northern Neth-
erlands 2010) [9]. Nutritional factors are associated with NTD formation. 
Maternal deficiencies of certain micronutrients or vitamins, especially folate, 
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play an important role in the pathogenesis of NTDs [1, 10]. Studies showed 
that women, pregnant of a child with a neural tube defect, have a lower serum 
level of vitamin B12 and inadequate intake of folic acid, before and during 
early pregnancy [7, 12]. Folates can be provided by both natural and fortified 
foods, as well as by supplementation. Improving folate status by folic acid 
supplementation reduces the risk as well as the recurrence risk of having a 
child with a neural tube defect [7, 9, 10, 13]. Several studies demonstrated that 
periconceptional supplementation of folic acid may prevent up to 70% of all 
NTDs [1, 6, 9]. These results led to the introduction of a periconceptional 
folic acid supplementation policy, formulated by the government in The 
Netherlands in 1993. Also a deficiency of vitamin B12 is associated with neu-
ral tube defects and disorders in the metabolism of folate or B12 can result 
in elevated homocysteine levels [10]. Studies showed that both the fasting 
homocysteine level and the homocysteine levels before and after the intake 
of methionine (methionine-load test) are elevated in women, pregnant of 
a child with spina bifida [10]. Despite the knowledge that improving folate 
status prevents more than two thirds of all neural tube defects, the preva-
lence of neural tube defects has not declined significantly in Europe between 
1980 and 2001 [6]. The reduction in live birth NTD prevalence relies more 
on prenatal screening and termination than on primary prevention. Also in 
the Dutch Eurocat registration there was no substantial decline in prevalence 
of spina bifida [14]. Intake of folic acid is important during the periconcep-
tional period, especially the first 28 days and in unplanned pregnancies, most 
women will realize they are pregnant after this period [5]. Also, 50% of all 
women did not routinely take periconceptional folic acid even one year after 
the campaign of the government in The Netherlands [15]. Despite of the fact 
that the goal of preventing NTDs with periconceptional folic acid supple-
mentation has not been reached, public health interventions to encourage 
and increase folic acid use should be continued.
Embryology
In the embryonic period, spinal cord and brain are developed from the neural 
tube. The sequence of events that form the neural tube is called neurulation. 
In the process of primary neurulation the cellular plate is formed. Folding of 
the neural plate by invagination leads to formation of the neural folds and 
neural groove. The groove gradually deepens as the neural folds become 
elevated, and ultimately the folds meet, fuse in the midline, and convert the 
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neural groove into the neural tube. The most caudal part of the spinal cord is 
formed by secondary neurulation. The process of development and closure 
of the neural tube is completed approximately 25th days post-conception. 
From the caudal part of the neural tube the spinal cord is formed. The brain 
develops from the cranial part. Vertebral arches, muscles and surrounding 
tissues are formed by migration of mesodermal cells around the neural tube 
and form a protective barrier [5]. Neural tube defects are disorders of pri-
mary neurulation [16]. Failure of closure of the cranial neural folds leads to 
anencephaly. An abnormal primary neurulation with failure of fusion in the 
caudal regions of the neural tube leads to spina bifida. Bone and muscle are 
unable to grow over the open section of the neural tube, thus resulting in a 
defect through which the spinal cord, nerves and meninges protrude [1]. The 
neuro-epithelium develops into a plate instead of a tube and the neural plate 
develops at the level of the defect into a dysplastic and malformed myelum 
called neural plaque or placode.
Symptomatology
The severity of symptoms is correlated with the level of the defect. Interrup-
tion of the spinal cord at the site of the defect can cause lifelong paralysis 
of the legs, bowel and bladder dysfunction, sensibility disorders of the skin, 
sexual dysfunction and deformation of the lower extremities and back. Most 
children with spina bifida are not mentally retarded but their intelligence 
quotient can be reduced [8, 17]. Although spina bifida can be compatible with 
independent life, lifelong supportive care is often needed and only about 50% 
of the patients are able to live independently as adults, even with adapted 
accommodations [3-5, 17, 18]. In brief, approximately two-thirds of children 
with spina bifida may reasonably expect to ambulate the majority of the time 
[17]. Only 1% of children born with an open spina bifida are free of handicaps 
[1]. Sacral lesions caudal to the first sacral level have the best prognosis for 
independent walking. Almost all lesions cranial to the second lumbar level 
lead to wheelchair dependency and scoliosis [9]. In addition, lesions at the 
thoracal level have the worst prognosis. Through the years, sensorimotor 
deficits in the lower extremities can worsen because of deformities of the 
lower extremities, orthopedic problems of the back (kyphosis and scoliosis) 
and tethered cord syndrome (adherence of the distal spinal cord or filum to 
adjacent structures most commonly to the area of the original repair) [4, 19]. 
Also social problems, attributable to fecal and urinary incontinence and sex-
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ual dysfunction become more prominent in adolescence [2]. The majority of 
children with spina bifida have a Chiari II malformation (CM) which is a com-
bination of hindbrain herniation and hydrocephalus, found only in patients 
with spina bifida [4]. Some believe the CM is caused by the leakage of CSF 
through the neural tube defect which causes the downward displacement 
of the hindbrain and collapse of the primitive ventricular system because of 
the pressure gradient [20]. Hydrocephalus is caused by the elongation and 
obliteration of the fourth ventricle due to downward herniation of the cer-
ebellum and brainstem [21, 22]. Others believe hydrocephalus is secondary to 
maldevelopment of the CSF pathway in the posterior fossa [23]. It is hypoth-
esized that the volume of the posterior fossa in spina bifida patients is small. 
In the past, it was believed that hindbrain herniation was part of an overall 
cerebrospinal dysgenesis, but experimental and clinical evidence has shown 
that both hindbrain herniation and hydrocephalus are acquired early in fetal 
life and progress in severity before birth [24, 25]. The CM is the leading cause 
of death in patients with spina bifida [25, 26]. Seventy-five percent of deaths 
in neonates and children with spina bifida are attributable to hindbrain dys-
function [24]. Hydrocephalus is present in more than 85% of all patients and 
80-90% of children with hydrocephalus will receive a CSF shunt to prevent 
additional damage to brain and brainstem [1, 9, 21, 24, 25]. The upper level 
of the spina bifida lesion appears to be a major determinant of the need for 
shunt placement [17]. Because of complications like mechanical problems or 
central nervous system infection, shunt revision is necessary in half of the 
patients [4, 24]. Complications and shunt revision can have a negative influ-
ence on intellectual development and hydrocephalus remains one of the 
main reasons for long-term morbidity and mortality [1, 4, 26, 27]. Before the 
introduction of neurosurgical treatment and shunt placement in the sixties, 
mortality was highly attributable to hydrocephalus, meningitis and perinatal 
problems. Despite the successes of postnatal neurosurgical repair and medi-
cal treatment of spina bifida, mortality still remains approximately 10%, rising 
to 35% in those children with symptoms of brainstem dysfunction secondary 
to the CM [1, 2, 4, 7, 9, 21, 28].
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Diagnosis
Neural tube defects can be detected by ultrasound in the first and second tri-
mester of pregnancy. Besides the typical U-shaped defect of the spinal cord 
of a fetus with an open spina bifida, the CM leads to the typical lemon shape 
of the fetal skull and the banana shape of the cerebellum and in most cases 
ventriculomegaly in the second trimester [29]. In some cases, microcephaly is 
also present [29]. Club feet are present in most cases. A recent study suggests 
that in open spina bifida caudal displacement of the brain is evident from the 
first trimester, resulting in compression of the fourth ventricle and loss of 
the normal intracranial translucency [30]. Since the increasing use of rou-
tine ultrasonography screening at 20 weeks’ of gestation in The Netherlands, 
being part of routine prenatal care, prenatal detection of spina bifida before 
24 weeks’ gestation has increased [31]. Besides ultrasound, spina bifida can 
also be detected by elevated levels of alpha-fetoprotein in the amniotic fluid 
after amniocenteses. With the high detection rate of the ultrasound scan to 
diagnose spina bifida, biochemical assessment of the AF has been replaced 
by ultrasonography [30].
In the region of Nijmegen, The Netherlands, all women, prenatally diagnosed 
with a spina bifida of their child are referred to the tertiary centre of Prenatal 
Diagnosis and Therapy at the Radboud University Nijmegen Medical Cen-
tre, Nijmegen, The Netherlands. After ultrasound and accurate assessment, 
the parents are informed about the results and the prognosis by the pediatric 
neurologist and perinatologist in a multidisciplinary approach. Amniocente-
sis is offered in every case because of the elevated risk of additional chromo-
somal abnormalities. A social worker offers the parents emotional support. 
All referred patients are advised to give birth in a tertiary centre to guarantee 
optimal care of the newborn after birth and to prevent delay in further diag-
nostic evaluation and surgical closure of the defect.
Delivery
Whether delivery of an infant with a prenatally diagnosed spina bifida should 
be by elective cesarean section or by vaginal birth remains controversial. 
Some studies have suggested improved motor function with elective cesar-
ean section prior to the onset of labor or rupture of membranes but others 
could demonstrate no positive effect on the neurological outcome [32-36]. 
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Prospective randomized controlled trials, comparing routes of delivery have 
not been performed. Elective cesarean section is often offered to the parents 
to protect the spinal cord from injury because of suggested pressure on the 
neural tissue and to prevent possible rupture of the meningeal sac [3, 37]. 
However, there is no conclusive evidence that cesarean section improves the 
outcome in children with spina bifida relative to vaginal delivery. In case of 
breech presentation or large defects, it might be justified to deliver by elec-
tive cesarean section to reduce the risk of trauma [12, 35].
Treatment
The current standard of postnatal care is neurosurgical closure of the defect. 
Main goals for surgery are to untether the placode, eliminate the liquor leak, 
prevent infection, preserve neural functions by preventing further damage 
to the cord and to prevent secondary tethering of the spinal cord at the site 
of surgical repair [4]. Surgical intervention does not improve neurological 
function but prevents further deterioration. Once a child with spina bifida 
is delivered, primary closure of the defect is performed within 48-72 hours 
of birth [1, 4, 5]. Before intervention, an extensive neurological evaluation is 
performed to assess the level of the lesion and prognosis for motor ability, 
the presence of hydrocephalus, deformities of the leg and leg movement. 
Also an urological evaluation is performed. If necessary, a ventriculoperito-
neal shunt is placed to drain excess CSF from the brain into the abdomen 
where it is absorbed.
Experimental therapy and the rationale for in utero repair
The question whether the neurological disorders associated with spina bifida 
are caused by either a primary disorder of neurulation during the embryonic 
development of the spinal cord or by secondary damage to a primarily normal 
spinal cord caused by the intrauterine environment or both, has been stud-
ied and described extensively in the literature [16, 38-43]. Heffez et al. [16] 
demonstrated in a rat model with a surgically created dysraphism that expos-
ing the spinal cord to the amniotic fluid induced paralysis of the hindlimbs 
and that significant neurological deficits occur after only 48 hours of expo-
sure. Meuli et al. [38] showed in his histological study of fetuses with spina 
bifida, born after termination of pregnancy between 19-23 weeks’ gestation, 
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that there is good development of spinal cord tissue, nerve roots, and ganglia 
within the area of the defect and that the phenomenon that accounts for the 
loss of neurological function is most likely a traumatic or toxic destruction of 
neural tissue during further gestation. In a study of mice there were no signs 
of significant traumatic or degenerative changes within the exposed spinal 
cord in fetuses with spina bifida at early stages of gestation. Results at a later 
gestational age provided evidence for secondary degenerative changes which 
progress with ongoing gestation to partial or complete loss of all exposed 
neural structures by birth [44]. Leg movement has been found on sonograms 
of affected fetuses before 17 to 20 weeks, whereas later in gestation and in 
neonates, some degree of deformity and paralysis was present [45]. The 
lower limb movements noted early in gestation could be secondary to spinal 
arc reflexes. However, such movements could be of cerebral origin and their 
absence in later gestation may be attributable to neural tissue damage.
This knowledge led to the ‘two-hit’ hypothesis; failure of primary neurula-
tion in the embryonic period leads to the development of myelodysplasia 
(first-hit) and due to the absence of skin and musculoskeletal coverage, the 
persistent exposure of the openly exposed neural tissue to the intrauterine 
environment can lead to secondary acquired neural tissue damage and, con-
sequently, irreversible loss of neurological function (second-hit) [16, 46, 47]. 
It is believed that part of this acquired damage is caused by the amniotic fluid 
(AF) [9, 47]. Experiments suggest that late gestation AF might be toxic to 
the exposed neural tissue and cause chemical injury [39]. This toxicity may 
be explained by the increased concentration of urea, especially in the third 
trimester, the presence of gastrointestinal waste products, like digestive 
enzymes, and the lower osmotic pressure which results in an osmotic pres-
sure gradient between AF and neural tissue [16, 48-54]. Destruction can also 
be caused by mechanical shearing and abrasive stresses on the surface of the 
delicate neural tissue, especially in the third trimester when there is increas-
ingly less AF with a greater probability of contact injury of the exposed spinal 
cord to the amniotic wall and during delivery [55].
 
This ‘two-hit’ hypothesis is the rationale for in utero repair of a spina bifida 
implicating that the second hit can be prevented by intrauterine closure of 
the defect [46]. Prenatal coverage would stop the progressive neural tissue 
destruction and improve the neurological outcome at birth. Also, in utero 
coverage of the defect may stop the leakage of CSF and consequently have 
a positive effect on the associated cerebral anomalies like hindbrain hernia-
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tion and hydrocephalus [26]. This theoretical basis for intrauterine repair was 
first proposed by Heffez et al. [16]. Later, Meuli et al. [40, 47, 56] showed in 
a sheep model that in utero repair of an experimental spina bifida stops the 
ongoing process of spinal cord destruction and preserves neurological func-
tion. Paek et al. [21] demonstrated that prenatal repair prevents or reverses 
development of hindbrain herniation in a fetal lamb model. Although the ani-
mal model has its limitations which need to be considered when interpreting 
results, it is widely used to study the effects of intrauterine repair of spina 
bifida and for evaluating new techniques [20-22, 40, 41, 47, 56-66].
The first cases of in utero coverage of spina bifida in humans were performed 
in 1994 with an endoscopic technique [48, 67]. At that moment, the tech-
nique proved unsatisfactory and was abandoned. In 1997, the first intrauter-
ine repair of spina bifida by hysterotomy was performed [68, 69]. The results 
of these first studies suggested improvement in hindbrain herniation and a 
significant reduction in shunt-dependent hydrocephalus relative to infants 
treated postnatally [3, 9, 25, 68, 70-72]. The mechanism of reversal of hind-
brain herniation remained undefined but shunt status affects cognitive func-
tioning in later life and is therefore a surrogate marker for long-term seque-
lae. Improvements in sensorimotor function and urodynamic function were 
disappointing and similar in infants treated in utero compared to infants 
treated postnatally [12, 72, 73]. One of the potential risks of open fetal sur-
gery is premature delivery. Mean gestational age at delivery after open fetal 
surgery is approximately 32-34 weeks’ gestation [8, 59, 70, 71, 74]. Extreme 
premature delivery (< 30 weeks) was seen in 11-13% of the patients [70, 74]. 
Other complications described are; chorioamnionitis, rupture of mem-
branes, separation of the amniotic and chorionic membrane, oligohydram-
nios, placental abruption, uterine rupture, dehiscence or a very thin uterine 
wall at the hysterotomy site at the time of delivery, pulmonary edema as side 
effect of tocolytics, neurological injury of the fetus, fetal demise, respiratory 
distress syndrome in the neonate, peroperative complications like bleeding 
and transfusions, and the need for cesarean section in subsequent pregnan-
cies [69, 72, 74, 75]. There have been no maternal deaths in any fetal surgery 
series [8].
From 2003 through December 2010, intrauterine repair of spina bifida was 
almost only practiced in the three participating centers of the MOMS trial 
(Management Of Myelomeningocele Study) in the USA; the University of 
California, San Francisco, California, The Children’s Hospital of Philadelphia, 
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Pennsylvania and Vanderbilt University Medical Center in Nashville, Ten-
nessee [74,76,77]. This randomized controlled three-center trial compared 
the two approaches to the treatment of children with spina bifida; fetal sur-
gery before 26 weeks of gestation and standard postnatal repair. The trial 
was stopped for efficacy of prenatal surgery after the recruitment of 183 
of a planned 200 patients (91 fetal and 92 postnatal repairs). One primary 
objective was to determine if intrauterine repair at 19-25 weeks’ of gesta-
tion improves outcome, as measured by fetal or neonatal death or the need 
for shunting by the age of 12 months, compared to postnatal repair [55,74]. 
Another primary outcome at 30 months was a composite of the child’s men-
tal development and motor function. Prenatal surgery was done at one of the 
three MOMS centers between the 19th and 25th week of pregnancy. Open 
fetal surgery was performed under maternal general and epidural anesthesia 
providing adequate fetal anesthesia and uterine relaxation [5,8]. After hys-
terotomy the fetus was positioned with the spina bifida lesion visible through 
the uterine incision. The spina bifida closure was similar to the standard post-
natal closure. The cystic membrane of the spina bifida was carefully excised 
from the placode and the attachments of the meninges to the skin and soft 
tissues were detached. If possible, dura was closed over the spinal cord as 
a first layer. Paraspinal myofascial flaps and carefully mobilized surrounding 
skin were closed over the defect. Every attempt was made to close it prima-
rily. If not possible, due to the size of the defect, an acellular human dermis 
graft patch was used to complete the closure [8,55]. Delivery by cesarean 
section around 37 weeks’ gestation was mandatory to prevent uterine rupture 
in the stapled scar. This clinical trial demonstrated that prenatal surgery for 
spina bifida reduced the need for shunting (actual rates of shunt placement 
40% and 82% in the prenatal-surgery group and postnatal-surgery group 
respectively) and improved the composite score for mental development 
and motor function at 30 months as compared with postnatal surgery, but 
was also associated with an increased risk of preterm delivery and uterine 
dehiscence at delivery [74]. In the prenatal surgery group, fetuses were born 
at an average gestational age of 34.1 weeks compared with 37.3 weeks in the 
postnatal surgery group.
Most of the complications of fetal therapy are associated with open fetal 
surgery and although the endoscopic coverage may reduce these maternal 
risks, technically this minimally invasive approach still remains a challenge 
[5]. A pilot study for the development of a percutaneous fetoscopic approach 
was done in Germany [78]. Percutaneous fetoscopic access could be estab-
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lished with 3 ports with an external diameter of 5 mm. In order to overcome 
the disadvantages of an in-fluid operative approach, partial amniotic carbon 
dioxide insufflation was used to maintain clear visualization throughout the 
procedure. The spina bifida was covered with patch material and skin after 
dissection of the placode and resection of pathological tissues [78]. However, 
also with the endoscopic approach, preterm delivery has been a substantial 
problem, probably related to the membranous damage [79]. 
Tissue engineering
Especially with large defects, primarily, tension-free, in utero closure with 
skin is sometimes not possible and a graft or patch may be used. Also in 
early repair, fetal tissue lacks the integrity required for extensive dissec-
tion and suturing. In human studies and in animal experiments, a great vari-
ety of different materials have been used to cover the spina bifida lesion 
[20,41,59,61,65,80-83]. Most of the materials are not specifically designed for 
fetal surgery but have been widely used in other fields of medicine.
It is a challenge to develop a tissue-engineered construct, specifically tailored 
to the needs of surgical reconstruction of birth defects in the fetal period, 
particular when looking at the prerequisites of fetal surgery. Tissue engi-
neering is a fast growing interdisciplinary field that applies the principles of 
engineering and life sciences to the development of biological substitutes 
that restore, maintain, or improve tissue function [84-86]. A scaffold is a 
three-dimensional matrix, sourced from natural or biosynthetic materials, 
that serves as an artificial extracellular matrix (ECM) for cellular migration 
from the surrounding tissue, adhesion, proliferation, and tissue regenera-
tion in three dimensions. Scaffolds based on an ECM protein, like collagen, 
can be prepared with both a known architecture and defined composition 
[87,88]. Special demands are put upon scaffolds and their preparation when 
used for fetal treatment of spina bifida. The material should be pure, not toxic 
with a low antigenicity, biocompatible and biodegradable, have appropriate 
mechanical strength and a porous matrix structure to allow cell migration, 
enhance tissue ingrowth and neovascularisation, and reduce wound contrac-
tion and scar formation [89]. The material should certainly not be degraded 
by the AF and bidirectional impermeable to both AF and CSF. The scaf-
fold must be easy to handle and to apply, also in an endoscopic approach. 
The scaffold must protect the spinal cord against intrauterine chemical and 
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mechanical injury without the formation of adhesions between neural tissue 
and skin with consequently tethering of the cord.
The scaffolds we used in our experiments were developed at the Department 
of Biochemistry, University Medical Center Nijmegen, The Netherlands 
and fashioned from the natural material, type 1 collagen [88-90]. One of the 
major advantages of this scaffold is that it has predefined physico-chemical, 
biomechanical, and morphological characteristics and can be modulated in 
different ways to comply with all the requirements for use in fetal therapy 
[90-92]. For instance, cell migration can be controlled by modifying the 
matrix structure and the incorporation of glycosaminoglycans and growth 
factors. In addition, vascular ingrowth can be enhanced and consequently, 
scar formation reduced [87-89,93-95]. Angiogenesis is especially important 
to generate sufficient oxygen and nutrients supply in constructs with large 
surface area to prevent central necrosis. By stimulating tissue ingrowth and 
neovascularisation, the scaffold will ultimately be replaced by native sur-
rounding tissue.
Although tissue engineering techniques offer good prospects for use in fetal 
therapy, before commencement of clinical trials and application of tissue-
engineered constructs in the human fetus, ethical issues still need to be 
addressed [96].
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thesis ‘fetal therapy for spina bifida in a sheep model 
using tissue engineering’
The aims of the thesis were:
•  To evaluate whether acute intrauterine coverage of an experimental, sur-
gically created, neural tube defect in fetal lambs can protect neural tissue 
from secondary injury during gestation, improve histological outcome 
and save neurologic functions after birth.
•  To evaluate whether a collagen scaffold is useful for delayed in utero repair 
of a surgically created spina bifida in the fetal lamb and can protect the 
spinal cord from secondary injury.
•  To investigate whether a collagen scaffold loaded with growth factors can 
be used to treat full-thickness fetal skin defects.
•  To evaluate the effect of amniotic fluid exchange on the concentrations 
of waste products in the amniotic fluid and to assess the histological out-
come in fetal sheep with a surgically created neural tube defect.
•  To provide an overview of adaptations and refinements of the protocols 
of the fetal sheep model for congenital birth defects to reduce the use of 
laboratory animals and to improve animal welfare. 
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Abstract
Objective: Persistent exposure of the unprotected spinal cord to amniotic 
fluid and the uterine wall can lead to progressive damage of neural tissue in 
case of a myelomeningocele (‘two-hit’ hypothesis). The aim of this study was 
to evaluate whether in utero repair of an experimental neural tube defect in a 
fetal lamb could protect neural tissue from secondary injury and save neuro-
logic functions after birth. 
Methods: In 19 fetal lambs, a neural tube defect was created at 79 days’ gesta-
tion. In 12 lambs the defect was covered either with a novel, molecular defined 
collagen-based biocompatible and biodegradable matrix (UMC) or with a 
small intestinal submucosa (SIS) biomatrix (Cook®) or by closing the skin 
over the defect.
Results: All lambs with the defect covered showed no or minor neurologic 
morbidity in contrast to the lambs with the defect uncovered in which major 
neurologic morbidity was seen.
Conclusions: These results demonstrate that long-term exposure of the open 
spinal cord to the intrauterine environment can lead to damage of neural tis-
sue and, consequently loss of neurologic functions and that coverage of the 
defect can lead to a better neurologic outcome. Furthermore, we could show 
that a UMC biomatrix and an SIS biomatrix are useful for in utero coverage 
of a surgically created neural tube defect in our model.
31in utero repair of a neural tube defect using biomatrices
Introduction
Myelomeningocele is one of the most common birth defects involving the 
central nervous system. It occurs in approximately 1 of every 2,000 live births 
and can lead to neurologic injury above and below the level of the lesion such 
as hydrocephalus, hindbrain herniation, mental impairment, paraplegia, uri-
nary and fecal incontinence, sexual dysfunction and skeletal deformities.
The etiology of myelomeningocele is usually unknown and most likely mul-
tifactorial in which both genetic and environmental factors (e.g. nutrition, 
vitamin deficiencies) play a role [1,2].
The pathogenic mechanism is either a primary disorder of neurulation with 
failure of the neural plate to close or failure of mesenchymal closure at the 
caudal neuropore in the embryonic period (first-hit). Consequently, due to 
the absence of the musculoskeletal coverage, the persistent exposure of the 
unprotected spinal cord to amniotic fluid and the uterine wall can lead to 
progressive mechanical and/or chemical damage (‘two-hit’ hypothesis) [3-6]. 
This secondary injury to the exposed neural tissue could be a main factor 
causing loss of neurological function. In utero repair of a myelomeningocele 
might arrest this process of progressive neural tissue destruction and rescue 
neurologic functions at birth [7,8].
The aim of this study was to evaluate whether in utero coverage of an exper-
imental neural tube defect in a fetal lamb with a novel, molecular defined 
collagen-based biocompatible and biodegradable matrix (UMC biomatrix), 
a small intestinal submucosa (SIS) biomatrix (Cook®) or by closing the skin 
over the defect could protect neural tissue from secondary injury and save 
neurologic functions after birth.
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Materials and methods
Animals
After obtaining approval from the Ethical Committee on Animal Research, 
pregnant sheep (Dutch Texel breed) were operated in this study at 79 days’ 
gestation (full term, 140-147 days). Anesthesia for surgery was induced by an 
intravenous injection of 20-25 ml pentobarbital (60 mg/ml) and 0.5 ml atro-
pine (0.5 mg/ml) and, following endotracheal intubation, maintained with 
2% isoflurane and O2/N2O ventilation with a respiration rate of 16/min. The 
uterus was exteriorized through a midline abdominal incision under sterile 
conditions and inspected for the number of fetuses. At a favorable location 
a hysterotomy was performed and the hindlimbs and back of the fetus were 
exposed. The uterus and fetus were wrapped in a warm saline-soaked towel.
 Preparation of collagen matrices
The SIS biomatrix was obtained from COOK® Biotechnology (Blooming-
ton, Ind., USA). Biochemically defined collagen-based matrices were made 
from bovine tendon by the Department of Biochemistry, UMC Nijmegen, 
The Netherlands. This procedure was described previously in detail by Pieper 
et al. [9]. 
In short, collagen suspensions were prepared by incubation of 0.8% insolu-
ble type I collagen in 0.5 M HAc (pH 2.5) for 16 h at 4 °C. Suspensions were 
homogenized at 4 °C. The collagen suspension was de-aerated under vacuum 
to remove entrapped air bubbles. Collagen suspension was poured into poly-
styrene culture flasks, quickly frozen at  -80 °C and lyophilized, resulting in 
porous matrices with a layer thickness of 5 mm. 
Chemical cross-linking of collagen matrices was performed using 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuc-
cinimide (NHS). Collagen matrices of 50 mg dry weight were incubated for 
30 min in 20 ml of 50 mM 2-morpholinoethanesulfonic acid (MES) (pH 5.5) 
containing 40% (v/v) ethanol. Subsequently, the matrices were cross-linked 
by immersion in 19.5 of 50 mM MES (pH 5.5) containing 33 mM EDC and 6 
mM NHS, containing 40% (v/v) ethanol. After reaction for 4 h, the matri-
ces were washed twice in 0.1 M Na2HPO4 (pH 9.1) for 1 h. Finally, the matri-
ces were washed with 1 M NaCl for 2 h and with 2 M NaCl for 1 day (with 6 
changes of washing solution), followed by washing with distilled water and 
lyophilization.
Before implantation the matrices were washed in 70% (v/v) ethanol (4 x 30 
min) and sterile phosphate-buffered saline (pH 7.4) (5 x 15 min) at 20 °C.
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Surgical Procedure
The animals were divided into 5 groups. In the first group (Sham control) 3 
skin lesions, approximately 1.5 x 1.5 cm, were made, 1 on each buttock and 1 in 
the middle of the lower back (fig. 1). The lesion on the left buttock was cov-
ered with the defined collagen UMC biomatrix. On the right side, the lesion 
was covered with the SIS biomatrix. The third lesion in the middle was left 
open. 
In the other 4 groups, a neural tube defect was created surgically by excising 
skin and paraspinal muscles and soft tissue and performing a laminectomy of 
3 lumbar vertebrae (L3-5). The outward flow of cerebrospinal fluid could be 
confirmed after opening of the dura in the midline over the length of the 3 
vertebrae. The lesions measured approximately 2 x 3 cm, as shown in figure 
2. In the second group, the above-described lesion was left uncovered so that 
the neural tissue remained exposed to the amniotic fluid. In the other groups, 
the defect was immediately covered during the same operation. In the third 
group, the lesion was covered with the defined collagen UMC biomatrix. In 
the fourth group, the defect was closed by closing the skin with 6-0 monocryl 
interrupted sutures. In the fifth group, the SIS biomatrix was used to cover 
the defect. Both biomatrices were sutured to the surrounding tissue with 
eight 6-0 prolene interrupted sutures. After the surgical procedure the fetus 
was replaced in the uterus and amniotic fluid volume was restored with warm 
sterile saline. 250 mg of  amoxicilline was instilled into the amniotic fluid and 
the uterus was closed with a running suture in 2 layers using 2-0 vicryl. Natri-
um Penicillium (1,000,000 IU) was given in the intra-abdominal space and 
the maternal laparotomy was closed in layers using 1-0 vicryl. Depomycin (20 
mg/kg, s.c.) was initiated preoperatively and maintained postoperatively for 3 
days. The animals stayed for 3-5 days at the Central Animal Laboratory of the 
University of Nijmegen and were fed normally before returning to the farm.
Neonatal Outcome
At 140 days’ gestation, the lambs were delivered by cesarean section under 
local anesthesia with 20-30 ml 2% lidocaine and were observed for 1 week. A 
neurological examination was carried out between day 2 and 7 of life accord-
ing to a standardized protocol including spontaneous and elicited behavior, 
with special emphasis on motor, sensory and reflex modalities of hind- and 
forelimbs, anal sphincter and urinary bladder. Experimental and control 
lambs were videotaped and photographed to enable comparison. The find-
ings were expressed as the upper level of loss of spinal function (S5 means no 
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loss of function). Continual urine loss and urine loss on bladder expression 
were taken as criteria of incontinence. Afterwards the lambs were sacrificed 
with xylazine (10 mg given intramuscular) and pentobarbital (60 mg/kg given 
intracardiac) and macroscopic and microscopic evaluation of the lesions 
were performed by a single experienced neuropathologist. Brain and spinal 
cord were examined for the presence of hindbrain herniation or hydrocepha-
lus. Hindbrain herniation was defined as the descent of the cerebellar vermis 
and brainstem below the level of the foramen magnum.
Results
Surgery was performed in 23 fetal lambs. Survival rates are shown in table 1. 
Three lambs were aborted after fetal surgery, 1 lamb died during the cesarean 
section and 3 lambs died at the first day of life. The overall fetal survival rate 
was 87% during the pregnancy period. No maternal deaths occurred in the 
study period.
The first group was used as sham control to assess wound healing in utero 
and to evaluate the reaction of the skin and underlying tissues in the used 
biomatrices. Table 2 describes the wound healing in this group. On macro-
scopic inspection, the skin covering the biomatrices was closed in all lambs. 
Above the lesion covered with the UMC biomatrix the fleece was thin or not 
table 1. survival rates
 
Group Operated Aborted Died 
postpartum
Survived
1. Sham control 4 0 2 2
2. NTD, uncovered 7 1 1 5
3. NTD, UMC biomatrix 4 1 1 2
4. NTD, muscle / skin 3 0 0 3
5. NTD, SIS biomatrix 5 1 0 4
Total 23 3 4 16
NTD = Surgically created neural tube defect.
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present at all in 3 of the 4 lambs. The skin covering the SIS biomatrix showed 
a normal fleece pattern although the biomatrix had a tendency to shrink in 
these lambs. On microscopic examination, the biomatrices were covered 
with scar tissue and seemed to be well integrated in the subcutaneous tissue. 
They were partially broken down and there was some ingrowth of fibroblasts 
from the surrounding tissue. Histologically the SIS biomatrix and the UMC 
biomatrix were comparable.
A neural tube defect was created surgically in 19 fetal lambs. Three of them 
aborted and these could not be further evaluated. Wound healing, neuro-
logic outcome and function of the urinary bladder are described in table 3. 
Two neurologically impaired lambs produced solid stools, all others smooth 
stools. On macroscopic inspection the skin covering the defect was normally 
healed in 11 lambs. In the other 5 lambs a small or large defect was present as 
shown in figure 3; 3 of them were within the group with the neural tube defect 
uncovered (second group). All lambs with a covered neural tube defect 
(third, fourth and fifth group) showed no or minor loss of spinal function. 
Four of the five lambs with the neural tube defect uncovered (second group) 
had paraplegia and sphincter paresis. Only 1 lamb within this group showed 
no neuromorbidity. Comparing these groups, there was a statistically signifi-
cant difference in neurologic outcome between the group with the defect 
uncovered and the groups with the defect covered (p=0.017). The differences 
within the group with the neural tube defect covered (either with the bioma-
table 2. wound healing in the first group
Lamb No. Skin lesion 
uncovered
Skin lesion 
covered with 
UMC biomatrix
Skin lesion covered with 
SIS biomatrix
1 skin closed skin closed, no 
fleece
skin closed
2 skin closed skin closed skin closed
3 skin closed skin closed, no 
fleece
skin closed
4 skin closed, thin 
fleece
skin closed, thin 
fleece
skin closed, thin fleece
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table 3. wound healing, neurologic outcome and urinary  
continence in lambs with a surgically created neural tube 
defect
Group Macroscopic 
appearance of 
the defect
Level of spinal 
dysfunction
Function of 
the urinary 
bladder
NTD uncovered 1 closed L1 incontinent
2 closed C4 incontinent
3* closed X*** X***
4 small defect S5 continent
5 large defect L1 incontinent
6 large defect C4 incontinent
NTD closure 1* closed X*** X***
UMC biomatrix 2 large defect S5 continent
3 closed/no fleece S5 continent
NTD closure 1** closed X*** continent
skin 2 closed S5 continent
3 closed S5 continent
NTD closure 1 closed S5 continent
SIS biomatrix 2 closed/no fleece S5 continent
3 closed/no fleece S5 continent
4 small defect S5 continent
* Died postpartum; ** no neurological examination was carried out; *** no values.
S5 means no loss of function.
The difference in neurologic outcome between the group with the defect covered 
and the groups with the defect uncovered is statistically significant (p = 0.017).
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trices or with skin) were small. This applied for neurologic outcome as well 
as for superficial wound healing. There were no signs of hydrocephalus or 
hindbrain herniation on macroscopic inspection of the brain and spinal cord.
Discussion
The theoretical basis for in utero repair of a myelomeningocele is the ‘two-
hit’ hypothesis. A primary failure in the embryonic period leads to the devel-
opment of myelodysplasia (first-hit) and consequently, due to the absence of 
the skin and musculoskeletal coverage, the persistent exposure of the unpro-
tected spinal cord to the intrauterine environment can lead to secondary 
destruction of neural tissue (second-hit) [5,7]. In utero repair of a myelom-
eningocele may improve neurologic outcome by preventing at least part of 
the secondary damage.
This hypothesis has been further developed in several animal experiments 
in which  an experimental neural tube defect was created in early pregnancy. 
Meuli et al. [3] showed in fetal sheep that exposure of the normal and undam-
aged spinal cord to the intrauterine environment leads to pathology that has 
clinical and morphological similarities to a human meningomyelocele. Paek 
et al. [4] found in a similar fetal lamb model, that prenatal repair prevents 
or reverses development of cerebral co-morbidity, in particular of hindbrain 
herniation. Michejda et al. [8] found that in utero coverage of an experimen-
tal spina-bifida-like lesion in a primate model with allogeneic bone paste 
leads to a normal neurological condition at birth. 
In this study we could show that creation and covering of an experimental 
neural tube defect in a chronic sheep model is feasible. However, a classical 
human like dysraphic lesion, such as the myelomeningocele, could not be cre-
ated nor did we find secondary morbidity such as hydrocephalus or hindbrain 
herniation. Four of five neurologically examined lambs with the defect uncov-
ered showed major neurologic impairment while all lambs with the defect 
covered were unimpaired. The latter implies that the operation itself cannot 
be the cause of the neurologic impairment, but instead the long-term expo-
sure of the spinal cord to the intrauterine environment (second-hit) might 
be the cause, as was shown in earlier studies. However, it should be noted 
that spontaneous closure of the defect was found in 3 of the 6 lambs with the 
defect uncovered. Maybe the created defect was too small so that spontane-
ous partial healing could occur. In spite of the fact that it is unknown as to 
how long the duration of exposure to the intrauterine environment must be 
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for neurologic injury to occur, in view of the observed neurologic morbidity 
it was long enough to cause damage to the neural tissue. In a fetal rat model 
Heffez et al. [5] found signs of extensive spinal cord injury 48 h after creating 
a surgically simulated spinal dysraphism. In this study we covered the defect 
immediately after creation. To simulate the untreated period of the human 
condition, coverage of the experimental defect should be delayed. However, 
to answer the question whether biomatrices are useful in intrauterine repair 
of an experimental neural tube defect and can protect the spinal cord for fur-
ther damage, delayed coverage is not necessary.
Various techniques, such as closure of the defect with an acellular skin matrix, 
latissimus dorsi muscle flap, maternal split thickness skin graft or neurosur-
gical closure in utero with dura have been used [4,7,10-13]. In this model we 
evaluated a novel molecularly defined UMC biomatrix and compared this 
with an SIS biomatrix, a xenogenic membrane that is composed mainly of 
the submucosal layer of the intestinal wall harvested from porcine small 
intestine. These biomatrices have been used earlier, especially for urogenital 
reconstructions in animals [14,15]. In this study we used the simplest defined 
biomatrix and the results of the UMC biomatrix were comparable to the SIS. 
We evaluated fetal wound healing in utero and the reaction of the skin and 
underlying tissues to the used biomatrices and could show that they can be 
useful for in utero coverage of a surgically created neural tube defect. The 
major advantage of defined biomatrices in comparison to SIS is that they can 
be modulated in different ways, e.g. incorporation of factors to promote cell 
growth. Development of biological substitutes designed to maintain, restore 
or improve tissue function, making use of biocompatible and biodegradable 
materials can have essential advantages in the field of tissue engineering.  
In humans, intrauterine myelomeningocele repair appears to result in a sig-
nificant reduction in shunt-dependent hydrocephalus and may reduce the 
degree of hindbrain herniation, however, the effects on the sensorimotor 
functions are disappointing [16-19]. At this moment, the benefits of intrau-
terine myelomeningocele repair might not outweigh the fetal and maternal 
risks of intrauterine surgery (premature delivery, operative complications 
and rupture of the uterus) outside closely monitored experimental studies. 
To reduce risks of intrauterine repair, further research should be performed 
to improve minimal invasive surgical techniques (e.g. endoscopic) for fetal 
surgery in which tissue-engineering methods might play a role [20,21]. The 
use of biomatrices offers good prospects for the endoscopic approach.
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Abstract
Objective: The aim of the study was to determine the histological effect on 
the neural tissue of in utero covering of an experimental neural tube defect in 
fetal lambs, with the use of two different biomatrices.
Materials and Methods: In 23 fetal sheep, surgery was performed at 79 days’ 
gestation. In 19 of these, a neural tube defect was created, while 4 fetuses 
served as sham-operated controls. In 7 of the 19 operated fetuses the defect 
was left uncovered. In the remaining 12 animals the defect was covered either 
with a collagen biomatrix (4 animals), skin (3 animals) or small intestinal sub-
mucosa biomatrix (5 animals). The lambs were sacrificed at 1 week of age and 
histological examination was performed.
Results: All lambs with an uncovered neural tube defect showed histological 
damage of the spinal cord. In lambs in which the neural tube defect was cov-
ered, one half showed a normal architecture of the spinal cord while minor 
histological damage was present in the other half. Between the three groups 
in which the defect was covered, the histological outcome was comparable.
Conclusions: Acute covering of an experimental neural tube defect in fetal 
lambs prevents severe histological damage to the spinal cord independent of 
the two biomatrices used in this study.
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Introduction
Spina bifida aperta (SBA) can result in lifelong impairment of the lower 
extremities, fecal and urinary incontinence, sexual dysfunction, and men-
tal impairment. In most cases hindbrain herniation and hydrocephalus are 
present. Because of the severe morbidity, lifelong supportive care is often 
needed. SBA has a worldwide incidence of about 1 per 2,000 live births.
Due to a maldevelopment of the neural plate in the embryonic period, sec-
ondary injury to the unprotected spinal cord resulting from local trauma 
or from amniotic fluid toxicity, can lead to additional neural damage [1,2]. 
The secondary damage may be prevented or even reversed by early fetal 
intervention.
The hypothesis that in utero repair of an SBA may preserve neurological 
function has been demonstrated in animal experiments [3-7]. We previously 
reported that covering of an experimental defect can lead to a clinically better 
neurologic outcome [8]. Currently, no robust scientific evidence proves that 
fetal surgery for SBA has a benefit for the postnatal functions of legs, bladder 
and bowel of human fetuses. However, it has been suggested that intrauter-
ine SBA repair in humans may result in reduction of the degree of hindbrain 
herniation and a reduction in the need for postnatal ventricular shunting 
[9-13]. Open fetal surgery is very invasive for the mother, as it requires mater-
nal laparotomy and hysterotomy. In order to decrease the maternal trauma 
from fetal surgery, less invasive access methods have been investigated [14-
16]. Because it is difficult to close a neural tube defect endoscopically with 
the use of current techniques, the endoscopic approach demands further 
research into materials to cover the defect. New covering materials should be 
equally effective as standard neurosurgical repair and should have no adverse 
effects on the neural tissues, including tethering of the spinal cord.  
The aim of the study was to determine the histological effect on the neural 
tissue of acute in utero covering of an experimental neural tube defect in fetal 
lambs with the use of two different biomatrices and to study the incorpora-
tion of the biomatrix in the surrounding tissues. The outcome was compared 
to covering the defect with skin or leaving the defect exposed.
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Materials and Methods
Biomatrices
For the purpose of this study we used two different biomatrices; a commer-
cially available small intestinal submucosa (SIS) biomatrix obtained from 
COOK Biotechnology (Bloomington, Ind., USA) and a molecular defined 
collagen-based biocompatible and -degradable biomatrix (UMC biomatrix) 
developed by the Department of Biochemistry of the Nijmegen Centre for 
Molecular Life Sciences (Radboud University Nijmegen Medical Centre, 
The Netherlands). This matrix is made from insoluble type I collagen, iso-
lated from bovine Achilles tendon as previously described in detail [8,17]. 
Surgical procedure
A total of 23 pregnant sheep of Dutch Texel breed underwent surgery at 79 
days’ gestation (term, 140-147 days). The protocol had been approved by the 
Ethical Committee on Animal Research of the Radboud University Nijmeg-
en, The Netherlands.
The animals were premedicated with an intravenous injection of pentobar-
bital (20-25 ml; 60 mg/ml) and atropine (0.5 ml; 0.5 mg/ml) and underwent 
general endotracheal anesthesia with 2% isoflurane and O2/N2O ventilation. 
Under sterile conditions, the uterus was exteriorized through a lower midline 
laparotomy and the position of the fetal lamb was identified by palpation. A 
hysterotomy was performed and the hindlimbs and back of the fetus were 
exteriorized. The exteriorized uterine horn and fetus were wrapped in warm 
saline-soaked towels.
The animals were divided into 5 surgical groups, as represented in figure 1. 
Group 1 consisted of sham-operated controls in which 3 skin lesions of 
approximately 1.5 x 1.5 cm,  were made, one on each buttock and one in the 
middle of the lower back. The lesion on the left buttock was covered with the 
UMC biomatrix, on the right side, the lesion was covered with the SIS bioma-
trix, and the lesion in the middle was left open. 
In the other 4 groups, a neural tube defect was surgically created. The skin, 
paraspinal muscles and soft tissue were removed and a laminectomy was per-
formed at L3-L5. The dura was opened in the midline over the length of the 
3 vertebrae and the outward flow of cerebrospinal fluid was confirmed. The 
lesions measured approximately 2 x 3 cm. In group 2 the lesion was left uncov-
ered with the neural tissue exposed to the amniotic fluid. In the other three 
groups the defect was covered  immediately in the same session. In group 3, 
the lesion was covered with the UMC biomatrix, in group 4 with skin, and in 
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group 5 with the SIS biomatrix. Both biomatrices were sutured to the sur-
rounding tissue using eight 6-0 prolene interrupted sutures, while for the 
skin 6-0 monocryl interrupted sutures were used. The fetus was replaced in 
the uterus and amniotic fluid volume was restored with warm saline solution. 
Amoxicilline (250 mg) was added to the amniotic fluid. The uterus was closed 
with a running 2-0 vicryl suture in two layers. Sodium penicillin (1,000,000 
IU) was administered to the intra-abdominal space and the abdominal wall 
was closed in layers using 1-0 vicryl. Depomycine (20 mg/kg, s.c.) was initi-
Fetal lambs
n=23
Cesarean section at 140 days’ gestation, histological evaluation
* Still available for histological evaluation.
Skin lesions
n=4
Skin lesions
n=2
No repair
n=7
No repair
n=7
Fetal loss,
n=1
Neonatal loss, 
n=2*
Covering with
UMC matrix
n=4
Covering with
UMC matrix
n=4
Fetal loss,
n=1
Neonatal loss, 
n=1*
Covering
with skin
n=3
Covering
with skin
n=3
Covering with
SIS matrix
n=5
Covering with
SIS matrix
n=5
Fetal loss,
n=1
Neonatal loss, 
n=1*
 Group 1 Group 2 Group 3 Group 4 Group 5
Sham 
operated 
control n=4
Creation of neural tube defect
79 days’ gestation
n=19
fig. 1. schedule of experiments and survival
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ated preoperatively and maintained postoperatively for 3 days. The animals 
stayed for 3 - 5 days at the Central Animal Laboratory of the University of 
Nijmegen and were fed normally before they were returned to the farm.
Histology
At 140 days’ gestation, the lambs were delivered by cesarean section under 
local anesthesia with lidocaine (20-30 ml; 2%) and were observed for 1 
week. A neurological examination was carried out between day 2 and 7 of 
life according to a standardized protocol. The findings were expressed as 
the upper level of loss of spinal function (S5 means no loss of function). At 
1 week of age, the lambs were sacrificed with an intramuscular injection of 
xylazine (10 mg) followed by intracardial injection of pentobarbital (60 mg/
kg). In the sham-operated control group, histological sections of the skin and 
subcutaneous tissues were made at the level of the skin lesions. In the other 
groups the vertebral column, spinal cord and brain were excised and fixated 
in formaldehyde 4%. The skull and cervical vertebral column were opened 
and examined for the presence of hydrocephalus and hindbrain herniation, 
defined as a downward displacement through the foramen magnum of the 
cerebellar vermis and medulla. Serial cross-sections of the spinal canal and 
cord with the surrounding tissues were taken at the lumbosacral level and 
included the site of surgery. Further cross-sections of the spinal cord were 
taken at the thoracic and cervical levels. The histological slides were stained 
with hematoxylin/eosin and luxol fastblue/hematoxylin. They were studied 
by light microscopy by a single experienced neuropathologist.
Results
The fetal survival rate during the pregnancy period was 87%. Three lambs 
aborted, 1 lamb died during the cesarean section and 3 lambs died on the 1st 
day of life. The outcomes of the neurological assessment have been previously 
reported [8]. Briefly, all lambs with a covered neural tube defect showed either 
no or minor loss of spinal function, while 4 of the 5 lambs with the neural tube 
defect uncovered had paraplegia and demonstrated urinary incontinence. 
On macroscopic inspection, in all sham-operated control lambs (group 1), 
the skin covering the biomatrices was closed. In group 2 (neural tube defect 
uncovered), in 3 of the 6 lambs the skin had closed spontaneously while in the 
other three lambs a skin defect was present. In group 3 (neural tube defect 
covered with UMC biomatrix), 1 lamb showed a large defect of the skin while 
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in the other 2 lambs the skin had closed. In group 4 (neural tube defect closed 
with skin), normal wound healing had occurred. In group 5 (neural tube 
defect covered with SIS biomatrix), 1 lamb showed a small defect of the skin 
while in the other 3 lambs the skin had closed.
The major histological findings are listed in table 1. Figure 2 shows an example 
of a normal spinal cord. In group 1 (sham-operated controls), in all 4 lambs 
table 1. neurological outcome and microscopical findings in 
lambs with a surgically created neural tube defect (ntd)
Group Animal Level of spinal
dysfunction
Microscopic appearance of the 
spinal cord
Group 2 1 L1 neuronal migration disturbances
NTD 2 C4 unilateral syringomyelia and focal 
hydromyelia
uncovered 3* X hydromyelia
4 S5 syringomyelia
5 L1 meningomyelocele
6 C4 meningomyelocele
Group 3 1* X neuronal migration disturbances
NTD closure 2 S5 normal
UMC biomatrix 3 S5 normal
Group 4 1** X hydromyelia and syringomyelia
NTD closure 2 S5 normal
skin 3 S5 normal
Group 5 1 S5 neuronal migration disturbances
NTD closure 2 S5 minor defect central canal
SIS biomatrix 3 S5 normal
4 S5 minor defect central canal
* Died postpartum; ** no neurological examination was performed. X no values.
S5 means no loss of function.
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the biomatrices had been well incorporated into the surrounding tissues. 
The matrices had been partially broken down and there was some ingrowth 
of fibroblasts from the surrounding tissues. In group 2 (neural tube defect 
uncovered), all 6 lambs showed histological abnormalities of the spinal cord. 
One lamb showed neuronal migration disturbances in which a few neurons 
or groups of neurons were found in anatomically abnormal locations in the 
white matter. Three of the 6 lambs in this group showed syringo- or hydromy-
elia (fig. 3) and 2 lambs an SBA with severe damage of the exposed dorsal part 
of the cord (fig. 4,5). The spinal cord of these 2 lambs had been split and the 
dorsal horns had merged with the skin. Both lambs showed major neurologi-
cal impairment. In group 3 (neural tube defect covered with UMC biomatrix), 
1 lamb showed neuronal migration disturbances similar to that in group 2. In 
the other 2 lambs the normal architecture of the spinal cord was preserved. 
In group 4 (neural tube defect closed with skin), 1 lamb showed hydro- and 
syringomyelia. In the other 2 lambs no damage of the spinal cord was found. 
In group 5 (neural tube defect covered with SIS biomatrix), 1 lamb showed 
neuronal migration disturbances and 2 lambs showed a minor defect of the 
ependymal lining of the central canal. In 1 lamb no damage of the spinal cord 
was found. Figure 6 shows examples of incorporation of the biomatrices into 
the surrounding tissues.
In all groups, hydrocephalus or hindbrain herniation could not be found on 
pathological examination. Signs of direct trauma due to the operation itself 
or to abrasion of the neural tissue with the uterine wall or an inflammatory 
reaction were not found. In all three groups with the neural tube defect cov-
ered, ingrowth of adjacent structures into the neural tissue was not found.
Discussion
All lambs with the defect uncovered showed histological abnormalities of 
the spinal cord. Neither signs of direct trauma due to the operation itself or 
recent trauma due to contact with the uterine wall, nor signs of an inflam-
matory reaction were found. This suggest that long-term exposure of an 
unprotected spinal cord to the intrauterine environment, more specifically 
the amniotic fluid, can lead to severe damage of the spinal cord (‘two-hit’ 
hypothesis) and that acute covering of a surgically created neural tube defect 
can preserve the architecture of the spinal cord [3,5,18].
We used a novel, molecularly defined, collagen-based, biocompatible and 
biodegradable biomatrix and compared it, because of earlier experience in an 
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animal model, with an SIS biomatrix [19]. The UMC biomatrix is made from 
insoluble type I collagen and after preparation the isolated collagen is free of 
other proteins. A physical method of cross-linking has stabilized the collagen 
and prevents collapse of the matrix. In vitro evaluation has confirmed that the 
matrices do not introduce cytotoxicity [17]. The pore diameters of the bioma-
trices that were used ranged from 50 to 100 μm. It has been hypothesized 
that due to its biodegradability the biomatrix will degrade and ultimately be 
replaced by native collagen. The main advantage of the UMC biomatrix is 
that it can be modulated in various ways. The porous matrix structure can be 
altered or growth factors can be incorporated to enhance wound healing. In 
this study, the simplest defined UMC biomatrix was used. The SIS biomatrix 
is a xenogenic membrane composed mainly of the submucosal layer of the 
porcine small intestine, from which mucosa, serosa and tunica muscularis 
have mechanically been removed from the inner and outer surfaces of the 
graft. 
The resemblance in histological findings between both biomatrices is in 
accordance with a previous study [19]. Both biomatrices were incorporated 
well into the surrounding tissues and ingrowth of fibroblasts was demon-
strated. In all groups with the defect covered, the architecture of the spinal 
cord was mainly well preserved although neuronal migration disturbances 
were not found in the group in which the defect was covered by closing the 
skin. The observation of neuronal migration disturbances, as observed in 
both the uncovered and the covered group, has not been previously reported 
and remains to be elucidated. Just as relevant is our observation that covering 
of the defect with biomatrices is not accompanied by ingrowth of the spi-
nal cord by adjacent structures. As long as the spinal cord keeps free from 
its surroundings, the risk of tethered cord is smaller. However in the human 
situation, the need for postnatal repair would still be necessary because the 
rostral and caudal ends of the neural placode remain attached to surround-
ing tissues but may be postponed beyond the neonatal period. The biomatrix 
itself would not have to be removed postnatally because it is biodegradable. 
The absence of adhesions between the spinal cord and patch material lowers 
the risk of functionally relevant damage to the cord during postnatal repair. 
Follow-up was too short to exlude the formation of adhesions in the long-
term. In 3 of the 6 lambs with the defect uncovered spontaneous closure of 
the skin occurred. Possibly the created defect was too small but it could also 
be attributed to the strong healing potential of fetal tissues at this early ges-
tation. In view of the histological findings the duration of exposure to the 
intrauterine environment was long enough to cause some damage to the 
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spinal cord; neuronal migration disturbances, syringo- or hydromyelia were 
found in these 3 cases.
This animal model seems to be suitable to investigate covering materials 
and techniques for fetal SBA repair; however, it does not exactly replicate 
the human malformation. Although in 2 lambs, the created defect remained 
open, the associated anomalies such as hydrocephalus or hindbrain hernia-
tion, as reported by Paek et al. [5] and Bouchard et al. [20], did not occur. 
However, in contrast to our study, the surgically created lesion in both stud-
ies referred to included also a myelotomy. Another difference with the natu-
ral spina bifida is that the surgical defect is artificially created in midgestation 
and exists for a shorter period of time before eventual repair. To simulate the 
untreated period of a human spina bifida, repair of the experimental defect 
should be delayed. For the aim of this present study, delayed covering was 
not essential.
In conclusion, covering of an experimental neural tube defect can preserve 
the architecture of the spinal cord and consequently, intrauterine repair 
might lead to a better neurological outcome. Difference in histological out-
come between the methods used to close the defect could not be demon-
strated. 
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Abstract
Background/Purpose: The aim of the study was to evaluate whether a col-
lagen biomatrix is useful for delayed intrauterine coverage of a surgically cre-
ated spina bifida in a fetal lamb.
Methods: In 20 fetal lambs, surgery was performed at 72 or 79 days’ gestation. 
In 15 lambs a spina bifida was created surgically. In 8 lambs it was covered with 
a collagen biomatrix 2 weeks later and in 7 lambs it was left uncovered. Five 
lambs served as sham operated controls. Neurological examination was per-
formed at 1 week of age and afterwards the lambs were sacrificed for further 
histological evaluation.
Results: None of the 5 surviving lambs with the defect covered showed loss 
of spinal function and the architecture of the spinal cord was preserved in 4 
of the 5 lambs. In the uncovered group, 1 of the 4 surviving lambs had loss of 
spinal function, 5 lambs were available for histological evaluation and 4 of 
them showed disturbance of the architecture of the spinal cord.
Conclusions: Collagen biomatrices can be used for intrauterine coverage of 
an experimental spina bifida and can preserve the architecture of the spinal 
cord. Neurological outcome is not different between fetuses with their spinal 
cord covered and fetuses with uncovered cords.
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Introduction
The first in utero repair of a surgically created spina bifida-like lesion in an 
experimental animal model was done in 1984 [1]. Since then, many animal 
studies have described the intrauterine fetal repair of spina bifida aperta 
[2-9]. The theoretical basis for in utero repair of a spina bifida aperta is the 
‘two-hit’ hypothesis. Intrauterine coverage of the unprotected spinal cord 
may prevent the neural damage (second hit) to the spinal cord caused by the 
intrauterine environment. The first in utero spina bifida repair of a human 
fetus was performed in 1994 and since then more than 200 in utero spina bifi-
da closures have been done [10-12]. Various materials, for example, Alloderm, 
split or full-thickness skin graft, allogeneic bone paste or Xenoderm, have 
been used for in utero coverage of the spinal cord [1,6,7,9,13-16]. Intrauterine 
repair may result in reduction of the degree of hindbrain herniation and the 
need for postnatal ventricular shunting. Benefits for the postnatal functions 
of legs, bladder and bowel have not yet been proven [13,16-21].
The aim of this study was to evaluate to what extent a collagen biomatrix is 
useful for the delayed coverage of a surgically created spina bifida aperta in 
the fetal lamb and whether it can protect the developing spinal cord from 
secondary injury.
Materials and methods
The study was approved by the local committee for experiments on animals 
of the Radboud University Nijmegen, The Netherlands.
Biomatrices
The biomatrix used in this study was made from type I collagen, developed 
by and manufactured at the Department of Biochemistry of the Nijmegen 
Centre for Molecular Life Sciences (Radboud University Nijmegen Medical 
Centre, The Netherlands). The collagen biomatrix was isolated from bovine 
Achilles tendon as previously described [22;23].
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Surgical procedure
Twenty pregnant sheep underwent their first operation at 72 or 79 days’ ges-
tation. (Dutch Texel breed; term 140-147 days). The animals were premedi-
cated with an intravenous injection of pentobarbital (17-45 ml; 60 mg/ml) 
and atropine (1 ml; 0.5 mg/ml) and were maintained on general anesthesia 
with 2% isoflurane and O2/N2O ventilation. Fetal anesthesia was achieved by 
transplacental passage of the medications, administered to the mother. After 
a low midline laparotomy under sterile conditions, one horn of the uterus was 
partially mobilized out of the abdominal cavity. The number and position of 
the fetal lambs was determined by palpation. For fetal surgery, the back and 
the hindlimbs of the fetus were exposed through a uterine incision and the 
fetus and uterus were wrapped in a warm saline-soaked towel.
The animals were divided into 3 groups. In group 1 and 2, an experimental 
surgical spina bifida aperta was created in the fetal lamb by excision of the 
skin (approximately 3 cm in diameter), paraspinal muscles and soft tissue and 
performing a laminectomy of 3 lumbar vertebrae (L3-5). After opening of the 
dura in the midline over the length of the 3 vertebrae, the outward flow of liq-
uor was confirmed in each case. In both groups, the lesions were left uncov-
ered. Four 5-0 prolene interrupted sutures were placed to mark the defect. 
Group 3 served as sham-operated controls. Two skin lesions, approximately 
1.5 x 1.5 cm, one on each buttock, were made. The lesion on the right side 
was covered with the biomatrix which was secured into place using four 5-0 
prolene interrupted sutures. The lesion on the left side was left uncovered. 
To mark the defect, four 5-0 prolene interrupted sutures were placed around 
each skin lesion. After surgery the fetus was returned to the uterus. Amniotic 
fluid volume was restored with warm sterile saline solution and amoxicillin 
(250 mg) was added to the amniotic fluid. After closing the uterus with a run-
ning suture in 2 layers using 2-0 vicryl, the uterus was replaced to its normal 
position and the maternal abdominal wall and skin were closed using 1-0 vic-
ryl. Natrium penicillium (1,000,000 IU) was administered intra-abdominally 
and depomycin (20 mg/kg, subcutaneously) was initiated preoperatively and 
maintained postoperatively for 3 days. Fetal viability was assessed by ultra-
sound postoperatively. The animals were returned to the farm after 3-5 days 
at the Central Animal Laboratory of the University of Nijmegen.
The second operation was performed 2 weeks later, at 86 or 93 days’ gesta-
tion. Under general anesthesia a laparotomy was performed as described 
above. In group 1, the surgically created spina bifida was covered with the 
defined collagen biomatrix. One horn of the uterus was exteriorized and the 
fetus was manually located through the uterine wall. A hysterotomy was per-
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formed and the spina bifida was exposed. The defect was covered with the 
collagen biomatrix, sutured to the skin using eight 5-0 prolene interrupted 
sutures. The fetus was returned to the uterus and amniotic fluid volume was 
restored with warm saline solution. The uterus, abdominal wall and skin were 
closed and antibiotics were given as described above. In groups 2 and 3, only 
an endoscopy without surgical intervention was performed to ascertain 
wound healing. After positioning of the fetal lamb, a 2-0 vicryl purse-string 
suture was inserted, which incorporated both the uterine wall and amniotic 
membranes. A 2-cm incision was made in the uterine wall and the amniotic 
cavity was opened. A 10-mm balloon cannula (Tyco, The Netherlands) was 
introduced into the amniotic cavity. The balloon was inflated and the can-
nula was secured inside the cavity by tying the purse-string suture to prevent 
leakage of amniotic fluid or carbon dioxide. Carbon dioxide was insufflated 
at a rate adjusted to maintain the ambient intrauterine pressure. The excess 
of amniotic fluid was sucked up through the cannula and collected in a ster-
ile bag. A standard 10-mm laparoscope (Karl Storz) was introduced, and the 
spina bifida or skin lesions were inspected. After fetal inspection, the laparo-
scope and cannula were removed and the opening was closed with the purse-
string suture and a 2-0 vicryl running suture in 2 layers. Prior to closure, the 
collected amniotic fluid was replaced and the total volume was restored with 
warm sterile saline solution. The uterus was replaced to its normal position 
and both the abdominal wall and skin were closed using 1-0 vicryl. Antibiot-
ics were given as described above. Fetal viability was assessed by ultrasound 
postoperatively. The animals were returned to the farm after 3-5 days at the 
Central Animal Laboratory.
Postpartum Evaluation
Cesarean delivery was performed under local anesthesia with 20-30 ml 2% 
lidocaine at 140 days’ gestation. The lambs were observed for 1 week and 
a neurological examination was carried out on day 7 or 8 with the use of a 
standardized protocol including spontaneous and elicited behavior, with spe-
cial emphasis on motor, sensory and reflex modalities of hind- and forelimbs, 
anal sphincter and urinary bladder. Afterwards, the lambs were sacrificed by 
an intramuscular injection of 10 mg xylazine followed by intracardial injec-
tion of 60 mg/kg pentobarbital. In groups 1 and 2, the skull and cervical verte-
bral column were opened and examined for the presence of hydrocephalus 
or hindbrain herniation. The vertebral column, spinal cord and brain were 
excised and fixated in 4% formaldehyde. Cross-sections of the spinal canal 
and cord with the surrounding tissues were taken at the lumbosacral level, 
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including the site of surgery. In group 3, histological sections of the skin and 
subcutaneous tissues were taken from the surgically created skin defects. The 
slides were stained with hematoxylin/eosin and luxol fastblue/hematoxylin. 
Immunohistochemical staining was performed on paraffin-embedded skin. 
Sections of 4 μm were incubated with a rabbit polyclonal antibody directed 
against human collagen I (Monosan, Uden, The Netherlands). As second 
antibody we used a biotinylated antibody, followed by incubation with an avi-
din-biotin peroxidase complex (Vector, Burlingame, Calif., USA). Detection 
was carried out with the use of AEC as substrate (Scytek, Utah, USA). They 
were studied by light microscopy by a single experienced neuropathologist.
Results
Twenty fetal lambs underwent surgery. Overall, 3 lambs died after the first 
operation, 4 lambs died after the second operation and 1 lamb died in the 
neonatal period. The overall fetal survival rate was 65%. Procedures and out-
comes for each group are summarized in figure 1. The neurological and histo-
logical results are listed in table 1.
In group 1 (spina bifida covered with collagen biomatrix), surgery was per-
formed in 8 fetal lambs. Two lambs died after the first operation. In both 
procedures, a hemorrhage of the paraspinal soft tissue of the fetal lamb had 
occurred. One lamb died after the second procedure, 6 days prior to the 
cesarean section. All second operations were uneventful. Five lambs survived 
and were available for further evaluation. The skin was closed in 4 of the 5 
lambs. In 3 lambs, remnants of the biomatrix were still present above the skin. 
In one of these lambs a small defect was present; this lamb showed no loss 
of spinal function but abnormalities of the spinal cord were found on histo-
logical examination. The architecture of the spinal cord was disturbed and 
complex syringomyelia was found. Glial fibers grew from the spinal cord into 
the dermal scar. The other 4 lambs showed no loss of spinal function and the 
architecture of the spinal cord was preserved. Syringomyelia was found in 1 
lamb and locally, scar tissue merged with the dura and very locally, with arach-
noidea. In 1 lamb hydromyelia and a purulent inflammation originating in scar 
tissue and growing in subdural fat was found. Locally, the inflammation grew 
into the dura. Locally in 2 lambs, the scar tissue intermingled with the dura. In 
1 lamb, minimal damage of the dorsal horn on one level was found. In lambs, 
with the biomatrix covered with skin, the biomatrix was largely replaced by 
native collagen and ingrowth of fibroblasts from the surrounding tissues was 
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found. Small remnants of the biomatrix were found on histological examina-
tion (fig. 2). At the level of the spinal cord in this picture, dural and epipial lay-
ers are intact. However at a higher level, iron-holding macrophages are found 
in the dura and the dura itself shows signs of thickening and scarring.
In group 2 (spina bifida uncovered), surgery was performed in 7 lambs. Three 
operations were complicated by the occurrence of a minor hemorrhage of 
* Still available for histological evaluation.
All groups
Cesarean section at 140 days’ gestation
Neurological and histological evaluation
Fetal lambs
n=20
Group 1
Creation of 
spina bifida aperta
72-79 days’ gestation 
n=8
Group 1
Covering with
biomatrix
86-93 days’ gestation 
Group 1
Covering with
biomatrix
survival = 5
Fetal loss n=2
Fetal loss n=1
Group 3
Sham operated control
72-79 days’ gestation 
n=5
Group 3
Endoscopic
observation
86-93 days’ gestation 
Group 3
Skin lesions
survival = 3
Fetal loss n=1
Fetal loss n=1
Group 2
Creation of 
spina bifida aperta
72-79 days’ gestation 
n=7
Group 2
Endoscopic
observation
86-93 days’ gestation 
Group 2
No repair
survival = 4
Fetal loss n=0
Neonatal loss n=1*
Fetal loss n=2
fig. 1. schedule of experiments and survival
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the paraspinal soft tissue of the fetal lamb while creating the defect. All lambs 
survived the first operation and 2 lambs died after the second operation. In 
one of these lambs it was difficult to visualize the lesion at endoscopy. One 
lamb died on the 5th day of life and a neurological examination could not 
be performed but incontinence of urine, indicating impaired neurological 
function, was found during the observation period. Histological evaluation 
was performed in all 5 live-born lambs. The skin was closed in all 4 surviv-
ing lambs. In the lamb, that died postnatally, the skin was not closed and a 
small cele (1.7 x 1.2 cm) was present. Within this group, 1 lamb showed loss of 
spinal function. On histological evaluation, all 5 lambs showed abnormalities 
of the spinal cord. In 3 lambs the spinal cord had separated (fig. 3), one lamb 
showed syringomyelia and 1 lamb asymmetry of the spinal cord. In groups 1 
and 2 there were no signs of hydrocephalus or hindbrain herniation.
In group 3 (sham-operated controls), surgery was performed in 5 fetal lambs. 
One lamb died after the first operation and was found dead at endoscopy. 
In one case, we experienced difficulty performing endoscopy because of the 
poor visibility. The lamb died after the second operation and was stillborn 
at the cesarean section. Histology was not performed in these 2 lambs. In 
the remaining 3 lambs, the operations were uneventful. The uncovered skin 
lesion on the left side of the back was found closed in all 3 surviving lambs. 
The covered skin lesion on the right side of the back was also found closed 
in 1 lamb (fig. 4) while in the other 2 lambs a small defect of the skin was still 
present. In one of these lambs, remnants of the biomatrix were still visible 
within the defect. In 1 lamb an inclusion cyst was found on both sides. The 
cyst on the right side (covered skin lesion) was accompanied with some acute 
infection and on the left side (uncovered skin lesion) with a deep infiltrating 
fibrotic inflammation.
Discussion
Seven lambs died during the pregnancy period. In 2 of them, a severe hem-
orrhage of the paraspinal soft tissue of the fetal lamb occurred while creat-
ing the defect, which may explain the death of these lambs. Because of the 
small amount of total circulating blood volume at this gestational age, every 
severe hemorrhage can be fatal. The same applies for the subcutaneous hem-
orrhages, which can be easily caused by frequent manipulations of the fetus. 
This may be the explanation why 2 lambs died after a difficult endoscopic 
procedure.
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In a previous study, we demonstrated that biomatrices are useful for experi-
mental fetal surgery and, in accordance with other animal studies, acute intra-
uterine covering of an experimental spina bifida aperta can lead to a better 
neurological outcome [23,24]. For a better simulation of the natural course 
of a spina bifida aperta, in utero repair of the experimental defect in this study 
was delayed for 2 weeks. This study confirmed that covering of an experimen-
tal spina bifida aperta preserves the architecture of the spinal cord. A major 
difference in neurological outcome between the 2 groups could not be dem-
onstrated because also the lambs with the defect uncovered did not demon-
strate major neurological complications despite the severely disturbed archi-
tecture of the spinal cord. In all 4 surviving lambs of the uncovered group 
the skin was found closed at birth, so one may speculate that the length of 
exposure of the spinal cord to the amniotic fluid may have been too short to 
cause loss of spinal function despite being long enough to cause histological 
disturbances. Despite the large size of 3 cm of the created defect, spontane-
ous closure of the skin occurs, which can be attributed to the known excellent 
healing potential of fetal tissues at this gestational age. It emphasizes that the 
neurological impairment in the case of a spina bifida aperta is not only caused 
by the secondary damage of the intrauterine environment to the spinal cord.
In the group with the spina bifida covered, 2 weeks of exposure of the unpro-
tected spinal cord to the amniotic fluid did not seem to cause serious damage 
to the spinal cord. This could be due to the short period of exposure of 2 
weeks or to the early gestational age in which the amniotic fluid may not yet 
be toxic enough to cause damage [25]. A 2-weeks exposure of the spinal cord 
to the intrauterine environment is clearly not enough to mimic the severity 
of spinal cord damage in human spina bifida aperta. One lamb of this group 
showed disturbance of the architecture of the spinal cord, which could pos-
sibly be ascribed to the small defect in the skin that was still present at birth.
When fibroblasts are bound to an extracellular matrix, such as the collagen 
biomatrix, the production of new collagen is enhanced. In the process of 
wound healing, the skin covers the biomatrix. The biomatrix is incorporated 
in the subcutaneous tissues and degraded by the fibroblast-produced col-
lagenases and replaced by native collagen [26]. This biodegradability of the 
collagen biomatrix makes it potentially useful for experimental fetal surgery, 
especially in these cases where primary closure with skin can be difficult. If 
the biomatrix was replaced by native tissue, it would not have to be removed 
after birth. Postnatal repair would still be necessary but may be postponed 
beyond the neonatal period. For use in human fetal repair, the biodegrad-
ability of the biomatrix can be changed by alteration of the strength of cross-
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linking, the amount of collagen in the suspension or the pore diameter of the 
matrix.
Endoscopy in this study was performed to gain experience with the proce-
dure in this model and to study whether intrauterine endoscopic coverage 
of a spina bifida aperta is possible. For this reason, a 10-mm laparoscope was 
used instead of a smaller instrument. From the difficulties that we encoun-
tered, we observed that the sheep model is not suitable to study the endo-
scopic coverage of a spina bifida aperta.
In conclusion, a collagen biomatrix can be used for in utero coverage of a 
surgically created spina bifida aperta. When a surgically created spina bifi-
da aperta is covered with a biomatrix, the architecture of the spinal cord is 
preserved.  When this defect is left uncovered, the architecture is disturbed. 
However, coverage of the defect did not result in a major improvement in 
the neurological outcome as neurological outcome was surprisingly good 
despite major disturbance of the spinal cord architecture.
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Abstract
In spina bifida the neural tube fails to close during the embryonic period and 
it is thought that prolonged exposure of the unprotected spinal cord to the 
amniotic fluid during pregnancy causes additional neural damage. Intrauter-
ine repair might protect the neural tissue from exposure to amniotic fluid and 
might reduce additional neural damage. Biodegradable collagen scaffolds 
may be useful in case of fetal therapy for spina bifida, but biochemical prop-
erties need to be studied. The aim of this study was to investigate whether 
biodegradable collagen scaffolds can be used to treat full-thickness fetal skin 
defects. We hypothesized that the pro-angiogenic growth factors VEGF and 
FGF2 would enhance vascularization, epidermialization and lead to improved 
wound healing. To investigate the effect of these two growth factors, a fetal 
sheep model for skin defects was used. Compared to wounds treated with 
bare collagen scaffolds, wounds treated with growth factor-loaded scaf-
folds showed excessive formation of capillaries and less myofibroblasts were 
present in these wounds, leading to less contraction. This study has demon-
strated that collagen scaffolds can be used to treat fetal skin defects and that 
the combination of collagen scaffolds with VEGF and FGF2 had a beneficial 
effect on wound healing.
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Introduction
There are different congenital structural anomalies in which closure of skin 
and underlying structures does not occur during embryonic development. 
In spina bifida (incidence rate 1 of every 2,000 live births) the neural tube 
fails to close during the embryonic period and it is thought that exposure 
of the neural tube to the amniotic fluid during pregnancy causes additional 
neural damage (‘two-hit’ hypothesis) [1]. Current treatment of spina bifida 
consists of surgical closure of the defect in the early postnatal period, in order 
to prevent infection and further damage. However, the damage caused by the 
exposure to the amniotic fluid is irreversible. 
It is expected that intrauterine repair of the defect diminishes the damage 
caused by exposure to amniotic fluid. An additional advantage of such a fetal 
intervention is that fetal tissue can regenerate, instead of repair with fibrosis 
[2]. During the first and second trimester of development, fetal skin wounds 
heal with a normal epidermal and dermal architecture. During the third tri-
mester a transition from scarless repair to fibrotic repair occurs, which is 
comparable to adult wound healing with more inflammation and fibrosis [2]. 
However, the ability of the fetus to heal full-thickness wounds without fibro-
sis depends on the size of the defect, independent of the gestational age [3].
The aim of this study was to investigate whether biodegradable collagen scaf-
folds can be used to treat full-thickness fetal skin defects to allow in situ fetal 
dermal repair and epidermal overgrowth. For this purpose we developed a 
fetal skin defect model in sheep, and treated the defects with a cross-linked 
type I collagen scaffold (which was previously applied in a rat model and 
sheep model [4-7]). Collagen scaffolds can be modulated in different ways 
to enhance and regulate wound healing. The porous matrix structure can be 
varied and growth factors can be incorporated to promote angiogenesis and 
cellular ingrowth. In this study we used a collagen scaffold and a collagen scaf-
fold loaded with heparin and two growth factors: vascular endothelial growth 
factor (VEGF) and basic fibroblast growth factor (FGF2). Heparin was used 
for optimal growth factor binding. VEGF is a 40-45-kDa homodimeric glyco-
protein promoting angiogenesis [8]. FGF2 can also act as angiogenic factor 
68 chapter 5
by directing endothelial cell migration and proliferation. The combination of 
VEGF and FGF2 has been reported to have potent synergistic effects on neo-
vascularization both in in vitro and in vivo experiments [9-12]. Furthermore, 
FGF2 reduces scar formation when exogenously applied to the wound site 
[13] and diminishes wound contraction, when used in combination with a col-
lagen matrix [14]. FGF2 can also act as a potent mitogen for fibroblasts and 
keratinocytes [15,16], indicating an effect on both dermal as well as epidermal 
healing. With the stimulation of vascular ingrowth and cellular infiltration, 
regeneration of tissue can be improved by supplying sufficient oxygen and 
nutrients. By regulating the host response to the scaffold in this way, forma-
tion of excess scar formation may be prevented.
We evaluated fetal wound healing and closure of full-thickness skin wounds 
by means of intrauterine tissue engineering using type I collagen scaffolds 
(COL) and heparinised type I collagen scaffolds loaded with VEGF and FGF2 
(COL-HEP/VF), and compared these with untreated defects 2, 4 and 8 weeks 
after fetal surgery. Cellular ingrowth, vascularization, scar tissue formation 
and degradation of the scaffolds were evaluated by histology and immuno-
histochemistry.
Materials and methods
The study has been approved by the local Ethics Committee on Animal 
Research of the Radboud University Nijmegen, the Netherlands (RU-DEC 
2007-239).
Preparation of collagen scaffolds
Type I collagen was purified from bovine Achilles tendon as described previ-
ously [17,18]. To prepare collagen scaffolds, a 0.67% (w/v) type I collagen sus-
pension in 0.25 M acetic acid was shaken overnight at 4°C and homogenized 
on ice using a Potter-Elvehjem homogenizer (Louwers Glass and Ceramic 
Technologies, Hapert, The Netherlands). Air bubbles were removed by cen-
trifugation at 100g for 15 min at 4°C. The suspension was then poured into 
6-well plates (4 ml per well), frozen at -20°C, and lyophilized. Scaffolds were 
pre-incubated with 50 mM 2-morpholinoethane sulfonic acid (MES) pH 
5.0 containing 40% ethanol for 30 min at 22°C. After removal of this solu-
tion, scaffolds were cross-linked using 33 mM 1-ethyl-3-(3-dimethyl amino-
propyl) carbodiimide (EDC) and 6 mM N-hydroxysuccinimide (NHS) in 
50 mM MES pH 5.0 containing 40% ethanol for 4 h at 22°C in the presence 
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or absence of 0.25% heparin (Diosynth, Oss, The Netherlands). Scaffolds 
were then washed, frozen and lyophilized. Scaffolds were disinfected in 70% 
ethanol (6 x 7 ml per well) followed by washings with sterile PBS (8 x 7 ml 
per well). The cross-linked type I collagen scaffold is abbreviated in the text 
as COL.
The growth factors vascular endothelial growth factor 165 (VEGF; human 
recombinant, R&D Systems, Minneapolis, MN, USA) and basic fibroblast 
growth factor 2 (FGF2; human recombinant, R&D Systems) were loaded 
onto the heparin-crosslinked collagen scaffolds by incubating six Ø 12 mm 
scaffolds in 5 ml PBS containing 3.5 μg/ml VEGF and 3.5 μg/ml FGF2, fol-
lowed by 3 washings with the same volume of PBS. This scaffold is abbrevi-
ated in the text as COL-HEP/VF.
Analysis of collagen scaffolds
The ultrastructure of the scaffolds was visualized by scanning electron 
microscopy (SEM). Specimens were mounted on stubs, sputtered with an 
ultrathin layer of gold in a Polaron E5100 coating system and visualized with a 
JEOL JSM-6310 SEM apparatus operating at 15 kV. The degree of cross-linking 
of the scaffolds was determined spectrophotometrically by determining the 
amine group content using 2,4,6-trinitrobenzene sulfonic acid. Cross-linking 
efficiency was expressed as the percentage of the total number of amine 
groups that were used in the crosslinking process [19,20]. 
The heparin content of the films was determined applying a hexosamine 
assay using p-dimethylamino-benzaldehyde, taking heparin as a standard 
[21,22].
The amount of growth factors bound to the scaffolds was determined with 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) on 
a 15% (w/v) gel, followed by silver staining using a 0.1% (w/v) AgNO3 solu-
tion. COL-HEP scaffolds incubated with growth factors and a standard curve 
of 0-100 ng of either VEGF of FGF2 were incubated for 15 min in a boiling 
water bath under reducing conditions using 5% (v/v) 2-mercaptoethanol. 
The intensity of the bands was analyzed using Adobe Photoshop. 
The location of growth factors in the scaffolds was visualized by immunohis-
tochemistry using the ABC method [23] with antibodies HS4C3 [24], goat 
anti-human VEGF (Sigma Chemical Co., St Louis, MO, USA) and rabbit anti-
bovine FGF2 (R&D Systems, Minneapolis, MN, USA).
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Animals and surgical procedures
Nine pregnant ewes of Dutch Texel breed underwent surgery at 79 days’ ges-
tation (term, 140-147 days). For sedation, the animals were pre-medicated 
with an intramuscular injection of midazolam (0.5 mg/kg). Anesthesia for 
surgery was induced by an intravenous injection of propofol (5 mg/kg) fol-
lowed by tracheal intubation. The ewes were maintained on general anesthe-
sia with 1.5% isoflurane. For analgesia, flunixin (2 mg/kg) and sufentanil (4 μg/
kg) were given intravenously followed by a maintenance dosage sufentanil 
of 2 μg/kg/h. Heart rate, temperature, oxygen saturation and carbon diox-
ide concentration of the expired air were monitored. Fetal anesthesia was 
achieved by transplacental passage of the medications, administered to the 
ewe. The abdomen was shaved, cleaned and aseptically prepared. After a low 
midline laparotomy under sterile conditions, the uterus was inspected for 
the number of fetuses. One uterus horn was exteriorized, wrapped in gauzes 
soaked with warm phosphate buffered saline (PBS), and the position of the 
fetal lamb was determined by palpation. At a favorable location over the cau-
dal side of the fetus a hysterotomy was made.
Three circular skin lesions, 12 mm in diameter, were made on the back of 
the fetus by excising the skin. The lesion on the left side was covered with 
a collagen scaffold (COL). The lesion on the right side was covered with the 
collagen-heparin scaffold with VEGF and FGF2 (COL-HEP/VF). The applied 
scaffolds were slightly thicker than the removed skin. The lesion in the mid-
dle of the back remained uncovered. The scaffolds were secured and marked 
with four 6-0 prolene (Ethicon, Somerville, NJ, USA) interrupted sutures 
around the skin lesion. After surgery the fetus was replaced in the uterus and 
the amniotic fluid volume was restored with warm PBS solution. Amoxicillin 
(250 mg) was added to the amniotic fluid. The uterus was closed with a run-
ning suture in 2 layers using 2-0 vicryl (Ethicon, Somerville, NJ, USA). In case 
of twin pregnancy the same procedure was performed using the techniques 
as described above. Sodium penicillin (1,000,000 IU) was administered to 
the intra-abdominal space and the abdominal wall was closed in 3 layers using 
EP6 Serafil for the fascia, 2-0 Vicryl for the subcutaneous tissue and 1-0 Vicryl 
Plus for the skin. Depomycin (20,000 IU penicillin ml-1, 200 mg streptomy-
cin ml-1) was initiated preoperatively (0.6 ml/10 kg) and maintained postop-
eratively (1 ml/10 kg) for 3 days via intramuscular injections. Buprenorphine 
(10 μg/kg, intravenous) and flunixin (2 mg/kg, intramuscular) were given for 
three days to provide postoperative analgesia. The ewes returned to the farm 
soon after they were able to stand.
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Macroscopic evaluation
The animals were sacrificed at three time points. Evaluation took place at 93 
days’ gestation (2 weeks post surgery), 107 days’ gestation (4 weeks post sur-
gery) and 140 days’ gestation (term) in group 1, 2 and 3 respectively. Ewes and 
fetal lambs were euthanized by 10 ml intravenously and 5 ml intracardiacally 
injected T61® (200 mg embutramide ml-1, 50 mg mebezoniumjodide ml-1 and 
5 mg tetracainhydrochloride ml-1; Intervet, Boxmeer, The Netherlands).
After macroscopic evaluation and photography of the wound, the size of the 
defect was measured between the marking sutures and was used to calculate 
wound contraction. Wound contraction was expressed as the percentage of 
the size of the defect at time of evaluation against the original size of the 
defect of 12 mm at time of surgery. All data are represented as mean ± stand-
ard error of the mean. The data were analyzed using computer statistical soft-
ware (GraphPad Prism, GraphPad Software Inc.). The statistic significance of 
differences in the findings was evaluated by a one-way ANOVA followed by 
post hoc Bonferroni analysis. A difference was considered statistically signifi-
cant when P < 0.05.
Histological techniques
Samples of the skin and subcutaneous tissue were taken at the level of the 
skin lesions, fixed in 4% (v/v) buffered formaldehyde and paraffin-embedded 
for histological analysis or snap-frozen and stored at -80°C. Serial cross sec-
tions were cut (4 μm) and stained with haematoxylin and eosin, toluidine 
blue and Masson’s trichrome. Additionally, immunohistochemical stainings 
for α-smooth muscle actin (α-SMA), pancytokeratin and type IV collagen 
were performed on paraffin-embedded sections. The sections were depar-
affinized and washed with PBS. Endogenous peroxidases were blocked with 
3% (v/v) H2O2/PBS for 30 min at room temperature. Heat mediated antigen 
retrieval in Sodium Citrate Buffer (10 mM Sodium Citrate, pH 6.0) during 
10 minutes was performed for sections stained for α-SMA and cytokeratin. 
Sections stained with anti-type IV collagen were treated with 0.1% (v/v) pro-
tease (Sigma-Aldrich, St. Louis, MO, USA) for 30 min at room temperature 
for antigen retrieval. Slides were pre-incubated with 5% serum from the spe-
cies that produced the secondary antibody. 
α-SMA was detected with mouse α-SMA (1:15.000, clone 1A4; Sigma-
Aldrich) and peroxidase-conjugated goat-anti-mouse antibody (1:200; SBA, 
Birmingham, USA, cat.no.1080-05). Immunostaining of cytokeratin was 
performed by overnight incubation at 4°C of mouse anti-cytokeratin (1:800, 
clone AE1/AE3; Labvision corporation, Fremont, USA), followed by bioti-
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nylated horse-anti-mouse and peroxidase conjugated ABC complex (Vector 
Laboratories, Burlingame, USA). Type IV collagen was detected using rabbit 
anti-type IV collagen (1:100; Abcam, Cambridge, UK), biotinylated goat-anti-
rabbit (Dako) and peroxidase conjugated streptavidine (Dako). Color devel-
opment was performed with power DAB (α-SMA and cytokeratin, Immu-
nologic, Duiven, The Netherlands,) and 3-amino-9-ethylcarbazole (type IV 
collagen, Sigma, Steinheim, Germany). Sections were counterstained with 
Mayer’s haematoxylin (Fluka Chemie, Buchs, Switzerland).
Results
 Scaffolds
Scanning electron microscopy revealed a porous scaffold with a rather open 
top side and a more closed pan side (Fig. 1A). Crosslinking efficiency was 31 
± 8% for COL scaffolds and 31 ± 4% for heparinised COL scaffolds (mean 
± SD). To heparinised COL scaffolds, 13.1 ± 2.4% heparin was bound (mean 
± SD). Heparin was bound evenly throughout the scaffold. The amount of 
growth factors bound per mg heparinised COL scaffold was 0.26 ± 0.05 
μg for VEGF and 0.10 ± 0.04 μg (mean ± SD) for FGF2. FGF2 was present 
throughout the scaffold whereas VEGF was mainly present at the edges of 
the scaffold (Fig. 1B).
Animal surgery
Eight ewes and 13 fetal lambs underwent surgery (6 ewes were bearing twins). 
The overall fetal survival rate was 85% during the pregnancy period. In one 
sheep, twin pregnancy could not be determined at time of surgery and only 
one fetus was operated. One sheep aborted 2 days after the surgery prob-
ably due to severe enteritis of the ewe and needed to be sacrificed accounting 
for the only maternal death in the study. At autopsy, herniation of a bowel 
loop between the fascial sutures was found. In one sheep, a thermal intestinal 
lesion occurred during the surgery which was repaired. All other procedures 
were uneventful. Eleven lambs were evaluated; four in group 1 (93 days), three 
in group 2 (107 days) and four in group 3 (140 days). The survival rate was 
similar to previously published data for fetal surgery on similarly aged fetal 
lambs [5-7].
Macroscopic evaluation
A macroscopic overview with examples of wound healing is depicted in Fig. 
2A. On macroscopic inspection, the skin defects were visible in all groups. 
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The untreated defects were completely closed at 8 weeks post surgery, with 
the wound edges contracted to each other. COL treated wounds showed 
remnants of the scaffold at 2 and 4 weeks post surgery, at term (8 weeks post 
surgery) the wound was completely closed without visible remnants of the 
scaffold. A reddish appearance of the remnants of the COL-HEP/VF treated 
wounds was present at 2 weeks, suggesting angiogenesis. In contrast to COL 
treated wounds, COL-HEP/VF treated wounds showed remnants of the scaf-
fold at term. 
The percentage of wound contraction of the treated and untreated defects 
is shown in Fig. 2B. At 2 weeks, the percentage of wound contraction of the 
COL treated defects was decreased and this was more obvious when using a 
COL-HEP/VF scaffold. At 4 and 8 weeks, contraction was also found in the 
COL treated defects but again the contraction of the COL-HEP/VF scaffold 
was less (~30%). At term, the degree of wound contraction of the uncovered 
group was almost 80%.
Microscopic evaluation
Two weeks after surgery (93 days’ gestation), the untreated wounds were cov-
ered by a fibrin clot. The newly formed epidermis fully closed the wound area 
and separated the granulation tissue from the clot; the epidermal cells had 
migrated over the interface between the clot and the developing granulation 
tissue. The newly formed epidermis was, at this time point, less than twice 
as thick as the normal epidermis distal from the wound area (Fig. 3A); the 
overall thickness was very regular (Fig. 4A). The granulation tissue consisted 
of a more open extracellular matrix (ECM) network compared to the normal 
dermis and was populated by numerous cells (Fig. 3A2). The latter appeared 
to be mainly myofibroblasts as based on their morphology and confirmed by 
α-SMA staining (Fig. 5A). Compared to the normal fetal dermis in develop-
ment, less mature blood vessels and capillaries were present in the wounded 
area (Fig. 3A). 
The wounds treated with the COL scaffold showed a fibrin clot covering the 
top of the scaffold (not shown). Interestingly, the epidermis grew from both 
sides through the upper part of the scaffold, but did not completely close 
at this time point. The thickness and shape of the newly formed epidermis 
was rather irregular (Fig. 3B, 4B) and was generally thicker than the epider-
mis of the untreated wound (i.e. the wound without a scaffold). New ECM 
formation occurred at the interface between the scaffold and the epidermis 
(Fig. 3B1), whereas less ECM formation was observed at the dermal side of 
the scaffold (Fig. 3B2). Infiltration of cells, mainly α-SMA positive (Fig. 5B), 
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was seen in the scaffold. In the scaffold only a few small blood vessels were 
formed (Fig. 3B). 
The wounds treated with the COL-HEP/VF scaffold also showed a fibrinous 
clot on top of the scaffold. Here again, the epidermis grew from both sides 
through the upper part of the scaffold. However, the newly formed epidermis 
was much more hyperplastic (Fig. 3C versus B; Fig. 4C versus B) with a high-
ly irregular shape. The wound area was also not completely covered by the 
epidermis. Less ECM formation was seen at the interface between the scaf-
fold and the epidermis compared to the wound treated with the bare COL 
implant (Fig. 3C1 versus B1; Fig. 3C2 versus B2) and fewer α-SMA-positive 
cells infiltrated into the scaffold (Fig. 5C versus B). A few small blood vessels 
were present in the scaffold (Fig. 3C), which was comparable to the amount 
in the COL treated wound at this time point.
Four weeks after surgery (107 days’ gestation), the clot of the untreated 
wounds was not longer present and the thickness of the newly formed epider-
mis was completely normalized (Figs. 3D and 4D). A more dense ECM net-
work was formed. A general decrease in cell number was seen (Fig. 3D1 and 
D2 versus A2); myofibroblasts were only sporadically seen (Fig. 5D). At this 
time point more small as well as mature blood vessels were observed at the 
dermal side of the newly formed tissue (Fig. 3D2) compared to two weeks, 
however less blood vessels than in the normal fetal dermis.
In the wounds treated with COL, the clot was still present (Fig. 3E). The thick-
ness of the newly formed epidermal layer was not normalized (Fig. 4E), but 
the wound area was completely covered by the epidermis at this time point. 
Single cells were present between the collagen bundles of the entire scaffold 
(Fig. 3E2) and numbers of α-SMA-positive cells were even decreased com-
pared to the earlier time point (Fig. 5E versus B). Most importantly, a newly 
formed ECM layer was present between the epidermis (Fig. 3E and E1) and 
the scaffold which was devoid of myofibroblasts (Fig. 5E) and in which several 
blood vessels were formed, comparable to the appearance of the normal der-
mis. Only a few mature blood vessels were formed in the scaffold as revealed 
by a collagen IV staining (Fig. 6A).  
In the wounds treated with COL-HEP/VF the clot was also still present. The 
newly formed epidermis was still hypertrophic with an irregular shape (Fig. 
4F). ECM formation was mostly observed at the epidermal side of the scaf-
fold (Fig. 3F1) and contained a decreased amount of myofibroblasts (Fig. 5F) 
compared to the earlier time point. In the scaffold further distal of the epi-
dermis hardly any ECM formation was seen (Fig. 3F2). Compared to the bare 
COL implant, less cells, mainly α-SMA-negative (Fig. 5F), were present in 
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the scaffold (Fig. 3F2 versus E2), but a similar amount of blood vessels was 
present in the scaffold (Fig. 6B versus Fig. 6A). 
Eight weeks after surgery (140 days’ gestation), the untreated wound had 
completely lost its clot. The granulation tissue was entirely replaced by ECM 
and had a density comparable with the normal dermis (Fig. 3G). There were 
no skin appendages in the newly formed tissue (Fig. 4G) and myofibroblasts 
were absent (Fig. 5G). A comparable amount of mature blood vessels was 
present in this newly formed ECM (Fig. 3G) when compared to the normal 
fetal dermis. 
In the wounds treated with COL, the clot was also lost, whereas still parts of 
the epidermis were thickened (Fig. 3H). Interestingly, the entire scaffold was 
degraded and replaced by ECM (Fig. 3H). A decreased amount of myofibrob-
lasts was seen compared to four weeks (Fig. 5E versus H).  A higher amount of 
blood vessels was present throughout the newly formed ECM layer (Fig. 3H1, 
H2 and 6C) compared to the normal dermis.
In contrast, in the wounds treated with COL-HEP/VF part of the clot was 
still present. The thickness of the epidermal layer had decreased (Fig. 3I and 
4I), but was still thicker than the newly formed epidermis of the untreated 
and the COL treated wound. Remarkably, some of the skin appendages of 
the epidermis were formed in the newly formed ECM (Fig. 3I1 and 4I). This 
ECM layer was not as dense as the newly formed ECM in the untreated and 
the COL treated wound. In contrast to the latter, a considerable part of the 
scaffold was still present (Fig. 3I). Although it still concerned low numbers, 
a higher influx of cells was seen in the scaffold at this time point compared 
to four weeks after treatment (Fig. 3I2 versus F2). The amount of myofibrob-
lasts was decreased compared to the four week time point (Fig. 5I versus F). 
Besides mature blood vessels, many capillaries were formed in the scaffold 
(Fig. 6D and DI).  
Discussion
Fetal tissue engineering has been proposed as a new concept in the surgi-
cal reconstruction of birth defects in the fetal period [25]. However, despite 
being a promising concept, hardly any studies have been published to tackle 
the various steps needed to establish a proof-of-concept. In this study we 
investigated whether biodegradable scaffolds with or without growth fac-
tors can be used to treat full-thickness fetal skin defects which facilitate epi-
dermal overgrowth and dermal repair. We studied the healing of these skin 
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defects by use of a bare collagen type I (COL) scaffold, a heparinised COL 
scaffold loaded with VEGF and FGF2 (COL-HEP/VF), or left untreated (no 
scaffold). We hypothesized that the pro-angiogenic growth factors VEGF 
and FGF2 might enhance vascularization and epithelialization, leading to 
improved wound healing.
The study showed that at term (8 weeks post surgery) proper epidermal layers 
were formed in all defects. Less wound contraction occurred in COL treated 
defects compared to untreated defects. Even less contraction was present in 
defects treated with COL-HEP/VF, but in contrast to COL treated defects, 
degradation of the scaffold was not completed at term. Concerning degrada-
tion of the scaffold, hardly or no macrophages infiltrated the COL and COL-
HEP/VF scaffolds, suggesting that these cells did not play a role in fetal tissue 
engineering. Similar amounts or even less blood vessels were formed in the 
defects compared to the developing fetal dermis, with exception of COL-
HEP/VF treated defects at term, showing excessive formation of capillaries in 
the scaffold. Overall, myofibroblasts were involved in the remodeling of the 
tissue, i.e. ECM formation and wound contraction. 
It is highly important that wound contraction and scar formation will be 
minimized after fetal skin defects, as the fetus grows rapidly. Therefore we 
investigated the formation of ECM and the amount of contraction in time. 
Previously, a fetal sheep model has shown that the transition period from 
scarless to healing with scar formation in sheep occurs between 100-120 days 
[3]. However, fetal skin repair is not only dependant on gestational age, but 
also on the size of the defect. Wounds in mid-gestation fetal lambs of 2-4 mm 
heal without scarring, whereas wounds of 6-10 mm heal with formation of a 
scar [3]. In our study, wounds of 12 mm were made at 79 days of gestation. It 
was expected that the untreated wounds would heal with scar formation due 
to the size of the wound. Indeed, all untreated defects showed healing with 
scar formation and contraction. However, clearly less wound contraction was 
observed with COL treatment. Myofibroblasts have contractile characteris-
tics in an attempt to close the wound. Another function of myofibroblasts is 
the production of new ECM components. A comparable amount of myofi-
broblasts was seen at two weeks post surgery in untreated and COL treated 
wounds. At 4 and 8 weeks myofibroblasts were still present in COL treated 
wounds, resulting in a larger area of newly deposited ECM. As hypothesized, 
treatment of the skin defect with COL-HEP/VF diminished contraction even 
more. In accordance with this, fewer myofibroblasts were present. This is 
probably due to the incorporation of FGF2, because in vitro and in vivo stud-
ies have shown that FGF2 can inhibit and reverse the differentiation of fibrob-
lasts to myofibroblasts [13,14,26,27]. 
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Implantation of a biomaterial, like our degradable type I collagen scaffold, 
will induce an inflammatory response by the non-specific immune system, 
known as the foreign body reaction (FBR). In general the FBR will induce 
resorption of degradable scaffolds after implantation. Key players in the adult 
FBR are macrophages and giant cells. However, little is known about the FBR 
in fetal applications. It is known that in fetal wound healing less inflammation 
is induced compared to adult wound healing, which can be due to the fact 
that the innate immune system is less mature in the fetus. In the current fetal 
lamb model hardly any or no macrophages were detected in any of the histo-
logical specimens, and most of the cells were myofibroblasts. We wanted to 
confirm the scarcity of macrophages by a macrophage staining, but antibod-
ies against sheep macrophages are not available. Several other macrophage 
antibodies have been tested to see if these cross-react, but none of these anti-
bodies were successful. In accordance with the absence of macrophages, also 
giant cells (fused macrophages) were not present in the fetal skin wounds. 
This is a major difference with the adult situation in which implanted bio-
degradable scaffolds are finally phagocytosed by giant cells. In the current 
fetal model, COL and COL-HEP/VF scaffolds did degrade but as mentioned 
giant cells were not involved, suggesting that the scaffolds were degraded by 
enzymes secreted by (myo)fibroblasts. 
In fetal tissue engineering it is important that a good balance exists between 
the degradation of the scaffold and new tissue formation, i.e. epithelial 
overgrowth and proper dermal regeneration. We observed a faster tissue 
remodeling in the COL treated wounds compared to COL-HEP/VF treated 
defects. At four weeks in COL treated wounds, part of the collagen scaffold 
was degraded and replaced by an ECM layer that integrated with the origi-
nal dermis. At eight weeks, the entire scaffold was degraded and replaced by 
new ECM. In contrast, in the COL-HEP/VF treated wounds, a large part of the 
scaffold was still present at 8 weeks post surgery, demonstrating that remod-
eling is still in progress. These differences between COL and COL-HEP/VF 
implicate that fetal TE can be influenced by growth factors leading to differ-
ent degradation patterns.
Another major difference between COL and COL-HEP/VF treated defects 
was the hyperplasia of the epidermis observed at 2 and 4 weeks post surgery 
in COL-HEP/VF treated wounds. This could be caused by FGF2 as well as 
VEGF. It is known that FGF2 can have a mitogenic effect on keratinocytes, 
thereby promoting epithelialization in adult wound healing [15,16]. VEGF 
can also stimulate the proliferation and migration of keratinocytes in vitro 
[28]. Furthermore, application of VEGF in a diabetic wound healing model 
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showed accelerated wound healing with enhanced epithelialization [29]. 
However, finally at 8 weeks a proper epidermal layer has been formed. Fur-
thermore, enhanced angiogenesis was observed in the COL-HEP/VF treated 
wounds. Both VEGF and FGF2 can promote angiogenesis and the combina-
tion of VEGF and FGF2 has been shown to have synergistic effects on neovas-
cularization both in vitro and in vivo [9-12]. Although excessive formation of 
capillaries was observed in these scaffolds 8 weeks post surgery, we do not 
know whether these capillaries are functional, because erythrocytes were 
not observed in these capillaries.  
A highly interesting observation is the formation of new appendages in the 
wounded area of the COL-HEP/VF treated wounds 8 weeks after surgery. 
Regeneration of these specialized structures indicates an enhanced function-
al healing. These newly formed appendages were less mature (smaller com-
pared to appendages in the normal skin at this time of development) than the 
appendages in the unwounded skin, indicating that the appendages have not 
migrated from the wound edges. 
For optimal binding of growth factors to the scaffold, the scaffolds were 
heparinised. We have to realize that directly after implantation the scaffold is 
in contact with the amniotic fluid. It is known that several growth factors are 
present in the amniotic fluid, like hepatocyte growth factor (HGF), insulin-
like growth factor (IGF), FGF2, and VEGF. We can not exclude that, in addi-
tion to the loaded growth factors, also growth factors from the wound site 
or from the amniotic fluid bound to the heparin in COL-HEP/VF, leading to a 
long-term effect of these growth factors.
For future tissue engineering approaches of congenital defects such as spina 
bifida, scaffolds could be useful for wound closure. In utero coverage of the 
defect with a scaffold will shorten the exposure time of the spinal cord to the 
amniotic fluid, which will likely improve the neurologic outcome by prevent-
ing further damage. However, future studies will be needed to investigate if 
the addition of growth factors is beneficial in the case of spina bifida. 
Conclusion
The evaluation of biomaterials for specific applications should be evaluated 
in model systems resembling the clinical situation. This study showed that 
tissue engineering in utero is a promising method in treatment of full thick-
ness fetal skin defects. Both COL and COL-HEP/VF treated wounds showed a 
proper re-epithelialization and healing without a (chronic) FBR. COL treated 
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wounds show less contraction than untreated wounds and this effect was 
even enhanced in COL-HEP-VF. Furthermore, the addition of these growth 
factors leads to an increased angiogenesis and to regeneration of the skin 
appendages. 
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Abstract
Introduction: In myelomeningocele, prolonged exposure of the unprotected 
spinal cord to harmful substances in the amniotic fluid (AF) has deleterious 
effects on the neural tissue. The aim of the study was to evaluate the effect 
of amniotic fluid exchange (AFE) on neural tissue damage in fetal sheep with 
a surgically created neural tube defect and to measure the concentrations of 
urinary and gastrointestinal waste products in the AF before and after the 
procedure.
Material and Methods: At 79 days’ gestation, an experimental neural tube 
defect was created in 11 fetal lambs. In 6 sheep, only samples of the AF were 
collected at a regular interval for assay of waste products. In 5 sheep, AFE 
was performed at regular intervals and samples of AF were collected and ana-
lyzed.
Results: After 1 week almost all concentrations returned to baseline concen-
trations prior to AFE and no difference in histological outcome was found 
between the two groups.
Discussion: Urinary and gastrointestinal waste product concentrations return 
to normal within 1 week after AFE. AFE with a frequency of 1 week does not 
reduce neural tissue damage in fetal lambs with surgically created spina bifi-
da aperta and is not useful for removal of waste products.
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Introduction
Prolonged exposure to amniotic fluid (AF) has been reported to have a dele-
terious effect on tissues that normally do not come into contact with AF, e.g. 
in congenital anomalies in which closure of skin and underlying structures 
does not occur during embryologic development (e.g. myelomeningocele, 
gastroschisis and bladder exstrophy) [1-7]. In myelomeningocele, experimen-
tal studies have shown that, the absence of the dermal-musculoskeletal cover 
results in persistent exposure of the unprotected neural tissue to AF which 
may lead to progressive chemical damage. In utero repair of a myelomenin-
gocele might protect the neural tissue from exposure to AF and arrest the 
process of progressive neural tissue destruction [8-14].
In myelomeningocele, urinary waste products, in particular, urea have been 
associated with neurotoxic effects on the exposed neural tissue [15-17]. How-
ever, experimental evidence suggests gastrointestinal waste products in the 
AF rather than urinary waste products may be responsible for the neural 
damage [18].
AF exchange (AFE) is performed by partial withdrawal of AF, followed by 
replacement with an equal amount of warm sterile physiologic saline solution 
to reduce and dilute deleterious waste products.
The aim of the study was to evaluate the effects of AFE on the concentrations 
of waste products in the AF compartment before and after the exchange pro-
cedure and to assess any reduction in histological neural tissue damage.
Material and methods
The study was approved by the Ethical Committee on Animal Research of 
the Radboud University Nijmegen, The Netherlands (CDL 27018/19).
Eleven sheep of Dutch Texel breed underwent surgery at 79 days’ gestation 
(term, 140-147 days). After induction of general anesthesia with an intrave-
nous administration of pentobarbital (20-25 ml; 60 mg/ml) and atropine (1 ml; 
0.5 mg/ml), the ewes underwent tracheal intubation and were maintained on 
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general anesthesia with 1.5-2% isoflurane in a mixture of oxygen and nitrous 
oxide. Heart rate, oxygen saturation and concentration in the inspired air and 
carbon dioxide concentration in expired air were monitored. Fetal anesthesia 
was achieved by transplacental passage of the medications administered to 
the ewe. The procedure took place under sterile conditions. The abdominal 
cavity was opened by low midline laparotomy and one horn of the uterus was 
exteriorized. The position of the fetal lamb was determined by palpation and 
a hysterotomy was performed over the caudal side of the fetus. After open-
ing of the uterus, AF was collected in a sterile syringe and the hindlimbs and 
back of the fetus were exteriorized. Uterus and fetal lamb were wrapped in 
warm saline-soaked gauzes. An experimental neural tube defect (NTD) was 
created in the fetal lamb by excision of the skin (diameter 3 cm), paraspinal 
muscles and soft tissue. Laminectomy was performed of 3 lumbar vertebrae 
(L3-5). The dura was opened in the midline and the outward flow of liquor was 
confirmed (fig. 1). The lesion was left uncovered and the fetus was replaced 
into the uterus. The AF volume was restored with warm saline solution and 
amoxicillin (250 mg) was added to the AF. Two catheters (diameter 3 mm) 
were left in the amniotic cavity and fixed to the uterine wall with an interrupt-
ed 2-0 vicryl suture (Ethicon, Somerville, NJ, USA). The uterus was closed 
with a running 2-0 vicryl suture in 2 layers and replaced to its normal position. 
Both catheters were exteriorized to the lateral abdominal side of the ewe 
through the abdominal cavity and were lead to the outside through a small 
opening in the skin. They were fixed to the skin using interrupted 2-0 vicryl 
sutures and stored in a pouch attached to the flank of the ewe. In the last 
two sheep (one in each group) a subcutaneous port-a-cath system (Deltec, 
Inc., St.Paul, USA) was used instead of catheters for sampling and exchange. 
Sodium penicillin (1,000,000 IU) was administered to the intra-abdominal 
cavity and the abdominal wall was closed in 2 layers using 1-0 vicryl. Depomy-
cine (20 mg/kg, s.c.) was initiated preoperatively and maintained postopera-
tively for 5 days. Fetal viability was assessed by ultrasound postoperatively. 
The animals stayed for a few days at the laboratory and were fed normally 
before they were returned to the farm.
The animals were divided into two groups. In group 1 (n=6), samples (10 ml) of 
the AF were collected at a regular interval of 1-3 days (n=3) or 7 days (n=3) for 
biochemical analysis of urea, creatinine, amylase, alkaline phosphatase, gam-
ma-glutamyltransferase (GGT) and bile acids. AF was placed on ice immedi-
ately after collection and then stored at -80°C until analysis. In group 2 (n=5), 
AFE was performed at regular intervals of 2 days (n=1) or 7 days (n=4) until 
the moment of birth. A maximum of 400 ml AF was aspirated and replaced 
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with warm sterile physiologic saline solution (0.9%). Before and after the 
procedure, samples of the AF were collected at regular intervals, placed on 
ice and stored at -80°C until analysis. At the end of each procedure, amoxicil-
lin was instilled into the catheter in both groups to prevent infection. With 
each sample, AF was also collected for microbiological analysis. If necessary, 
other antibiotics were given depending on the microbiological outcome. 
Cesarean section was performed at 140 days’ gestation under local anesthesia 
with lidocaine (20-30 ml; 2%). The lambs were examined macroscopically at 
birth. The defect was left uncovered. After one week the lambs were sacri-
ficed by intramuscular injection of xylazine (10 mg) followed by intracardial 
injection of xentobarbital (60 mg/kg). Tissue samples of the spinal cord and 
column and surrounding tissues were taken at the lumbosacral level includ-
ing the site of surgery, fixated in 4% (v/v) formaldehyde in 10 mM phosphate 
buffer (pH 7.2) for at least 24 h at 4°C and embedded in paraffin. Consecutive 
5 μm sections were mounted onto glass slides, dewaxed in xylol and rehy-
drated through a graded series of ethanol. Haematoxylin and Eosin (HE), HE-
Luxol fast blue and Elastin Van Gieson (EVG) stainings were employed to 
histologically evaluate each sample with conventional light microscopy by an 
experienced neuropathologist for changes in the architecture of the spinal 
cord.
Results
Successful experiments in both groups with evaluable data were achieved 
in 5 of 11 animals. The other 6 animals were lost to follow up due to intrau-
terine infection and consequently abortion. The fetal survival rate was 45%. 
No maternal deaths occurred in both groups. In most cases the microbio-
logical cultures of the aborted lambs (n=7) were positive for Streptococcus, 
Staphylococcus, Escherichia coli or Candida. In 2 ewes a port-a-cath system 
was used instead of catheters because of the high infection rate. Six of the 11 
surgical procedures were uneventful. In 5 cases a small hemorrhage of the 
paraspinal soft tissue occurred, but adequate hemostasis could be achieved.
In group 1 (n=6), 3 sheep aborted (postoperative day 18,21 and 35 respectively) 
and 1 sheep delivered spontaneously at 138 days’ gestation. In one sheep the 
catheters were damaged during transport to the farm and sampling could not 
take place. Sampling was performed in 5 of 6 lambs. In 3 of 6 lambs histologi-
cal evaluation was performed.
In group 2 (n=5), 4 sheep aborted (postoperative day 19, 21, 24 and 51 respec-
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tively). In one sheep the catheters were damaged during transport to the 
farm. The volume of AF that could be exchanged varied between 100 and 
400 ml. In the 2 lambs with the port-a-cath system, only infusion with saline 
was performed after 2 exchange procedures because no AF could be with-
drawn from the amniotic cavity. Sampling was performed in 4 of 5 lambs. 
Histological evaluation was performed in 2 of 5 lambs.
The major macroscopic and histological findings are listed in table 1. In sum-
mary, all 5 lambs showed major histological abnormalities of the spinal cord 
at the lumbar level. No differences were seen between both groups. Figure 
2 shows an example of the abnormal architecture of the spinal cord in both 
groups besides a normal spinal cord at different lumbar levels.
Biochemical constituents in the AF of one sheep of group 2, before and after 
AFE are presented in figure 3. AFE was performed at 4 time points with 350, 
300, 180 and 120 ml warm sterile physiologic saline solution (0.9%) respec-
tively. The first exchange was performed 3 days after surgery. Measurements, 
1h after exchange show a sharp decrease in concentrations of both urinary 
and gastrointestinal waste products. After the second and third AFE, it is vis-
ible that the concentration of waste products returns to their level before 
exchange within 2-3 days.
Table 2 represents the mean change of concentration of biochemical constit-
uents in the AF at 93 days’ gestation expressed as a percentage of the starting 
point at 86 days’ gestation. Concentrations at 86 and 93 days’ gestation were 
available in 4 of 6 sheeps in group 1 and 2 of 5 sheeps in group 2. These results 
demonstrate that after 1 week almost all concentrations reached their level 
of concentration before AFE. Urea and amylase reached a mean concentra-
tion of 77 and 67 percent respectively of the starting point concentration at 
86 days’ gestation. From the data from individual animals we know that urea 
sometimes reached a level of 93 percent of the starting point concentration 1 
day after AFE and this can also be seen in figure 3.
Discussion
Amniotic Fluid Exchange is performed by partial withdrawal of AF followed 
by replacement with an equal amount of physiologic saline solution. It is sup-
posed to act by reducing concentrations of deleterious waste products in the 
AF. Olguner et al. [19] showed in a study on chick embryos that neural tis-
sue damage can be prevented by AFE. Correia-Pinto et al. [18] demonstrated 
that exposure of a surgically created meningomyelocele in fetal rats to meco-
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nium leads to severe functional impairment and that necrosis of neural ele-
ments was increased in those animals that were exposed to diluted human 
meconium in the AF. Urea may have cytodestructive or neurotoxic effects on 
exposed neural tissue but these results support the hypothesis that besides 
urinary waste products, intestinal waste products may be held responsible 
for the neural tissue damage in spina bifida aperta [17]. This is also supported 
by the study of Danzer et al. [20] which demonstrated that meconium pas-
sage appears to occur early in fetal life in case of a myelomeningocele. Nor-
mally a sharp decrease of digestive enzymes in the amniotic fluid is found 
after 18 weeks due to maturation of the anal sphincter and accumulation of 
meconium in the cecum but this may be impaired in some cases with mye-
lomeningocele due to anal incontinence and defective anal innervation lead-
ing to continuous in utero defecation, meconium leakage and abnormally 
high concentrations of digestive enzymes in the amniotic fluid [21].
In different animal models on gastroschisis, AFE proved to be effective in 
terms of reducing intestinal damage, however a substantially beneficial effect 
in human studies has not yet been clearly demonstrated [5,22-24]. Only two 
small human studies demonstrated a positive result of amniotic fluid infusion 
and AFE in the clinical outcome of children born with gastroschisis but in 
some of these cases oligohydramnios was also present [25,26]. There is no 
consensus on the volume and frequency of exchange. The frequency varied 
between 1 to 3 weeks and the volume between 50 and 500 ml.
This is the first study in which the effect of AFE on neural tissue damage is 
examined in a larger animal model. Overall we experienced a low survival rate 
of 45%. Comparing to other studies with survival rates between 65 and 87%, 
we must conclude that the abortion rate was higher than expected [11,13]. 
This may be explained by the high infection rate. Despite the use of antibiot-
ics during the AFE, the presence of the catheters made the procedure vulner-
able for infections. For this reason, the protocol was changed and in the last 
two sheep a port-a-cath system was used. A port-a-cath system is implanted 
subcutaneously where it can be maintained in a comfortable and sterile con-
dition for use in clinical human conditions but also in long term projects in 
laboratory animals [27]. Because there is no chronic exit site wound, infec-
tion risks are considerably lower than with external catheters. In this study 
we demonstrated that a port-a-cath system can also be used for sampling AF 
and to administer medications in the amniotic cavity. It turned out to be less 
suitable for AFE.
No difference in both macroscopical and histological outcome could be 
observed between the two groups. In both groups the architecture of the 
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spinal cord was disturbed. Concerning the results of the waste products in 
AF after AFE and the interval of 1 week between the exchanges, the lack of 
histological difference is not surprising. Most of the concentrations were nor-
malized after one week or even earlier and this is well illustrated in figure 3. 
As the study groups are very small, no hard conclusions can be drawn from 
this results.
Concentrations of urea and amylase reached a mean concentration of 77 and 
67 percent respectively of the starting point concentration at 86 days after 1 
week. However, threshold levels of intraamniotic concentrations of possible 
harmful substances to cause neuronal damage are not known.
In the study on chick embryos of Olguner et al. [19] AFE was performed with 
an interval of 24 hours. After 24 hours we found that most of the gastrointes-
tinal waste products have not reached their initial level so with this interval 
a substantial dilution of the gastrointestinal waste products in the AF may 
be realized. However an interval of 24 hours of AFE is not recommendable 
because of the invasiveness and side effects of the procedure. If, according 
to other studies, urea is responsible for the neural tissue damage, AFE will 
not be effective in reducing neural tissue damage because urea reaches the 
starting point concentration already within 24h in most of the cases. Data 
of biochemical analysis of the AF support the hypothesis that there is a fast 
turnover of AF in the third trimester [28,29].
As gestation proceeds, creatinine, urea and alkaline phosphatase show an 
increase in concentration in the AF towards term according to other studies 
[30-32]. The increase in creatinine, being more pronounced than that of urea, 
reflects of course the maturation of tubular function. By contrast, amylase, 
bile acids and GGT show a decrease in concentration in the AF.
In summary, our results indicate that the frequency of AFE of 1 week is too 
low to reduce neural tissue damage in fetal lambs with a surgically created 
spina bifida aperta. The fast turnover of the AF makes that urinary and gas-
trointestinal waste products, which supposed to be harmful for the unpro-
tected spinal cord tissue, will reach their normal concentration in the AF 
within 1 week after AFE.
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table 1. macroscopic and microscopic evaluation of lambs with 
a surgically created ntd without and with afe (l=lumbar 
level of the spinal cord). in group 1 (ntd without afe, n=6) and 
group 2 (ntd with afe, n=5), 3 and 2 lambs were available for 
macroscopic and microscopic evaluation respectively
Group Lamb
No.
Macroscopic
appearance
L
e
v
e
l
Microscopic appearance of the spinal cord
group 1 
NTD
without
AFE
1 no skin defect L1
L2
L3
L4
L5
posterior funiculi are missing
posterior funiculus and posterior horns are 
missing
posterior funiculi, posterior horn and 
central canal are missing, cyst formation
normal
normal
2 small skin 
defect
L1
L2
L3
L4
L5
normal
posterior funiculi slightly compressed
posterior funiculi compressed and 
asymmetrical with cyst formation
fused dura
normal
3 large cele
(50x15 mm)
L1
L2
L3
L4
L5
not evaluated
normal
fused posterior horn, posterior funiculi 
partly missing, dilated central canal
small remnant of the spinal cord fused 
with the dermis
split spinal cord with fused posterior 
funiculi and horns, dura is missing, 
inflammation in spinal cord and dermis
group 2 
NTD
with
AFE
1 no skin defect L1
L2
L3
L4
L5
central canal slightly closed
posterior funiculi compressed and almost 
absent with cyst formation
fused dura and abscess formation
normal
normal
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Group Lamb
No.
Macroscopic
appearance
L
e
v
e
l
Microscopic appearance of the spinal cord
2 large cele
(20x15 mm)
L1
L2
L3
L4
L5
not evaluated
normal
dura fused with subcutaneous tissue
dilated central canal, hydromyelia, 
inflammation in dermis
cyst formation in flattened anterior 
horn, syringo- and hydromyelia, dilated 
central canal, posterior horn fused with 
subcutaneous tissue
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Abstract
Introduction: To study the use of tissue engineering techniques for the treat-
ment of congenital birth defects in the pre- and postnatal period, several dif-
ferent sheep models are currently investigated. Several congenital defects 
were reconstructed in sheep models using collagen-based materials. Accord-
ing to the 3 R’s (replacement, refinement and reduction), adaptations to the 
protocols were made for the re-use (reduction) and refinement to improve 
animal welfare.
Materials and methods: Pregnant sheep underwent fetal surgery around 79 
days’ gestation. A neural tube defect, gastroschisis, bladder exstrophy or skin 
defect was created surgically in the fetal lamb and reconstructed with differ-
ent highly molecularly defined type 1 collagen scaffolds in the fetal or neona-
tal period.
Results: One hundred and seventy two surgical procedures were performed 
in 163 pregnant sheep divided over 12 different study protocols. The experi-
ment could be finished successfully in 65% of all cases. The overall fetal 
survival rate was 74% during the pregnancy period. There were 5 maternal 
deaths due to complications, most of them were due do abdominal wound 
dehiscence.
Discussion: The sheep model is a well suited large animal model to perform 
fetal interventions (e.g. to create congenital defects) and to study the use of 
collagenous scaffolds for the treatment of these severe defects. With refine-
ments of our study protocols, the number of animals used could be reduced 
and the welfare of the laboratory animal enhanced.
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Introduction
Treatment of congenital birth defects is still challenging. Outcomes are still 
disappointing in extreme difficult cases. Because therapy can have major 
implications for the quality of life, innovative techniques are developed in 
this field of healthcare. The use of a biological substitute, designed to main-
tain, restore or improve tissue function is one of the promising approaches to 
treat newborns with severe birth defects. Biocompatible and biodegradable 
scaffolds may serve as a template to guide the growth and organization of 
wound healing [1].
Different fetal sheep models have been developed and used to investigate 
tissue engineering techniques and new treatment options for congenital 
structural anomalies [2-15]. Our research group has used several sheep mod-
els to study the reconstructive and regenerative properties of different col-
lagen scaffolds with respect to improvement of the clinical outcome using 
intra uterine treatment [16-21]. Fetal sheep models for neural tube defect, 
gastroschisis and bladder exstrophy have been used to study whether tissue 
engineering techniques can improve the clinical and histological outcome 
after birth. Intrauterine covering of an experimental neural tube defect with a 
collagen scaffold can preserve the architecture of the spinal cord which con-
sequently leads to a better outcome [16-18,22]. Also, fetal bladder wall regen-
eration in bladder exstrophy and fetal abdominal wall tissue regeneration in 
gastroschisis using a collagen scaffold is feasible in animal models [19,20]. A 
fetal skin model was used to study the effects of collagen scaffolds with or 
without heparin and growth factors on the surrounding tissue and the for-
eign body reaction in a full-thickness skin defect [21]. For these experiments, 
animal models are indispensable since application in humans is not yet tech-
nically or ethically possible. 
In the past 10 years, 172 surgical procedures on fetal lambs were performed. 
Despite the promising results, these studies warrant further description of 
the biotechnical details on the sheep models. In this paper, we share our 
experience with the use of fetal sheep models, with respect to survival rate, 
surgery, biotechnical details, complications, refinements and reductions.
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Materials and methods
Approval from the Ethical Committee on Animal Research of the Radboud 
University Nijmegen Medical Centre (RUNMC), The Netherlands, was 
obtained for each study separately.
In total, 163 pregnant sheep (172 lambs) of Dutch Texel breed or a crossbred 
between Swifter breed and Texel breed of known gestational age underwent 
surgery at 79 days’ gestation (term, 140-147 days). The number of included 
animals per study is listed in table 1.
Fertility protocol. Sponging was performed in 2 ewes simultaneously. On day 
zero, ewes received intravaginal sponges containing medroxyprogesterone 
acetate (veramix, 60 mg, Pfizer, Capelle a/d IJssel, The Netherlands) for 12 
days followed by injection of 500 IU of pregnant mare serum gonadotropin 
(PMSG, folligonan, 500-750 IU subcutaneous, Intervet, Boxmeer, The Neth-
erlands) at sponge removal. Since dosage of PMSG is season dependent, 
500 IU was given during and 750 IU after regular breeding. A fertile ram was 
allowed with the ewe on day thirteen, one day after sponge removal. In this 
way, gestational age was exactly known at the time of operation.
Preoperative management. All collagen-based scaffolds were made by the 
Biochemistry Department, RUNMC, Nijmegen, The Netherlands. In the 
last studies, the experiment animal was accompanied during the transport 
from the farm to the animal laboratory and/or stay by a ‘buddy sheep’. Fresh 
grass and grass hay were withdrawn 48h and 16h before surgery respectively 
and ewes were weighed. In all studies, except the last, anesthesia was induced 
by an intravenous injection of pentobarbital (17-45 ml; 60 mg/ml, Faculty of 
Veterinary Medicine, Utrecht, The Netherlands) and atropine (0.5-1 ml; 0.5 
mg/ml, Pharma Chemie, Haarlem, The Netherlands). In the last study, ani-
mals were premedicated with an intravenous injection of propofol (5 mg/
kg, B. Braun, Melsungen, Germany). Following endotracheal intubation, the 
ewes were maintained on general anesthesia with 1.5-2% isoflurane (Nicho-
las Piramal, London, UK) and O2/N2O or, after the first study, O2/air venti-
lation. In the last study, flunixin (2 mg/kg, Schering Plough, Segre, France) 
and sufentanil (4 μg/kg, Janssen Cilag BV, Tilburg, The Netherlands) were 
given intravenously followed by a maintenance dosage sufentanil of 2 μg/kg/h 
for analgesia. Heart rate, temperature, oxygen saturation and carbon diox-
ide concentration in the expired air were monitored. Fetal anesthesia was 
achieved by transplacental passage of the medications, administered to the 
ewe.
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Intra operative management.
Due to the complexity of most procedures, surgery was performed on only 
one fetus in case of twin or triplet pregnancy except for the skin defect proto-
col in which surgery was performed on both fetuses in case of twin pregnan-
cy. For all protocols there were 3 surgeons who performed the operations, 
based on logistics. Concerning all experiments, 5 surgeons and 2 operating 
room assistants were involved. In all studies, surgery took place under asepti-
cally conditions. The abdominal wall was shaved, washed with soap and asep-
tically prepared and sterilely draped before a low midline laparotomy was 
performed (Fig. 1A, B and C). After palpation to determine the number and 
position of fetuses, the appropriate horn of the uterus was exteriorized and a 
hysterotomy was performed by opening the uterus diathermically parallel to 
the vasculature (Fig. 1D and E). Depending on the type of surgery, with mini-
mal handling of the fetus to prevent the formation of subcutaneous hemato-
ma, hindlimbs and back (neural tube defect, skin defect) or the abdominal 
wall (gastroschisis and bladder exstrophy (Fig. 1F)) was exposed through the 
uterine incision. The exteriorized uterine horn and fetus were wrapped in 
gauzes soaked with warm phosphate buffered saline (PBS). According to the 
type of protocol, the specific surgery was performed as described earlier [16-
21]. In the study on neural tube defects, a neural tube defect was created sur-
gically by excising skin and paraspinal muscles and soft tissue and performing 
a laminectomy of 3 lumbar vertebrae (L3-5) [16-18]. The dura was opened in 
the midline over the length of 3 vertebrae (Fig. 2A). The lesion was left uncov-
ered, covered with a collagen scaffold or closed by suturing the skin over the 
defect. In the first study, covering was performed immediately, in the sec-
ond study, coverage was delayed for two weeks. In the second study, in some 
groups also an endoscopy in the amniotic cavity was performed during the 
second procedure. In the third study, a neural tube defect was created, left 
uncovered and catheters were left in the amniotic cavity to perform amni-
otic fluid exchange during the remainder of pregnancy. In the gastroschisis 
study, an incision was made in the left lower quadrant of the fetal abdominal 
wall [20]. The bowel was exposed through this full-thickness abdominal wall 
defect and the lesion was left uncovered (Fig. 2C) or the bowel was manipu-
lated back into the abdominal cavity and covered by a collagen scaffold. In 
the bladder exstrophy study a vertical infra-umbilical median incision was 
made through the skin in female fetuses and a paramedian skin incision was 
made next to the urethra in male fetuses followed by a midline incision of 
the abdominal wall [19]. The bladder was exposed and an incision was made 
into the anterior bladder wall. In one group the edges of the bladder wall 
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were sutured to the abdominal wall resulting in an exstrophic bladder (Fig. 
2B). Depending on the protocol, the lesion was left uncovered or closed by 
placing a collagen scaffold into the bladder defect and closing the abdomi-
nal wall. Postnatal reconstruction of the bladder defect was performed in an 
additional protocol. In the skin protocol, three circular lesions were made on 
the back of the fetus by excising the skin [21]. The lesions were left uncovered 
or covered with different types of collagen scaffolds (Fig. 2D). Scaffolds were 
sutured to the surrounding tissues and, if necessary, marked with interrupted 
sutures (monocryl 6-0 and prolene 6-0, Ethicon, Norderstedt, Germany) 
[23]. After the surgical procedure, the fetus was replaced into the uterus and 
the amniotic fluid was restored with warm sterile PBS solution together with 
amoxicillin (250 mg, Centrafarm Services B.V., Etten-Leur, The Netherlands). 
The uterus was closed in two layers with a running 2-0 vicryl suture (poly-
glactin 910, Ethicon, Somerville, NJ, USA). Gestational membranes were 
closed with the uterine wall in the first layer. Sodium penicillin (1,000,000 
IU, Astellas Pharma, Leiderdorp,The Netherlands) was administered into the 
intra abdominal space. The abdominal wall and skin were closed in two lay-
ers using 1 vicryl interrupted sutures (polyglactin 910, Ethicon, Somerville, 
NJ, USA) in all, except the last protocol, or in three layers using EP6 Serafil 
(Serag-Wiessner, Naila, Germany) for the fascia, 2-0 vicryl for the subcutane-
ous tissue and 1 vicryl plus for the skin (skin protocol). Depomycin (20 mg/kg, 
subcutaneous, Intervet, Boxmeer, The Netherlands) was initiated preopera-
tively and maintained postoperatively for 3 or 5 days via intramuscular injec-
tions. In the last study the dosage was changed to 0.6 ml / 10kg and 1 ml / 10kg 
intramuscular, pre- and postoperative respectively.
Postoperative management.
To provide postoperative analgesia, buprenorphine (10 μg/kg, intravenous, 
Schering Plough, Segre, France) and flunixin (2 mg/kg, intramuscular) were 
given for three days in the last study on skin defects. In this study the ewes 
returned to the farm 1-2 hours after recovery accompanied by a ‘buddy sheep’ 
during their transport. In earlier studies, the animals stayed at the Central 
Animal Laboratory, RUNMC, Nijmegen, The Netherlands for 3-5 days. 
The surgical wound was sprayed every 2 days for 2 weeks with CTC spray 
(Eurovet Nederland, Bladel, The Netherlands) containing Chlortetracycline 
to prevent wound infection. Temperature, feeding behavior and wound con-
trol were monitored daily by the animal care takers from the Central Animal 
Laboratory and the farm. The animals stayed inside for several weeks (3-4 
weeks depending on the season) before going outside to the meadow (Fig. 3).
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Delivery and postnatal management.
In most studies cesarean delivery was performed under local anesthesia with 
lidocaïne (20-30 ml, 2% (v/v), subcutaneous and intramuscular, Fresenius 
Kabi, Bad Homburg, Germany). The ewes were euthanized as soon as the 
lambs were born.
In the latest study on bladder exstrophy, lambs were born vaginally. Parturi-
tion was induced at 140 days’ gestation with dexadreson (12-15 ml, intramus-
cular, Intervet, Boxmeer, The Netherlands) and trilostane (Vetoryl, 60 mg, 
oral, Janssen-Cilag GmbH, Tilburg, The Netherlands). Labor started 36-48 
hours later and was closely watched as the lambs were born a few days before 
term. The ewes were not sacrificed and gave breastfeeding during the first 
weeks.
For further evaluation, the newborn lambs were sacrificed immediately after 
birth or after one week depending on the protocol using medetomidine (0.5 
mg, intramuscular, Orion pharma, Espoo, Finland) and pentobarbital (60 
mg/kg, intracardial, AST Pharma, Oudewater, The Netherlands). In the stud-
ies on neural tube defects we performed also a functional surveillance of the 
lamb during one week besides a histological evaluation. In that period neuro-
logical tests were performed according to a standardized protocol. In the skin 
protocol, both ewes and fetal lambs were sacrificed at three time points (93, 
107 and 140 days’ gestation) using T61 (10 ml, intravenous; 5 ml, intracardial, 
Intervet, Boxmeer, The Netherlands).
Results
Outcomes for each study are summarized in table 1. In total, 172 surgical pro-
cedures were performed on fetal lambs divided over 12 different study pro-
tocols. Thirty seven sheep appeared to be not pregnant on ultrasonography 
prior to surgery and were excluded from the experiments. With our fertil-
ity protocol with intravaginal sponging we had a bearing incidence of 82% 
(163/200).
Miscarriage or stillbirth occurred in 44 cases. The overall fetal survival rate 
was 74% during the pregnancy period. Additional tests were performed con-
cerning infections with Brucella melitensis, Toxoplasmosis or Chlamydia, 
however no infections with these specific micro-organisms could be found 
as a leading cause for miscarriage. In the study on amniotic fluid exchange, in 
most cases the microbiological cultures of the aborted lambs were positive 
for Streptococcus, Staphylococcus, Escherichia coli or Candida.
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The experiment could be finished successfully in 65% of all experiments. 
Complications besides miscarriage or stillbirth are listed in table 2. In 22 
experiments (13%) the complication led to death of the ewe and/or the lamb. 
In 4 cases, abdominal wound dehiscence in the ewe occurred after the surgi-
cal procedure necessitating euthanasia of the ewe. One ewe needed to be 
sacrificed because of severe diarrhea and at autopsy, herniation of a bowel 
loop between the fascial sutures was found. All complications in the ewe 
could be related to the laparotomy scar and did not occur after improve-
ments of surgical technique. In the bladder exstrophy study with postnatal 
reconstruction, 4 experiments could not be finished because of a bowel her-
niation through the abdominal wall along the bladder exstrophy defect in 
the lamb. Three ewes delivered spontaneously before their planned cesarean 
section and the newborn lambs died immediately after birth. Four lambs died 
during or shortly after vaginal delivery. Postnatal cardiac failure, inflamma-
tion of the abdominal wall and a feeding problem of one lamb accounted for 
three postnatal deaths. One lamb died after the postnatal surgery of the blad-
der exstrophy. Inflammation, swelling of the wound and abdominal wound 
dehiscence with relaparotomy and survival of the ewes were seen as minor 
complications (n=5). One ewe delivered spontaneously which was unin-
tended, but the lamb survived. One lamb developed a bowel inflammation 
table 1. outcomes for each study
Numbers of operated fetal lambs are listed (n=172). Percentages are given in brackets 
and except for maternal death calculated as percentage of total procedures of oper-
ated lambs. Maternal death is calculated as percentage of total procedures of oper-
ated sheep (n=163) (NTD: neural tube defect, AFE: amniotic fluid exchange)
Experiment NTD
covering
NTD
AFE
Gastro
schisis
Bladder
exstrophy
Skin
defect
All
n (%) n (%) n (%) n (%) n (%) n (%)
Total procedures 44 11 27 64 26 172
Successful 
experiments
36 (82) 4 (36) 17 (63) 33 (52) 22 (85) 112 (65)
Fetal death 8 (18) 7 (64) 10 (37) 16 (25) 3 (12) 44 (26)
Maternal death 0 0 3 (11) 1 (2) 1 (6) 5 (3)
Complications 0 1 (9) 7 (26) 15 (23) 4 (15) 27 (16)
105reconstruction of congenital birth defects in fetal sheep models
without further consequence. In the skin defect protocol, a surgical proce-
dure was performed on both lambs in case of twin pregnancy in 9 of 17 ewes 
which means a reduction in the use of laboratory animals of 35%. Keeping the 
ewe alive after vaginal delivery to re-use it in following experiments means an 
additional reduction of 100%.
Details on functional and histological outcome of the different studies were 
described previously [16-21].
table 2. summary of complications in the ewe or in the lambs
Description n
Ewe Euthanasia of the ewe subsequent to abdominal wound dehiscence 4
(n=9) Death of the ewe due to herniation of a bowel loop between the 
fascial sutures
1
Inflammation of the abdominal laparotomy wound and uneventful 
recovery
1
Abdominal wound dehiscence with relaparotomy and uneventful 
recovery
2
Swelling of the laparotomy wound with relaparotomy and 
uneventful recovery
1
Lamb Death of the lamb due to bowel herniation along fetal bladder 
exstrophy defect
4
(n=18) Postnatal death due to preterm delivery 3
Death during birth 4
Postnatal death due to cardiac failure 1
Euthanasia of the lamb subsequent to postnatal inflammation of 
abdominal wall
1
Postnatal death after neonatal bladder exstrophy surgery 1
Postnatal death after 5 weeks due to a feeding problem 1
Euthanasia of the lamb subsequent to severe urogenital problems 1
Preterm labor and survival 1
Bowel inflammation 1
Total 27
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Discussion
This paper describes our experience with different sheep models for fetal 
surgery over the past 10 years. Sheep were chosen in these experiments for 
different reasons. The anatomy is comparable to the human fetus and has a 
translational fetal development. The size of the fetal lamb at 79 days’ gesta-
tion is comparable to the human fetus at 18-22 weeks’ gestation and is suf-
ficient to be suitable for complex fetal surgery [6]. Sheep are docile, tough 
and easy to handle [24]. During the experiment they can stay in their natural 
habitat. Because of the low rate of premature labor, no tocolytics are needed 
after intrauterine surgery. Myometrial contractions are present in pregnant 
sheep during fetal surgery but are suppressed by anesthesia. Inhalational 
agents provide uterine relaxation which allows handling of the uterus without 
contractions [25,26]. Anesthesia for the ewe is easy to induce and has a steady 
intra operative management without dangerously deep anesthetic levels 
and with a brief recovery period [24]. Complications due to anesthesia with 
this short duration of surgery did not occur within our studies. Additionally, 
there are a small number of fetuses present in each pregnancy and delivery 
induction is easy to control. Disadvantages of the use of sheep is the length 
of gestation (term, 140-147 days) which limits the number of experiments 
within a certain period of time and the experiments are expensive mainly 
due to the length of stay on the farm during the whole experiment and trans-
port to the animal laboratory. Sheep mask pain, which makes assessment 
of postoperative pain difficult. Also, complete food deprivation prior to sur-
gery is not possible. Several species (e.g. chicken, rat, rabbit, monkey, sheep) 
have been used to study the possible harmful effects of the intrauterine 
environment on congenital birth defects and the protective effect of fetal 
surgery [2,4,5,9,10,12,14,15,27-31]. Due to the many advantages, sheep are 
widely used as large animal model in experimental studies on fetal surgery. 
Of course, the surgically created defect is not completely comparable to 
the embryological defect in humans and the sheep model has its limitations, 
but it is reproducible and certainly valuable for testing treatment options 
such as new covering materials and techniques for fetal repair and fetal 
wound healing [3].
In total, 12 different studies with eight different surgical procedures have been 
performed, from which 172 fetal lambs and 163 ewes have been operated. 
Three studies on a neural tube defect, 2 of gastroschisis, 4 of bladder exstro-
phy and 3 on skin defects. After fetal surgery, 128 lambs survived pregnancy 
leading to an overall fetal survival of 74% which is consistent with the litera-
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ture in which survival is documented ranging from 25 to 100% with a mean of 
62% in all studies with fetal intervention [2,4,5,8-15].  
The following improvements were made to the protocols.
Fertility protocol. To enhance pregnancy rate, crossbred between Swifter 
breed and Texel breed was used since the end of 2008 instead of Dutch 
Texel breed. The Swifter originally, is a crossbred between the Texel and the 
Flemish breeds. One of the characteristics and advantages of this breed is 
the high fertility and the better birth characteristics. In addition, by allow-
ing the ram with the ewe on day thirteen instead of day fourteen, we try 
to improve pregnancy rate. In 2009, only one of the 28 sheep was not 
bearing (4% in comparison with 23% in 2008). In 2010, all 5 sheep were bear-
ing.
Housing, handling and transport. In the latest studies, the ewes arrived at the 
Central Animal Laboratory a few hours prior to surgery and returned to the 
farm 1-2 hours after recovery, in contrary to previous studies, in which the 
animals stayed at the laboratory (at 21°C) for 3-5 days. For the welfare of the 
sheep, housing at the laboratory should be minimized and the animals should 
go back to their familiar environment as soon as possible (day case surgery). 
Because sheep are herd animals, the experiment animal was accompanied 
during their transport and/or stay by a ‘buddy sheep’ to enhance welfare and 
reduce stress for the animal. The operated sheep are housed separately for 
at least 3 to 4 weeks, but as such that the sheep still have nose to nose con-
tact and can see and hear other sheep (Fig. 3A). The newborn lambs were 
housed with the mother for at least 1 or 2 months to reduce stress and to 
enable a proper follow-up of the operated sheep or lamb (Fig. 3B and C). The 
good condition of our bearing sheep, an uneventful postoperative course and 
the absence of feeding disorders are indicators of animal welfare in which 
the environment of the sheep plays an important role. Enhancement of wel-
fare reduces stress and consequently keeps the animals in a better condition 
which is particularly important for an uneventful postoperative recovery. In 
addition, animals in stress eat less causing a digestional disorder which is a 
problem for ruminants.
Food deprivation. Sheep without a starvation period form gasses in their 
stomach and subsequent bowel dilatation which can cause problems dur-
ing anesthesia and surgery. Because prolonged food deprivation of pregnant 
ewes will result in a negative energy balance which induces stress, the starva-
tion period was reduced to a maximum of 16h. With the current protocols 
the sheep only eat dry grass hay 48h before surgery. In all cases the sheep had 
free access to water.
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Anesthesia and analgesia. The methods of anesthesia and surgical proce-
dures in the mother sheep had minor adaptations throughout the different 
experiments but did not change essentially. In the last study, propofol was 
given instead of pentobarbital for general anesthesia and flunixin and sufen-
tanil to provide analgesia. Also buprenorphine and flunixin were given for 
three days to provide postoperative analgesia. Although probably the fetus 
perceives pain in a different way than in postnatal life, it is still necessary to 
provide analgesia and anesthesia to the fetus during fetal surgery [26,32]. 
Fetal analgesia for open fetal surgery is facilitated by maternal anesthesia. 
Lipophilic drugs, like isoflurane or propofol, can easily cross the placenta and 
in combination with opioids makes it suitable for combined mother/fetus 
anesthesia and are considered to provide adequate fetal anesthesia [33,34]. 
Studies in sheep suggests that the fetus requires a lower concentration of 
halothane to achieve the same level of anesthesia as the ewe does, so inha-
lational agents are considered to provide adequate fetal anesthesia [26,35]. 
After the neural tube defects studies, oxygen/nitrous oxide ventilation (O2/
N2O) was replaced by oxygen in air ventilation (O2/air) to prevent bloating of 
the stomach. 
Surgery. Number of fetal deaths was highest in the neural tube defect 
exchange study, mainly caused by the high rate of infection by bacteria prob-
ably introduced by the intrauterine catheters. For this reason, a subcuta-
neous port-a-cath system (Deltec, Inc., St.Paul, USA) was used instead of 
catheters for sampling and exchange in two sheep in which no infection 
occurred. In the gastroschisis study, 3 maternal deaths occurred caused by 
an abdominal wound dehiscence of the ewe for which it had to be sacrificed 
accounting for 3 of the fetal deaths. Abdominal wound dehiscence was the 
major complication leading to maternal death because in all cases the ewe 
needed to be sacrificed as part of animal welfare. Therefore, the protocol 
considering closure of the abdominal wall and skin was improved. Instead 
of closing in two layers using 1 vicryl interrupted sutures, abdominal wall and 
skin were closed in three layers using EP6 Serafil for the fascia, 2-0 vicryl for 
the subcutaneous tissue and 1 vicryl plus for the skin. After this improve-
ment, abdominal wound dehiscence with consequent euthanasia of the ewe 
was not seen since 2007. To prevent postoperative wound infection the sur-
gical wound was sprayed every 2 days for 2 weeks with CTC spray (Eurovet 
Nederland, Bladel, The Netherlands) containing Chlortetracycline. With 
this preventive measure we haven’t had any wound infection in the past two 
years.
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In the bladder exstrophy protocol, we changed to a running suture technique 
to close the edges of the fetal bladder instead of interrupted sutures to pre-
vent bowel herniation in the fetal lamb.
Delivery and postnatal care. In most studies, lambs were delivered by cesar-
ean section under local anesthesia and the ewes were euthanized as soon as 
the lambs were born. In the skin protocol, ewes and fetal lambs were sacri-
ficed together because a neonatal observational period of the lamb was not 
necessary and this method causes less inconvenience to the ewe. In the ear-
lier studies our aim was to deliver all ewes by cesarean section but 4 animals 
had a preterm vaginal delivery. Three of these lambs died immediately after 
birth due to prematurity. Considering this small number, it is not our experi-
ence that ewes who have undergone fetal surgery labor a few days before 
expected term. Lambs were delivered by cesarean section because it is more 
controllable than vaginal delivery. In this way each lamb was born at exactly 
140 days’ gestation. In addition, we were concerned that a normal delivery 
could damage our surgical defects and thereby would influence the outcome. 
As an alternative, lambs were born vaginally after induction of parturition 
in the latest studies. In this way, the ewe doesn’t have to be sacrificed and 
can be used in further studies. To prevent complications during delivery it 
is extremely important that delivery is closely observed by the animal care 
taker. After birth the mother sheep can give full attention and feed the new-
born lambs, which is particularly important for the lambs with a defect. New-
born lambs receive mother’s milk instead of bottle-feeding which also saves 
time for the animal care taker. In addition, we have positive experience with 
the re-use of earlier operated sheep for intrauterine surgery. This is also the 
case for the sibling, which has had no fetal surgery and can be used in further 
studies in later life. In this way, less laboratory animals are needed. Perform-
ing simple surgical procedures on both lambs in case of twin pregnancy (e.g. 
in the skin defect protocol) also contributed in reduction of the use of labo-
ratory animals. At this moment we’re developing an electronic registration 
for animal experiments similar as the digital patient file in hospitals. In this 
way all information about the animal, like surgical procedure, postoperative 
controls, food, medication and complications are kept in a central file which 
can be consulted by our researchers and animal care takers for information 
at any moment.
A summary of the most important improvements is listed in table 3.
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Conclusions. The sheep models as described are well suited large animal 
models to study the reconstructive and regenerative properties of collagen 
scaffolds and tissue engineering techniques and the outcome of fetal and 
neonatal therapy for severe congenital birth defects. Besides use of labora-
tory animals, our fetal surgery group is also developing alternatives to replace 
animal models to study the properties of collagen scaffolds. With growing 
experience over the past 10 years and with refinements of the protocols the 
table 3. summary of most important improvements with the 
results in the different protocols
Protocol Improvement (expected) results
Fertility Use of crossbred Swifter/Texel 
breed
Enhances fertility
96% pregnancy rate in 2009
Housing and 
transport
Minimize housing at the 
laboratory
Enhances welfare
Buddy sheep during transport Enhances welfare
Reduces stress
Housing of the newborns with 
the mother
Reduces stress
Mother’s milk instead of bottle 
feeding
Electronic registration for 
animal experiments
Enhances quality of animal 
studies
Food Reduction of the starvation 
period to 16h
Reduces stress
Anesthesia and 
analgesia
Postoperative analgesia Enhances welfare
Reduces stress
O2/air ventilation instead of 
O2/N2O
Prevents bloating of the 
stomach
Surgery Closure of the abdominal wall 
in three instead of two layers
Reduces abdominal wound 
dehiscence with almost 100%
Use of Chlortetracycline spray Reduces postoperative wound 
infection with almost 100%
Use of running suture to close 
the edges of the fetal bladder
Prevents bowel herniation
Delivery Vaginal delivery after induction 
instead of SC
Reduces the use of animals 
with almost 100%
Surgery on both lambs in case 
of twin pregnancy
Reduces the use of animals 
with 33%
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number of animals can be reduced to gather the same results and the welfare 
of animals can be enhanced.
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General discussion
Spina bifida is a devastating condition with a substantial lifelong morbidity. 
Periconceptional folic acid supplementation reduces the risk as well as the 
recurrence risk of having a child with a neural tube defect and remains cur-
rently the only treatment to prevent neural tube defects. The introduction of 
routine ultrasonography screening programs allows the early, prenatal diag-
nosis of spina bifida. Early reliable prenatal detection of spina bifida offers 
opportunities for fetal repair which may be a viable alternative for prospective 
parents to the standard options of pregnancy termination or expective man-
agement. The MOMS trial, a large randomized trial of prenatal versus post-
natal repair of spina bifida demonstrated that prenatal surgery for spina bifida 
reduced the need for a cerebrospinal fluid shunt and improved the degree of 
hindbrain herniation. Motor outcomes at 30 months were improved as com-
pared with postnatal surgery. However prenatal therapy was associated with 
maternal and fetal risks. Premature rupture of membranes and preterm labor 
remains the ‘Achilles heel’ of fetal intervention and limits its effectiveness.
From the results of this thesis we can conclude that creation of an experi-
mental neural tube defect in a chronic sheep model is feasible and long-term 
exposure of the unprotected spinal cord to the intrauterine environment can 
lead to damage of neural tissue and, consequently neurologic impairment. 
Coverage of the defect with a collagen scaffold can lead to a better neuro-
logic outcome and can preserve the architecture of the spinal cord. Our 
findings provide further support for the practice of fetal surgery to prevent 
the secondary acquired damage to the spinal cord and strongly support the 
potential of tissue engineered collagen based constructs. The sheep model is 
a well suited large animal model to perform fetal interventions and to study 
the reconstructive and regenerative properties of collagen scaffolds and tis-
sue engineering techniques for the intrauterine treatment of spina bifida. The 
collagen based scaffold used in this thesis offers good prospects for the use 
in fetal therapy.
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Now the MOMS trial is finished and the first positive results are published, 
we should answer the question whether the potential benefits of fetal repair 
outweigh the fetal and maternal risks associated with in utero intervention. 
The introduction of fetal surgery for spina bifida in clinical practice raises 
important ethical questions which need to be addressed. In maternal-fetal 
surgery there are two patients and mother and fetus often have conflict-
ing interests. Surgery for fetal therapy of spina bifida is also maternal sur-
gery and the most important considerations in weighing the risks versus the 
benefits is the safety of the mother, her ability to have other children in the 
future and the risks in subsequent pregnancies. The potential benefits of 
fetal therapy must outweigh the maternal risks but a favorable risk-benefit 
ratio both for the woman and the fetus is difficult to determine. Originally, 
because of the maternal risks, fetal surgery was limited to lethal congenital 
anomalies. Although spina bifida can be devastating and severely disabling, in 
general it is not-life-threatening. The major potential benefit of fetal therapy 
is improvement in neurological outcome which may increase the probabil-
ity of an independent life and this may justify fetal therapy. Especially when 
termination of pregnancy is no option for prospective parents, fetal surgery 
can be offered as a viable alternative instead of expective management until 
delivery.
Caution is necessary to start fetal therapy for spina bifida in many centers 
scattered around the world without making strict agreements. For years, fetal 
therapy for spina bifida in the US was only done in the three study centers. 
By diluting experience, fetal outcomes may not be as good as those in the 
MOMS trial and the maternal risks could be increased. The questions where 
these interventions should take place and by whom need to be addressed 
first. All involved maternal-fetal medicine specialists should have consensus 
about treatment and offering fetal therapy as an alternative to the patient 
before implementation. Fetal surgery should take place under strict condi-
tions and the inclusion criteria should be specified and described in a proto-
col.
Although most of the complications like preterm premature rupture of 
membranes and preterm delivery are associated with open fetal surgery, 
also the endoscopic approach with the current techniques demonstrated 
an increased risk of preterm delivery, probably related to the membranous 
damage. In the MOMS trial, fetal repair of spina bifida was performed rela-
tively late in gestation, after damage to the neural tissue probably has already 
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occurred. A less invasive and traumatic approach, applied earlier in gestation 
would theoretically increase the benefit and reduce the maternal and fetal 
risks. It should be emphasized that the positive outcomes of the MOMS trial 
cannot be simply translated to outcomes after endoscopic repair. Risks and 
benefits should also be evaluated in a randomized controlled trial comparing 
the current open approach to the endoscopic approach. Collagen based scaf-
folds offer good prospects for the use in endoscopic fetal therapy because 
they can be modulated and specially tailored to the needs of the endoscopic 
approach.
Future perspectives
Future studies should focus on early prenatal intervention with a minimally 
invasive approach and the use of tissue engineering techniques. Research 
should be done to develop smaller endoscopic instruments to reduce the 
risk of preterm delivery due to membranous damage. Smaller endoscopic 
instruments put high demands on the coverage materials. Future studies on 
collagen scaffolds should focus on those scaffolds which are eligible for appli-
cation through an endoscope with a small diameter. Anticipating the endo-
scopic approach, the use of an easy applicable and biocompatible sealant to 
secure a scaffold to the defect should be taken into consideration to simplify 
and shorten the procedure.
Our study on skin defects demonstrated a beneficial effect of the use of scaf-
folds loaded with growth factors on fetal wound healing and incorporation 
of the scaffold in the surrounding tissue. The use of an advanced scaffold for 
fetal repair of spina bifida should also be evaluated in future animal studies. 
Postnatal follow up for 3 to 6 months is necessary to study the formation of 
adhesions and consequently tethered cord syndrome. Optimal concentra-
tion in which these growth factors need to be used still has to be established. 
Also the effects of growth factors other than VEGF and FGF2 can be evalu-
ated.
Due to their reparative function and their role in the regenerative process, 
stem cells have emerged as a potential therapeutic modality for several dis-
eases. Intrauterine coverage of spina bifida prevents further damage to the 
spinal cord but the spinal cord remains dysplastic. The hypothesis that the 
use of cell-seeded scaffolds or the application of stem cells to the site of the 
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defect as an adjuvant to fetal repair may promote regeneration of the dys-
plastic spinal cord and their role in fetal repair of spina bifida should be fur-
ther evaluated.
Which collagen based scaffold has the best qualities to be used in fetal repair 
of spina bifida is still under evaluation in our studies. After the final conclu-
sion, future studies should be directed to the use of a collagen based scaffold 
in a clinical trial and the application of tissue-engineered constructs in the 
human fetus.
121summary
Summary
Spina bifida results from failure of closure of the neural tube (neurulation) 
during early embryonic life and is one of the most common neural tube 
defects with a worldwide incidence of 1 in 2,000 live births. It is one of the 
most handicapping nonlethal congenital birth defects in humans, almost 
always leading to various problems with the lower extremities, bowel and 
bladder dysfunction, deformation of the lower extremities and back, sexual 
dysfunction, impaired mental development, hindbrain herniation and hydro-
cephalus. Children born with spina bifida suffer from lifelong disabilities and 
supportive care is often needed.
Improving folate status by folic acid supplementation reduces the risk as well 
as the recurrence risk of NTDs and periconceptional folic acid use should 
be encouraged. Advances in prenatal diagnosis and the use of routine ultra-
sonography screening programs now permit diagnosis of spina bifida as early 
as the first trimester. Early diagnosis makes spina bifida eligible for prenatal 
intervention and besides the choices of termination of pregnancy or expec-
tive management, fetal therapy can be seen as a third option for expectant 
parents. The rationale for in utero repair is the ‘two-hit’ hypothesis. Failure 
of primary neurulation in the embryonic period leads to the development of 
myelodysplasia (first-hit) and subsequently, the persistent exposure of the 
unprotected spinal cord to the intrauterine environment (e.g. amniotic fluid) 
can lead to secondary acquired destruction of neural tissue (second-hit) 
which may be prevented by in utero coverage of the defect.
From 2003 through December 2010, fetal surgery of spina bifida in humans 
was practiced in the USA in the three participating centers of the MOMS 
trial (Management of Myelomeningocele Study) in a randomized controlled 
trial comparing the two approaches of the treatment of children with spina 
bifida; fetal surgery and postnatal surgery. The long-expected results from 
this study were published in 2011. Prenatal surgery for spina bifida reduced 
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the need for shunting and improved motor outcomes at 30 months as com-
pared with postnatal surgery. 
Minimal access fetal surgery of spina bifida or coverage of larger defects 
requires the use of a degradable patch. Tissue engineering techniques have 
allowed the development of a scaffold, that can be used early in gestation 
in a minimally invasive approach. A biocompatible and biodegradable colla-
gen scaffold offers good prospects for in utero coverage of a spina bifida and 
can protect the spinal cord against the intrauterine environment to prevent 
further neurological damage. The advantage of using such a tailor-made col-
lagen scaffold is that with modulation of the matrix structure and the applica-
tion of growth factors, cell attraction from the surrounding fetal tissue and 
wound healing can be enhanced. 
Fetal therapy places the mother at risks for intraoperative complications and 
premature labor remains the ‘Achilles heel’ of open fetal surgery. Therefore, 
a less invasive approach is desirable. In addition, with an early endoscopic 
approach, damage to the spinal cord may be further prevented earlier in ges-
tation to maximize preservation of neural tissue.
In this thesis, the development of an animal model is described, to study 
the use of tissue engineering techniques for the fetal treatment of spina 
bifida. The use of an advanced collagen matrix, loaded with growth factors, 
to improve fetal wound healing was evaluated. The feasibility of minimally 
invasive approaches, like endoscopy and amniotic fluid exchange for fetal 
therapy, was studied. 
This thesis contains the following chapters:
In chapter 1, the epidemiology, etiology, clinical outcome, prenatal diagno-
sis and current postnatal treatment of spina bifida is described. The rationale 
for in utero repair and the tissue engineering approach is discussed.
In chapter 2 we evaluated whether acute intrauterine coverage of an experi-
mental, surgically created, neural tube defect in fetal lambs could protect 
neural tissue from secondary injury during gestation and save neurologic 
functions after birth. We created a neural tube defect in fetal lambs at 79 days’ 
gestation and covered it with either a molecular defined collagen-based bio-
compatible and biodegradable scaffold, a small intestinal submucosa (SIS) 
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biomatrix (Cook®) or by closing the skin over the defect. The outcome was 
compared to leaving the defect exposed to the intrauterine environment. All 
lambs with the defect covered were unimpaired while four of five neurologi-
cally examined lambs with the defect uncovered showed major neurologic 
impairment after birth. The results of this study demonstrated that creation 
of an experimental neural tube defect in a chronic sheep model is feasible 
and that long-term exposure of the open spinal cord to the intrauterine envi-
ronment can lead to damage of neural tissue (second-hit) and, consequently, 
neurologic impairment. Acute coverage of the defect can lead to a better 
neurologic outcome. Both the collagen-based scaffold and the small intesti-
nal submucosa biomatrix seem to be useful for in utero coverage of a surgi-
cally created neural tube defect in a sheep model.
In chapter 3, the histological outcome of the study described in chapter 
2 is assessed. The effect on the neural tissue of intrauterine coverage of an 
experimental neural tube defect in fetal lambs with two different biomatrices 
and the incorporation of the biomatrix in the surrounding tissues was deter-
mined. The outcome was compared to covering of the defect with skin or 
leaving the defect exposed to the intrauterine environment. All lambs with 
the defect uncovered showed histological abnormalities of the spinal cord 
without either signs of direct trauma attributable to the operation itself or 
recent trauma due to contact with the uterine wall nor signs of an inflamma-
tory reaction. In lambs with the neural tube defect covered, one half showed 
a normal architecture of the spinal cord while minor histological damage was 
present in the other half. Between the three groups in which the defect was 
covered (collagen-based scaffold, a small intestinal submucosa (SIS) bioma-
trix (Cook®) or skin), the histological outcome was comparable. This study 
demonstrated that acute coverage of an experimental neural tube defect in 
fetal lambs prevents severe histological damage to the spinal cord and pre-
serves the architecture of the spinal cord, independent of the two biomatri-
ces used in this study. Long-term exposure of an unprotected spinal cord to 
the intrauterine environment can lead to severe damage of the spinal cord 
(second hit).
In chapter 4 we evaluated whether the collagen scaffold, used in the previ-
ous studies, is useful for delayed in utero repair of a surgically created spina 
bifida in the fetal lamb and can protect the spinal cord from secondary injury. 
Instead of acute coverage, delayed repair was done for a better simulation 
of the natural course of spina bifida. Endoscopy in this study was performed 
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to achieve experience with the procedure in the sheep model and to study 
whether in utero endoscopic coverage is possible. In fetal lambs a spina 
bifida was created surgically at 72 or 79 days’ gestation. The defect was cov-
ered with a collagen scaffold 2 weeks later or left uncovered. None of the 
surviving lambs with the defect covered showed loss of spinal function and 
the architecture of the spinal cord was preserved in 4 of the 5 lambs. Four of 
five lambs with the defect uncovered showed disturbance of the architecture. 
Due to technical difficulties with the endoscopic approach it was concluded 
that this model was less suitable to study the in utero endoscopic coverage 
of spina bifida. Collagen scaffolds can be used for delayed in utero covering 
of an experimental spina bifida and coverage preserves the architecture of 
the spinal cord. A major difference in neurological outcome between the 2 
groups could not be demonstrated.
In chapter 5 was investigated whether a collagen scaffold loaded with 
growth factors can be used to treat full-thickness fetal skin defects. Although 
most covered defects in our earlier studies were closed after birth, wound 
healing was not optimal. When collagen scaffolds are loaded with growth 
factors, angiogenesis and cellular infiltration are stimulated and conse-
quently this may lead to an improved supply of oxygen and nutrients, which 
is particularly important when scaffolds of wider diameter are used. It was 
hypothesized that the pro-angiogenic growth factors VEGF and FGF2 might 
enhance vascularization and epithelialization, leading to improved wound 
healing. The study was performed to evaluate the biochemical properties 
of the collagen scaffold and the effects on fetal wound healing and for this 
reason only a fetal skin defect in a fetal sheep model was made. Three cir-
cular full-thickness skin defects were made on the back of fetal lambs at 79 
days’ gestation. Two lesions were covered with either a collagen scaffold or a 
collagen-heparin scaffold with VEGF and FGF2. One lesion was left uncov-
ered. We evaluated fetal wound healing and closure of full-thickness wounds. 
All uncovered defects showed healing with scar formation and contraction. 
Compared to wounds treated with bare collagen scaffolds, wounds treated 
with growth factor-loaded scaffolds showed excessive formation of capil-
laries and less myofibroblasts, leading to less contraction. Interestingly, new 
appendages in the wounds treated with a collagen-heparin scaffold with 
VEGF and FGF2 were formed, 8 weeks after surgery. This study demon-
strated that collagen scaffolds can be used to treat fetal skin defects and that 
the combination of collagen scaffolds with VEGF and FGF2 had a beneficial 
effect on wound healing.
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In chapter 6, the effect of amniotic fluid exchange on the concentrations 
of waste products in the amniotic fluid and the histological outcome in fetal 
sheep with a surgically created neural tube defect was evaluated. It is believed 
that both urinary waste products and gastrointestinal waste products are 
associated with neurotoxic effects on neural tissue. We hypothesized that 
amniotic fluid exchange is a minimally invasive approach that might prevent 
in utero neural tissue damage. The concentrations of urinary and gastroin-
testinal waste products in the amniotic fluid before and after exchange were 
measured. An experimental neural tube defect was created in fetal lambs 
and left uncovered. In one group only samples of amniotic fluid were col-
lected at a regular interval and analyzed for assay of waste products. In the 
other group also amniotic fluid exchange was performed. Urinary and gas-
trointestinal waste product concentrations in the amniotic fluid return to 
normal within one week after amniotic fluid exchange. From these results 
we concluded that a frequency of amniotic fluid exchange of one week is too 
low to prevent neural tissue damage. In both groups, all lambs showed major 
histological abnormalities of the spinal cord and a reduction of neural tissue 
damage could not be demonstrated. Since the study groups were very small, 
no definite conclusions can be drawn from the histological evaluations. How-
ever, this study indicates that in utero coverage is a more realistic approach of 
fetal therapy of spina bifida than amniotic fluid exchange.
In chapter 7, an overview is provided of the animal models (pregnant sheep 
and fetal lamb) which we developed in the past 10 years to study fetal sur-
gery and the use of tissue engineering techniques for the treatment of con-
genital birth defects (spina bifida, gastroschisis, bladder exstrophy) and an 
experimental skin defect, in the pre- and postnatal period. Since application 
of a collagen scaffold in humans is not technically or ethically possible at this 
moment, animal models are indispensable. According to the 3 R’s (replace-
ment, refinement and reduction), adaptations to the protocols were made for 
re-use (reduction) and refinement to improve animal welfare. One hundred 
and seventy two surgical procedures were performed in fetal lambs divided 
over 12 different study protocols. The overall fetal survival rate was 74% dur-
ing the pregnancy period and the experiment could be finished successfully 
in 65% of all the cases. From our experience we concluded that the sheep 
model is a well suited large animal model to perform fetal interventions and 
to study the reconstructive and regenerative properties of collagen scaffolds 
and tissue engineering techniques for the treatment of severe congenital 
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birth defects. With the achieved experience over the past 10 years and with 
refinements of the protocols, the number of animals can be reduced and the 
welfare of the laboratory animal be enhanced.
In chapter 8, a general discussion and future perspectives are given. With 
this thesis we provide further evidence for the ‘two-hit’ hypothesis of spina 
bifida. Intrauterine coverage of the defect with a collagen scaffold preserves 
the architecture of the spinal cord and the incorporation of growth factors 
has a beneficial effect on fetal wound healing.
Future studies on fetal repair of spina bifida should focus on minimally inva-
sive techniques applied early in pregnancy, with the use of tissue engineering 
techniques. Ethical issues concerning fetal therapy for spina bifida and the 
use of tissue engineering techniques in the human fetus are discussed.
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Samenvatting
Een spina bifida is een sluitingsdefect van de neuraalbuis en is een van de 
meest voorkomende aangeboren afwijkingen van het centrale zenuwstelsel. 
De afwijking ontstaat al vroeg in de zwangerschap tijdens de embryonale 
periode. De wereldwijde incidentie bedraagt 1 op de 2000 levendgeborenen. 
Spina bifida is een van de meest invaliderende, niet-letale aangeboren afwij-
kingen en kan aanleiding geven tot verlammingsverschijnselen en sensibili-
teitsstoornissen van de onderste extremiteiten, disfunctioneren van darm en 
blaas, vergroeiingen van de benen en de rug, sexuele functiestoornissen, ver-
standelijke handicaps, hydrocephalus en een inklemming van de kleine herse-
nen en hersenstam (Chiari II malformatie). Door de handicaps zijn patiënten 
vaak levenslang afhankelijk van medische en sociale zorg en ondersteuning.
Periconceptioneel gebruik van foliumzuur verlaagt zowel het risico als het 
herhalingsrisico op neuraalbuisdefecten en het gebruik in de periconcep-
tionele fase moet worden aangemoedigd. Verbeteringen in de prenatale 
screening en diagnostiek en de invoering van het structureel echoscopisch 
onderzoek bij iedere zwangere vrouw, maken een vroege diagnose mogelijk, 
soms zelfs al in het eerste trimester. Een vroegtijdige diagnose van spina bifida 
biedt naast de keuzes van afbreking van de zwangerschap of een expectatief 
beleid, de mogelijkheid van foetale interventie om de uitkomst van kinderen, 
geboren met een spina bifida, te verbeteren. De ratio achter de toepassing 
van intra-uteriene behandeling van spina bifida is de zogenaamde ‘two-hit’ 
hypothese. Door een sluitingsdefect in de neuraalbuis is het ruggenmerg niet 
goed aangelegd en wordt niet beschermd door bot en omliggende weefsels. 
Het zenuwweefsel staat ten gevolge hiervan blootgesteld aan de toxische 
en mechanische schadelijke invloeden van het intra-uteriene milieu zoals 
het vruchtwater. Deze schadelijke invloeden kunnen leiden tot verdere 
be schadiging van een, in aanleg al, afwijkend ruggenmerg. De ‘first-hit’ is 
de embryonale stoornis waarbij er een dysplastisch ruggenmerg gevormd 
wordt. De intra-uterien verworden, secundaire schade wordt de ‘second-hit’ 
genoemd.
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Van 2003 tot december 2010 werd foetale behandeling van spina bifida in de 
Verenigde Staten verricht in de drie deelnemende centra aan de “MOMS 
trial” (Management Of Myelomeningocele Study), een gerandomiseerde 
multicenter studie waarbij de uitkomsten na foetale behandeling vergeleken 
werden met de uitkomsten na standaard postnatale behandeling. De lang-
verwachte uitkomsten van deze studie werden gepubliceerd in 2011. De resul-
taten laten een daling zien van het aantal plaatsingen van een shunt voor de 
behandeling van hydrocephalus na de geboorte na foetale behandeling en 
een verbetering van de motoriek op de leeftijd van 30 maanden in vergelij-
king met postnatale behandeling. 
Foetale behandeling van grote defecten of een endoscopische benadering 
maakt het gebruik van een biologisch afbreekbare patch als afdekmateriaal 
wenselijk. Door gebruik te maken van weefseltechnologie wordt het mogelijk 
om een matrix te ontwikkelen die vroeg in de zwangerschap op een minimaal 
invasieve manier aangebracht kan worden. Een biocompatibele en biologisch 
afbreekbare collageenmatrix is goed toepasbaar bij het prenataal bedekken 
van een spina bifida en beschermt het zenuwweefsel tegen de intra-uteriene 
omgeving om verdere neurologische schade te voorkomen. Een van de voor-
delen van de toepassing van een collageenmatrix is, dat door aanpassing van 
de driedimensionale structuur en het aanbrengen van groeifactoren, het aan-
trekken van cellen uit het omliggende weefsel en wondgenezing kan worden 
bevorderd.
Foetale behandeling stelt de zwangere vrouw bloot aan intra-operatieve 
complicaties en het risico op vroeggeboorte blijft het grootste probleem van 
open foetale chirurgie waarbij een hysterotomie wordt verricht. Een mini-
maal invasieve ingreep, zoals een endoscopische benadering zou daarom de 
voorkeur hebben. Een endoscopische behandeling zou verder als voordeel 
hebben dat deze in een vroeger stadium in de zwangerschap verricht kan 
worden waardoor secundaire schade aan het ruggenmerg door de intra-ute-
riene omgeving eerder voorkomen kan worden.
In dit proefschrift wordt de ontwikkeling van een diermodel beschreven om 
de toepassing van weefseltechnologie bij de foetale behandeling van spina 
bifida te kunnen onderzoeken. Door gebruik te maken van een geavanceerde 
collageenmatrix met groeifactoren werd onderzocht of de foetale wondge-
nezing kan worden verbeterd. Minimaal invasieve benaderingen zoals, endo-
scopie en vruchtwaterwisselingen, werden geëvalueerd op hun toepasbaar-
heid in de foetale therapie.
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Het proefschrift is onderverdeeld in de volgende hoofdstukken:
 
In hoofdstuk 1 wordt een overzicht gegeven van de epidemiologie, etiolo-
gie, symptomatologie, prenatale diagnostiek en huidige postnatale behande-
ling van spina bifida. De foetale behandeling van spina bifida en de toepassing 
van weefseltechnologie wordt besproken.
In hoofdstuk 2 worden de resultaten beschreven van een studie waarin 
werd onderzocht of directe intra-uteriene bedekking van een experimenteel, 
chirurgisch aangelegde spina bifida in het foetale lam het neurale weefsel kan 
beschermen tegen de secundaire schade van de intra-uteriene omgeving en 
normale neurologische functies na de geboorte behouden kunnen worden. 
In het foetale lam werd bij 79 dagen zwangerschapsduur een neuraalbuis 
defect gemaakt en gesloten met, een moleculair gedefinieerde, biocompa-
tibele en biologisch afbreekbare collageenmatrix, een SIS matrix (vervaar-
digd uit dunne darm submucosa, Cook®) of met het sluiten van de huid over 
het defect. Alle lammeren waarbij het defect tijdens de zwangerschap werd 
gesloten lieten geen neurologische uitval zien terwijl vier van de vijf neuro-
logisch onderzochte lammeren met een niet afgedekt defect ernstige neuro-
logische afwijkingen hadden na de geboorte. De resultaten van deze studie 
laten zien dat het aanleggen van een experimenteel neuraalbuisdefect in een 
chronisch schapenmodel mogelijk is en dat langdurige blootstelling van het 
niet afgedekte ruggenmerg aan de intra-uteriene omgeving kan leiden tot 
schade aan het zenuwweefsel (de zogenaamde ‘second-hit’) wat neurologi-
sche uitval tot gevolg heeft. Directe sluiting van het defect geeft een betere 
neurologische uitkomst. Zowel de collageenmatrix als de SIS matrix zijn bei-
den bruikbaar voor het intra-uterien sluiten van een chirurgisch aangelegd 
neuraalbuis defect in een schapenmodel.
In hoofdstuk 3 worden de histologische uitkomsten beschreven van de 
studie genoemd in hoofdstuk 2. De effecten op het zenuwweefsel na het 
intra-uterien bedekken van een experimenteel neuraalbuis defect met twee 
verschillende matrices en de incorporatie in het omliggende weefsel werden 
onderzocht in het foetale lam. De uitkomsten werden vergeleken met lam-
meren waarbij primair de huid over het defect werd gesloten en lammeren 
waarbij het defect onbedekt werd gelaten. Alle lammeren waarbij het defect 
niet werd afgedekt laten histologische afwijkingen zien van het ruggenmerg. 
Er zijn geen aanwijzingen van direct trauma veroorzaakt door de operatie 
zelf of door contact met de wand van de uterus, of tekenen van een ontste-
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kingsreactie. In lammeren waarbij het defect werd afgedekt liet de helft een 
normale architectuur van het ruggenmerg zien. In de andere helft werden 
geringe histologische veranderingen gevonden. Tussen de drie verschillende 
groepen onderling (collageenmatrix, SIS matrix en huid), was de histologi-
sche uitkomst vergelijkbaar. Deze uitkomsten laten zien dat het direct bedek-
ken van een experimenteel neuraalbuis defect in het foetale lam, ernstige his-
tologische schade aan het ruggenmerg kan voorkomen en de architectuur 
van het ruggenmerg kan behouden. Langdurige blootstelling van het niet 
afgedekte zenuwweefsel aan de intra-uteriene omgeving kan leiden tot ern-
stige schade van het ruggenmerg. De uitkomsten zijn onafhankelijk van de 
gebruikte matrix.
In hoofdstuk 4 wordt een studie beschreven waarin werd onderzocht of de 
eerder gebruikte collageenmatrix ook bruikbaar is voor het afdekken van een 
chirurgisch gecreëerde spina bifida in het foetale lam, twee weken nadat het 
is aangelegd, en het ruggenmerg kan beschermen tegen secundaire schade. In 
tegenstelling tot de eerdere studies waarbij het defect direct tijdens dezelfde 
ingreep werd aangelegd, werd hier gekozen voor het twee weken later afdek-
ken van de laesie om het natuurlijke beloop van een spina bifida beter te simu-
leren. In deze studie werd tevens gebruik gemaakt van een endoscopische 
benadering om ervaring op te doen met de procedure en te onderzoeken, 
of het aanbrengen van een matrix via de endoscopische weg mogelijk is. In 
het foetale lam werd chirurgisch een spina bifida aangelegd bij 72 of 79 dagen 
zwangerschapsduur. Het defect werd twee weken later gesloten met een col-
lageenmatrix of onbedekt gelaten. Geen van de overlevende lammeren met 
een gesloten defect liet verlies van neurologische functies zien en de archi-
tectuur van het ruggenmerg bleef behouden in 4 van de 5 lammeren. Vier 
van de vijf lammeren met het niet afgedekte defect, lieten veranderingen zien 
van de architectuur van het ruggenmerg. Hieruit kon geconcludeerd worden 
dat een collageenmatrix ook bruikbaar is voor het afdekken van een chirur-
gisch gecreëerde spina bifida twee weken na het aanleggen van het defect. 
Na afdekken blijft de architectuur van het ruggenmerg behouden. Een groot 
verschil in neurologische uitkomst tussen de twee groepen kon niet worden 
aangetoond. Door de moeilijkheden met de endoscopische benadering in 
deze studie, kon geconcludeerd worden dat dit model minder geschikt is om 
onderzoek te doen naar het endoscopisch bedekken van het defect.
In hoofdstuk 5 wordt een studie beschreven waarin de toepasbaarheid 
werd onderzocht van het intra-uterien behandelen van een huiddefect met 
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een collageenmatrix beladen met groeifactoren. Bij de eerder beschreven 
studies waarin defecten intra-uterien werden bedekt met een collageenma-
trix zonder groeifactoren, bleek de huid gesloten te zijn bij de geboorte maar 
het wondgenezingsproces was niet optimaal. Wanneer een collageenmatrix 
beladen wordt met groeifactoren, wordt de angiogenese en cellulaire infil-
tratie bevorderd. Dit heeft een positief effect of de aanvoer van zuurstof en 
voedingsstoffen wat vooral van belang is wanneer een matrix met een gro-
tere diameter wordt gebruikt. De hypothese dat de pro-angiogene groeifac-
toren VEGF en FGF2, wondgenezing zouden kunnen verbeteren door hun 
stimulerende effect op vascularisatie en epithelisatie werd in deze studie 
onderzocht. In deze studie werd alleen gekeken naar de biochemische eigen-
schappen van de collageenmatrix en de effecten op de foetale wondgenezing 
en om die reden werd het onderzoek beperkt tot het aanleggen van alleen 
een huiddefect. Bij een zwangerschapsduur van 79 dagen werden drie circu-
laire defecten aangelegd in de volledige huidlaag op de rug bij het foetale 
lam. Twee van de drie defecten werden gesloten. Eén met een collageen-
matrix zonder en één met een collageen-heparine matrix met de groeifac-
toren VEGF en FGF2. Het derde defect werd niet gesloten. Wondgenezing 
en sluiting van de wond werden geëvalueerd. Alle defecten die niet werden 
gesloten lieten wondgenezing met littekenformatie en contractie zien. In ver-
gelijking met de defecten met een collageenmatrix, werd in de defecten met 
een collageen-heparine matrix met groeifactoren, uitgebreide nieuwvorming 
van capillairen gevonden en waren er minder myofibroblasten aanwezig en 
dientengevolge minder contractie. In de defecten die werden gesloten met 
een collageen-heparine matrix met groeifactoren werden, 8 weken na chi-
rurgie, zelfs nieuwe huidappendices gevonden. De resultaten laten zien dat 
een collageenmatrix toepasbaar is bij het sluiten van een foetaal huiddefect 
en dat een collageenmatrix beladen met de groeifactoren VEGF en FGF2 een 
positief effect op de wondgenezing laat zien.
In hoofdstuk 6 wordt een studie beschreven waarin het effect van vrucht-
waterwisselingen op de concentratie van uitscheidingsproducten in het 
vruchtwater en op de histologische uitkomst van een chirurgisch aangeleg-
de spina bifida in het foetale lam werd onderzocht. De in het vruchtwater 
aanwezige, urinaire en gastro-intestinale uitscheidingsproducten hebben 
mogelijk een neurotoxisch effect op het zenuwweefsel bij spina bifida. Onze 
hypothese is dat vruchtwaterwisseling als minimaal invasieve benadering, 
intra-uteriene schade aan het ruggenmerg bij spina bifida kan voorkomen. 
Hiervoor werd chirurgisch een neuraalbuis defect aangelegd in foetale lam-
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meren wat niet werd afgedekt. De concentraties van de urinaire en gastro-
intestinale uitscheidingsproducten in het vruchtwater werden gemeten 
voor en na wisseling. In één groep werden op regelmatige tijdstippen alleen 
monsters genomen van het vruchtwater en geanalyseerd op de aanwezigheid 
van uitscheidingsproducten. In de andere groep vond ook wisseling van het 
vruchtwater plaats. Concentraties van urinaire en gastro-intestinale uitschei-
dingsproducten in het vruchtwater keerden binnen een week terug naar hun 
normaalwaarden, waaruit geconcludeerd kon worden dat een frequentie van 
vruchtwaterwisselingen van één week te laag is om schade aan het zenuw-
weefsel te voorkomen. In beide groepen werden bij alle lammeren ernstige 
histologische afwijkingen aan het ruggenmerg gevonden en kon schade aan 
het ruggenmerg niet worden voorkomen door het wisselen van vruchtwater. 
Beide studiegroepen zijn echter te klein in aantal om definitieve conclusies te 
trekken uit de histologische uitkomsten. Deze studie laat echter wel zien dat 
het intra-uterien bedekken een realistischer vorm van foetale behandeling 
van spina bifida is dan vruchtwaterwisseling.
In hoofdstuk 7 wordt een overzicht gegeven van alle diermodellen (drach-
tig schaap en foetale lam) die wij in de afgelopen 10 jaar hebben ontwikkeld 
om foetale chirurgie en de toepassing van weefseltechnologie bij de behan-
deling van aangeboren afwijkingen (spina bifida, gastroschisis, blaasexstrofie) 
en een experimenteel huiddefect in de pre- en postnatale periode te onder-
zoeken. Onderzoek van deze technologie en de toepassing van een collageen 
matrix blijft vooralsnog noodzakelijk in diermodellen omdat toepassing in 
mensen technisch en ethisch gezien nog niet mogelijk is. Met als uitgangs-
punt de 3V’s voor dierproeven (vervanging, vermindering en verfijning) zijn 
de protocollen de afgelopen jaren aangepast, in het bijzonder op het gebied 
van hergebruik van proefdieren en bevordering van het welzijn.
In totaal zijn er 172 chirurgische procedures verricht in foetale lammeren ver-
deeld over 12 verschillende onderzoeksprotocollen. De foetale overleving tot 
aan de geboorte bedroeg 74%. Vijfenzestig procent van alle experimenten 
kon succesvol worden afgerond. Vanuit deze ervaringen kunnen wij conclu-
deren dat het schapenmodel een zeer geschikt, groot diermodel is om foetale 
interventies op uit te voeren en de reconstructieve en regeneratieve moge-
lijkheden van een collageenmatrix voor de behandeling van aangeboren 
afwijkingen te onderzoeken. Met onze ervaring die we hebben opgedaan in 
de afgelopen 10 jaar en met verfijning van de onderzoeksprotocollen hebben 
wij het gebruik van proefdieren in onze studies kunnen verminderen en het 
welzijn voor de proefdieren kunnen verhogen.
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In hoofdstuk 8 worden een algemene discussie beschreven en perspectie-
ven voor de toekomst genoemd. De uitkomsten van dit proefschrift geven 
een verder bewijs voor het bestaan van de ‘two-hit’ hypothese bij spina bifida. 
Intra-uterien afdekken van het defect met een collageenmatrix geeft behoud 
van de architectuur van het ruggenmerg en de toevoeging van groeifactoren 
aan de collageenmatrix kan de wondgenezing verbeteren. Toekomstig onder-
zoek naar de foetale behandeling van spina bifida dient zich te richten op een 
minimaal invasieve benadering, vroeg in de zwangerschap, daarbij gebruik 
makend van weefseltechnologie. De ethische vraagstukken met betrekking 
tot foetale therapie bij spina bifida en de toepassing van weefseltechnologie 
bij de humane foetus worden besproken. 
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Abbreviations
ABC Avidine-biotine complex
AEC 3-amino-5-ethylcarbazole 
AF Amniotic fluid
AFE Amniotic fluid exchange
CM Chiari II malformation
COL Collagen scaffold
COL-HEP/VF Collagen scaffold loaded with VEGF and FGF2
CSF Cerebrospinal fluid
DAB Diaminobenzidine
ECM Extracellular matrix
EDC 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide
EuroSTEC  Integrated project on ‘Soft tissue engineering for congenital 
birth defects in children’
EVG Elastin Van Gieson
FBR Foreign body reaction
FGF2 Basic fibroblast growth factor
GGT Gamma-glutamyltransferase
HE Hematoxylin/eosin
HGF Hepatocyte growth factor
IGF Insulin-like growth factor
MES 2-morpholinoethane sulfonic acid 
MMC Myelomeningocele
MOMS Management Of Myelomeningocele Study
NHS N-hydroxysuccinimide 
NTD Neural tube defect
NTDs Neural tube defects
PBS Phosphate buffered saline
PMSG Pregnant mare serum gonadotropin
RR Relative risk
RU-DEC  Local Ethics Committee on Animal Research of the 
Radboud University Nijmegen
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RUNMC Radboud University Nijmegen Medical Centre
SB Spina bifida
SBA Spina bifida aperta
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SEM Scanning electron microscopy
SIS Small intestinal submucosa
TE Tissue engineering
UMC University Medical Centre Nijmegen
VEGF Vascular endothelial growth factor
α-SMA α-smooth muscle actin
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Dankwoord
Dit proefschrift heb ik met veel plezier geschreven. Ik heb bijzonder onder-
zoek kunnen doen samen met bijzondere mensen met wie ik mijn enthousi-
asme voor het onderwerp heb mogen delen. Mijn promotie heb ik mede te 
danken aan de hulp, motivatie, stimulans en het enthousiasme van de vele 
mensen met wie ik in de afgelopen jaren heb samengewerkt. 
Mijn dank gaat uiteraard uit naar al die mensen die op hun manier een bijdra-
ge hebben geleverd aan het tot stand komen van dit proefschrift. Een aantal 
van hen wil ik graag in het bijzonder noemen en danken.
Wout Feitz. Beste Wout. Ik heb met ontzettend veel plezier met je samen- 
gewerkt en ik ben je dankbaar dat je mijn eerste promotor wilde zijn. Jouw 
doorzettingsvermogen, je positieve houding en je enthousiasme hebben 
altijd een enorme stimulerende werking gehad. Aan elk commentaar van een 
reviewer wist je altijd een positieve draai te geven. Typen, typen, typen en 
het komt altijd weer goed. Door deze positieve, rustige en stimulerende hou-
ding, je heldere visie en je conflict oplossende vermogen ben je een groot 
voorbeeld voor je onderzoekers en je collega’s.
Paul van den Berg. Beste Paul. Jij was acht jaar geleden degene die mij vroeg 
of ik promovendus wilde worden in jullie projectgroep. Die stap heeft heel 
veel voor mij betekend. Naast het prachtige onderzoek dat ik in de afgelopen 
jaren heb mogen doen, heeft het uiteindelijk ook mijn klinische richting be-
paald. Door de IFMSS congressen (International Fetal Medicine and Surgery 
Society) hebben we in de loop der jaren heel wat uithoeken van de wereld 
gezien. Veel dank voor de prettige samenwerking, zowel in de kliniek als bin-
nen onze onderzoeksgroep, en voor de gezellige momenten op onze con-
gresreizen.
Fred Lotgering. Beste Fred. Ik heb in de afgelopen periode veel van je mogen 
leren. Ik kon er altijd op vertrouwen dat je elk manuscript tot op de punten 
en de komma’s had gelezen en heb veel gehad aan je kritische suggesties. 
Ook in de kliniek heb ik dankbaar gebruik kunnen maken van jouw jaren- 
lange ervaring in de verloskunde. Uiteraard kon ik je Rotterdamse achter-
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grond wel waarderen. Veel dank voor de fijne samenwerking in de afgelopen 
jaren.
Toin van Kuppevelt. Beste Toin. Waar ik zorgde voor de relevante klinische 
vraagstelling, gaf jij de aanvulling vanuit de hoek van de tissue engineering. 
Dank voor deze bijzondere samenwerking in de afgelopen jaren.
Paul Geutjes. Beste Paul. Als de manager van onze onderzoeksgroep heb je 
alles op een perfecte manier geregeld. Wetenschappelijk hadden we een to-
taal verschillende achtergrond, maar dat maakte onze samenwerking zo bij-
zonder. Op die manier hebben we veel van elkaar kunnen leren. Ik heb met 
veel plezier, en niet te vergeten ook veel humor, met je samengewerkt en de 
vele uren op het CDL met je doorgebracht. Veel dank voor deze fijne samen-
werking en voor het feit dat je alles voor de projectgroep in de afgelopen 
periode zo goed hebt geregeld.
René Wijnen. Beste René. We hebben de afgelopen jaren op het CDL veel 
operaties samen mogen doen en ik heb veel van jouw vaardigheden kunnen 
leren. Nu onze wegen weer samen zijn gekomen in Rotterdam, hoop ik de 
plezierige samenwerking te kunnen voortzetten.
Luc Roelofs. Beste Luc. Als copromovendi hebben we in de beginfase van 
ons onderzoek vele uren samen op het CDL doorgebracht. Altijd met de no-
dige humor én het nodige cynisme. Veel dank voor de leuke samenwerking. Ik 
hoop voor jou dat je ook spoedig je promotieonderzoek kunt gaan afronden. 
Laat dit een mooie stimulans voor je zijn.
Jane Crevels. Beste Jane. Wat zijn schapenexperimenten in Nijmegen eigen-
lijk zonder jou? Door jouw decennialange ervaring op het dierenlab is je naam 
onlosmakelijk verbonden met het CDL. Door de jarenlange samenwerking 
en de vele operaties die we samen deden heb ik enorm veel van je geleerd 
over schapen. Iedere vrijdag stond je weer voor de experimenten klaar, ook in 
de vrieskou op de boerderij, waarbij ik weleens dacht: wat doe ik hier toch als 
gynaecoloog te midden van de schapen? De eerste Ahopamak bijeenkomst 
bij jou in de tuin blijft voor mij een mooie herinnering. Dank voor de vele 
uren samenwerking en gezelligheid.
Alex Hanssen, Conrad van den Broek, Jeroen Mooren, Maikel School en 
alle andere betrokken medewerkers van het CDL. Zonder jullie voorberei-
dingen, assistentie en de liefdevolle verzorging voor onze schapen was al dit 
onderzoek niet mogelijk geweest, waarvoor veel dank. Dat ik met veel plezier 
terugdenk aan al die uren op het CDL komt mede door de ontspannen en 
gezellige sfeer die er heerste. Alex Hanssen, ik kan mij eigenlijk niet herinne-
ren dat ik ooit een operatie heb verricht zonder jou. Jouw toewijding voor de 
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dieren en de betrokkenheid bij onze projectgroep in de afgelopen jaren zijn 
met recht bijzonder te noemen.
De afdeling Verloskunde en Gynaecologie van het Universitair Medisch Cen-
trum St Radboud. Al mijn collega’s wil ik graag danken voor de leerzame pe-
riode en de goede samenwerking. De afdeling ben ik veel dank verschuldigd 
voor de mogelijkheid die zij mij gaf om promotieonderzoek te verrichten. 
Een bijzonder woord van dank gaat uit naar mijn collega’s van de Verloskun-
de voor de mogelijkheid die zij mij hebben geboden om al die jaren naast de 
klinische taken mijn onderzoek te blijven doen, en vooral ook voor de tijd 
die ik heb gekregen in de afrondingsfase. Ik zal met veel plezier terugdenken 
aan onze samenwerking en aan de gezellige momenten die we samen hebben 
gehad.
De afdeling Verloskunde en Gynaecologie van het Erasmus MC te Rotter-
dam. Mijn collega’s wil ik bedanken voor de mogelijkheid die zij mij gaven 
om mijn onderzoek in Nijmegen af te ronden. Ik hoop met jullie een mooie 
tijd tegemoet te gaan. Mede dankzij jullie voelde ik mij alweer snel thuis in 
Rotterdam.
Merel Ritskes-Hoitinga, Jan Deprest en Michèl Willemsen. De leden van 
de manuscriptcommissie wil ik graag danken voor het doornemen en goed-
keuren van het manuscript. Jan, bedankt voor de plezierige samenwerking 
in de afgelopen jaren. Jouw betrokkenheid en het feit dat je altijd bereikbaar 
voor me was heb ik zeer gewaardeerd. Ik hoop dat we onze samenwerking 
de komende jaren op deze goede manier kunnen voortzetten. Michèl, ik heb 
enorm leuk met je samengewerkt in de afgelopen jaren. Vooral de zorg die we 
samen op ons namen voor onze patiënten en je scherpe, vaak ook kritische 
visie zal ik enorm missen.
Martin Lammens, Willeke Blokx en Kiek Verrijp. Dank voor het verwerken en 
de histologische beoordeling van al onze preparaten. Jullie hebben hiermee 
een belangrijke bijdrage aan onze studies geleverd.
Willem Agema en Kees IJsselstein. Mijn paranimfen. Logisch natuurlijk dat 
ik jullie op deze belangrijke dag aan mijn zijde heb staan. Als beste vrienden 
hebben we in de afgelopen 26 jaar al zoveel avonturen beleefd dat ik dit grote 
avontuur graag ook met jullie wil delen. We zullen samen nog vaak genoeg 
terugkijken op deze bijzondere gebeurtenis en ik hoop nog veel plezier met 
jullie te beleven.
Lieve ouders. Ik ben jullie onuitsprekelijk dankbaar dat jullie mij de moge-
lijkheden hebben geboden die ervoor hebben gezorgd dat ik dit nu bereikt 
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heb. Jullie hebben mijn werk en mijn onderzoek altijd nauwlettend gevolgd 
en hadden altijd weer goede kritische vragen. Ik wil jullie bedanken voor alle 
zorg, liefde en steun die ik heel mijn leven van jullie heb mogen ontvangen.
Lieve Hanneke en Mariken.  Jullie dank ik voor jullie niet aflatende betrokken-
heid bij mijn onderzoek in de afgelopen jaren. Eindelijk hebben jullie nu het 
antwoord in handen op de vraag: ‘hoe staat het met je proefschrift ?’
Lieve Eva Maria. Naast echtgenote was je ook nog eens de eerste kritische 
reviewer van al mijn artikelen. Dat is altijd een grote steun voor mij geweest. 
Uiteraard is de tijdsinvestering een negatieve keerzijde van het promoveren 
voor het gezinsleven. Vooral in de afrondende fase heb ik heel wat zondagen 
achter mijn computer moeten doorbrengen. Dank daarom voor al je geduld 
en je lieve steun in de afgelopen jaren.
Lieve Carolien. Het boek over de ’zieke schaapjes‘ is nu af. Kunnen we heerlijk 
op de zondagen weer andere leuke dingen gaan doen.
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chapter 1
fig. 1.  Features of neural tube development and neural tube defects.
Panel A shows a cross section of the rostral end of the embryo at approximately 
three weeks after conception, showing the neural groove in the process of closing, 
overlying the notochord. The neural folds are the rising margins of the neural 
tube, topped by the neural crest, and demarcate the neural groove centrally.
Panel B shows a cross section of the middle portion of the embryo after the 
neural tube has closed. The neural tube, which will ultimately develop into the 
spinal cord, is now covered by surface ectoderm (later, the skin). The intervening 
mesoderm will form the bony spine. The notochord is regressing.
Panel C shows the developmental and clinical features of the main types of 
neural-tube defects. The diagram in the center is a dorsal view of a developing 
embryo, showing a neural tube that is closed in the center but still open at the 
cranial and caudal ends. The dotted lines marked A and B refer to the cross 
sections shown in Panels A and B. Shaded bars point to the region of the neural 
tube relevant to each defect. In anencephaly, the absence of the brain and 
calvaria can be total or partial. Craniorachischisis is characterized by anencephaly 
accompanied by a contiguous bony defect of the spine and exposure of neural 
tissue. In open spina bifida, a bony defect of the posterior vertebral arches (in 
this case, the lower thoracic vertebrae) is accompanied by herniation of neural 
tissue and meninges and is not covered by skin. In iniencephaly, dysraphia in the 
occipital region is accompanied by severe retroflexion of the neck and trunk. In 
encephalocele, the brain and meninges herniate through a defect in the calvaria. 
In closed spina bifida, unlike open spina bifida, the bony defect of the posterior 
vertebral arches (in this case, the lumbar vertebrae), the herniated meninges, and 
neural tissue are covered by skin. Figure reproduced with permission from The 
New England Journal of Medicine [7].
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fig. 2.  Lateral view of the spinal cord in three types of spina bifida.
Spina bifida occulta occurs most often at S1, S2, or both and is a bony defect of 
the spine, usually covered by normal skin. A meningocele is a saccular herniation 
of meninges and cerebrospinal fluid through a bony defect of the spine. 
Meningoceles are usually covered by normal skin. A myelomeningocele is the 
most common type of spina bifida and is characterized by herniation of the spinal 
cord, nerves, or both through a bony defect of the spine. Myelomeningoceles are 
usually open defects in which either meninges or neural tissue is exposed to the 
environment. Of these three types, only meningocele and myelomeningocele 
are typically included in studies of spina bifida and are often jointly referred to 
as spina bifida cystica. The spinal cord and nerves are depicted in yellow and the 
cerebrospinal fluid is in black. Figure reproduced with permission from The New 
England Journal of Medicine [7].
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fig. 1.  Sham control with skin lesions. The lesion on the right side is covered 
with the  SIS biomatrix (A), the left side is covered with the UMC biomatrix (C) 
and the lesion in the middle remains uncovered (B).
fig. 2.  Surgically created neural tube defect.
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fig. 3. Neonatal lamb with surgically created neural tube defect.
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fig. 2. Cross-section (HE staining) of the normal spinal cord of a 
sham-operated control. D = Dorsal horn; V = ventral horn.
fig. 3. Cross-section (HE staining) of an uncovered neural tube defect 
(group 2) showing hydromyelia of the central canal (C). The normal 
architecture of the spinal cord is largely preserved.
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fig. 4. Cross-sections (HE staining) of an uncovered neural tube defect 
(group 2) showing central sagittal splitting of the spinal cord with severe 
damage of the dorsal columns and horns (D). There is widening of the 
posterior fissure (F), the dorsal horn has been split and has merged 
with the skin. The architecture of the ventral horn (V) has been better 
preserved.
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fig. 5. Cross-section (HE staining) of the dorsal part of the exposed spinal 
cord of an uncovered neural tube defect (group 2) showing destruction of 
the normal architecture with flattening of the spinal cord and the formation 
of a meningomyelocele. V = Ventral horn; M = meningomyelocele.
fig. 6. Cross-sections (HE staining) of the dermis and subcutaneous tissues 
covering the spinal cord in a lamb with the neural tube defect covered with 
an UMC biomatrix (I) and an SIS biomatrix (III). Pictures II and IV are detailed 
views ( x 100) of the rectangles in picture I and III ( x 12.5), respectively. 
Remnants of the biomatrices can be found just beneath the dermis in the 
subcutaneous tissues (between the arrows). Ingrowth of fibroblasts is visible  
in the detailed views. The scar tissue covering the defect contains no adnexes 
of the skin. B = Remnants of the biomatrix; D = dermis; S = spinal cord.
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fig. 2. Cross-section of the skin (S) covering the spinal cord in a lamb with 
the spina bifida covered with a collagen biomatrix (group 1). The architecture 
of the spinal cord is preserved. Small remnants of the biomatrix (B) can be 
found in the subcutaneous tissues. Luxol fastblue-HE. x25.
fig. 3. Cross-section of the spinal cord in a lamb with the spina bifida not 
covered (group 2). There is a clear abnormal architecture of the neural 
tissue. The spinal cord is separated and the dorsal horns (D) are merged 
with the skin (S). HE. x25.
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fig. 4. Cross-section of the dermis and subcutaneous tissues of a sham-operated 
control lamb (group 3). Remnants of the biomatrix (B) can be found just beneath 
the skin (S) in the subcutaneous tissues. Ingrowth of fibroblasts is visible in the 
detailed view. Immunohistochemical staining. x50, insert x200.
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fig. 1. Scanning electron microscopical images of collagen scaffolds cross-
linked in the absence (top row) or presence of heparin (bottom row) (A). 
Shown are the top view, bottom view and cross-section. The more closed 
pan side was implanted such that it was in contact with the amniotic fluid. 
Immunolocalisation of heparin, VEGF and FGF2 in the COL-HEP/VF scaffolds 
(B). Note that heparin and FGF2 were evenly distributed through the scaffold, 
while VEGF was mainly found at the edge of the scaffold.
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fig. 2. Macroscopical overview of wound healing after surgery at 93 days’ (2 weeks 
post surgery), 107 days’ (4 weeks post surgery) and 140 days’ gestation (term) (A). 
Note the shape of contraction of the untreated lesion and the reddish appearance 
of the wound treated with COL-HEP/VF. Percentage of wound contraction (B). At 
2 and 4 weeks post surgery less contraction was present in COL treated wounds 
compared to untreated wounds. At all time points less contraction was present 
in COL-HEP/VF treated wounds compared to untreated wounds. * significant 
difference between untreated and COL or COL-HEP/VF (p < 0.05). # significant 
difference between COL and COL-HEP/VF treated (p < 0.05).
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fig. 3. Masson’s trichrome staining of skin defects at different time points. 
Untreated defect at 2 weeks (A), 4 weeks (D) and 8 weeks (G). Defect treated with 
COL at 2 weeks (B), 4 weeks (E) and 8 weeks (H). Defect treated with COL-HEP/
VF at 2 weeks (C), 4 weeks (F) and 8 weeks (I). The black striped line indicates the 
edge of the defect; the black dotted line indicates the border between surrounding 
tissue and the scaffold.  E = epidermis, D = dermis, S = scaffold. The boxed 
areas denote the corresponding region of higher magnification images. Original 
magnifications: x50 (A–I) and x200 (A1-I1).
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fig. 5. Myofibroblasts. α-SMA staining of skin defects at different time points. 
Untreated defect at 2 weeks (A), 4 weeks (D) and 8 weeks (G). Defect treated 
with COL at 2 weeks (B), 4 weeks (E) and 8 weeks (H). Defect treated with  
COL-HEP/VF at 2 weeks (C), 4 weeks (F) and 8 weeks (I). Original magnifica- 
tions: x50 (A–I).
fig. 4. Epithelialization. Cytokeratin staining of skin defects at different time points. 
Untreated defect at 2 weeks (A), 4 weeks (D) and 8 weeks (G). Defect treated with 
COL at 2 weeks (B), 4 weeks (E) and 8 weeks (H). Defect treated with COL-HEP/VF 
at 2 weeks (C), 4 weeks (F) and 8 weeks (I). Original magnifications: x50 (A–I).
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fig. 6. Vascularization. Collagen IV staining of skin defects at different time 
points.  Defect treated with COL at 4 weeks (A) and 8 weeks (C). Defect treated 
with COL-HEP/VF at 4 weeks (B) and 8 weeks (D). The boxed areas denote the 
corresponding region of higher magnification images. Original magnifications: 
x50 (A–E) and x200 (A1-E1).
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fig. 1. Surgically created neural tube defect.
Skin, paraspinal muscles and soft tissue has been excised. Laminectomy is 
performed of 3 lumbar vertebrae (L). The spinal cord is exposed (S).
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fig. 2. Cross-sections of the spinal cord in a lamb with a NTD (group 1, fig. 2a and 
b) and with a NTD and AFE (group 2, fig. 2c and d).
At lumbar level 2 in fig. 2a there is a clear abnormal architecture of the neural 
tissue; the posterior funiculi and horns are missing. At lumbar level 4 in fig. 2b the 
spinal anatomy is grossly normal. At lumbar level 5 in fig. 2c, cyst formation in a 
flattened anterior horn, syringomyelia, hydromyelia and a dilated central canal are 
seen. The posterior horns are fused with the subcutaneous tissue. At lumbar level 
2 the anatomy is normal (D: dorsal side, S: spinal cord). HE-Luxol fast blue (fig. 2a 
and b), HE (fig. 2c and d). x25.
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fig. 3. Concentration of biochemical constituents in AF of urea (top) and 
creatinine, amylase, alkaline phosphatase, gamma-glutamyltransferase and 
bile acids (bottom) before and after AFE at 4 time points with 350, 300, 
180 and 120 ml warm sterile physiologic saline solution (0.9%) respectively. 
Y-axis indicates the concentration of waste products (urea in mmol/l, creat: 
creatinine in μmol/l, amyl: amylase in U/l, alk.P: alkaline phosphatase in U/l, 
GGT: gamma-glutamyltransferase in U/l, bi ac: bile acids in μmol/l). X-axis 
indicates the time in hours after first sample. Urinary waste products: dotted 
lines, gastrointestinal waste products: not interrupted lines. Arrows indicate 
the first sample 1 hour after AFE.
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fig. 1. Overview of intra operative management of the pregnant ewe and the fetal 
lamb (79 days’ gestation). The abdominal wall was shaved, washed with soap, 
aseptically prepared and sterilely draped before a low midline laparotomy was 
performed (A, B and C). The appropriate horn of the uterus was exteriorized 
and a hysterotomy was performed (D and E). The fetus was exposed through the 
uterine incision (F).
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fig. 2. Overview of different surgical procedures in fetal sheep (79 days’ 
gestation). Fig. 2A. Neural tube defect. After excising skin, paraspinal muscles 
and soft tissue, a laminectomy was performed and the dura was opened. The 
exposed spinal cord is visible [16-18]. Fig. 2B. Bladder exstrophy. After opening 
of the abdominal wall and making an incision in the anterior bladder wall, the 
edges of the bladder wall were sutured to the abdominal wall resulting in an 
exstrophic bladder [19]. Fig. 2C. Gastroschisis. After making an incision in the left 
lower quadrant of the fetal abdominal wall the bowel was exposed through this 
full-thickness abdominal wall defect [20]. Fig. 2D. Skin defects. Three circular 
lesions were made on the back of the fetus by excising the skin. One lesion was 
left uncovered (superior) and two lesions were covered with a collagen scaffold 
(inferior) [21].
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fig. 3. Images of the refined housing conditions of the operated sheep 
and lambs at the farm of the Central Animal Facility, Radboud University 
Nijmegen Medical Centre, Nijmegen, The Netherlands. Separately housed 
pregnant sheep after fetal operation (A). After normal delivery, sheep are 
housed with lambs for proper care (B). After 1 to 2 months, sheep and lambs 
are housed in herds and enjoy the open field (C).
